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SUMMARY
The aspartic  proteinases are members of a family of enzymes, the 
c a ta ly t ic  a c t iv i t y  of which depends on the presence of two aspartic  
residues in the active s i te .  This thesis concerns four members of th is  
group - pepsin, gas tr ics in , cathepsin D and slow moving protease (SMP). 
The defining charac te r is t ics , nomenclature and general biochemistry of 
the aspartic  proteinases are reviewed in Chapter 1 and an attempt is  
made to c la r i f y  the various systems which have been used to c lass ify  
th is  group of enzymes. Assay and p u r if ic a t io n  methods, the structure  
and mechanism of action of the enzymes and th e i r  immunological 
properties are outlined. Pure supplies of these enzymes are not 
commercially available  and Chapter 2 describes the method by which these 
were obtained and how anti sera were developed. The anti sera are used to 
show that cathepsin D and SMP, previously thought to be id e n t ic a l,  are 
separate enzymes. In Chapter 3 the immunohistochemical methods are 
introduced and th e ir  use in determining the d is tr ib u t io n  of the above 
enzymes in normal gastroduodenal mucosa is described, at both l ig h t  and 
electron microscopic le v e l .  I t  is  shown that pepsinogen is mainly 
confined to the gastric body, while progastricsin co-localises with 
pepsinogen but is also present in the gastric  antrum and duodenum. 
Cathepsin D is demonstrated in parieta l c e l ls ,  in gastric  antral glands 
and ce lls  in the lamina propria, while SMP is  demonstrated mainly in the 
surface epithelium of the stomach. These studies raise the general 
problem of the e ffects  d iffusion  may have on the lo c a lis a t io n  of tissue 
antigens. This problem appears not to have been widely discussed in the 
l i t e r a tu r e  and is dealt with in Chapter 4, in which d iffus ion  was 
studied by immunolocalisation of pepsinogen and progastricsin in 
autolysing gastric  mucosa and confirmed experimentally by 
immunolabelling of antigens introduced in to  various normal tissues.
Enzyme a c t iv i ty  at low pH has long been recognised in seminal 
f lu id .  In Chapter 5 th is  is shown to be due to the presence of 
g as tr ics in ,  apparently identica l to that in normal gastric  ju ic e .  The 
zymogen, progastricsin , was localised to the acinar c e l ls  of the 
prostate, which appear to secrete and presumably synthesise i t .  In 
Chapter 6 , the d is tr ib u t io n  of aspartic  proteinases in normal tissues 
apart from stomach, duodenum and prostate is discussed. No evidence of 
pepsinogen or progastricsin was found in other tissues, while cathepsin 
D appears widely d is tributed  both in macrophages and in e p ith e l ia l  
c e l ls .  SMP appears to be confined to the surface membrane or c i l i a  of a 
few tissues, such as chorionic v i l l i  and resp ira tory  epithelium , but i ts  
presence even in these tissues could be derived from the red blood 
c e l ls ,  on the membranes of which i t  is demonstrated. Studies on the 
d is tr ib u t io n  of the aspartic proteinases are extended to the fe ta l  
stomach in Chapter 7, where i t  is shown that SMP is  the dominant enzyme 
from 12 weeks gestation onwards, while progastricsin becomes prominent 
by about 17 weeks, when pepsinogen and cathepsin D also appear. Some 
attempt is  made to re la te  the order of th e i r  appearance to the molecular 
evolution of aspartic  proteinases.
The rest of the thesis deals with the presence and d is tr ib u tio n  of 
the aspartic proteinases in neoplastic t issues. In Chapter 8 , i t  is  
shown that gastr ic  carcinomas produce aspartic  proteinases, namely 
cathepsin D (100%), SMP (50%), progastricsin (30%) and pepsinogen (6%). 
There appears to  be no re la t io n  to prognosis and both in te s tin a l  and 
diffuse  types of carcinoma contain aspartic proteinases. In Chapter 9, 
the studies which showed progastricsin in normal prostatic  epithelium, 
described in Chapter 5, are extended to carcinomas, up to 40% of which 
produce progastricsin . Progastricsin co-localises with acid phosphatase 
but is ,  however, less widely d is tr ib u ted . In Chapter 10 the 
d is tr ib u tio n  of aspartic proteinases in non-gastric tumours is
described. While pepsinogen is highly specific  to gastr ic  carcinomas, 
progastricsin occasionally occurs in tumours of some other s i te s ,  
especia lly  pancreas, while cathepsin D is found in almost a l l  tumours 
studied. SMP appears to be present in certa in  tumours, mainly kidney.
In Chapter 11, progastricsin is more f u l ly  studied in metastatic
/
tumours, f i r s t l y  in local lymph node secondaries near primary gastric  
carcinomas and secondly in deposits fu rther  a f ie ld ,  both in lymph node 
and l i v e r ,  from a range of primaries in d if fe re n t  s i te s .  I t  is shown 
th a t  in most cases the presence of progastricsin in a lymph node 
metastasis of adenocarcinoma indicates a primary in the stomach or in  
pancreas but tha t  occasionally metastases from other s ites contain 
progastricsin . While progastricsin was commonly found in l iv e r  
metastases, the corre la t ion  with a primary in stomach did not reach 
s ta t is t ic a l  s ign ificance. These results  could be useful to the 
diagnostic histopathologist in determining the primary s i te  from which a 
given metastasis has orig inated. The f in a l  discussion (Chapter 12) 
incorporates recent evidence tha t the pol gene of the HIV I virus 
codes fo r  an aspartic  proteinase and that re tro v ira l  proteinase a c t iv i ty  
is inh ib ited  by the aspartic  proteinase in h ib ito r ,  pepstatin. Knowledge 
of the d is tr ib u t io n  of the aspartic proteinases might therefore be 
relevant to  possible treatment of AIDS with aspartic  proteinase 
in h ib ito rs .
PREFACE
The work described in th is  thesis began as an attempt to use 
immunohistochemical methods to id e n t ify  the primary s i te  of a given 
metastatic deposit of malignant tumour. Various enzymes, including  
pepsin, which was thought might be specif ic  to stomach, were in jected  
in to  rabb its . Pig pepsin yielded antiserum which gave strong lab e llin g  
of human gastr ic  mucosa by the peroxidase-anti peroxidase (PAP) method 
and which was used in a study of a series of gastr ic  carcinomas. 
Although a small number of tumours were pos it ive , the purity  of the 
anti serum was open to some doubt. With the biochemical advice of Dr.
J. Kay, C a rd if f ,  with whom much collaborative  work was subsequently 
undertaken, commercial pig pepsinogen was p urif ied  to homogeneity and 
used to block immune la b e l l in g  by antipepsin, the s p e c if ic i ty  of which 
was thereby proven. Continued scepticism about staining of parieta l  
c e l ls  led to fu r th e r  work on d iffus ion  of antigen (Chapter 4 ) .  I t  
became clear th a t  the gastric  mucosa and ju ic e  contained other important 
enzymes, of which gastrics in  and slow-moving protease (SMP) might also 
prove useful as markers of gastr ic  carcinoma. I n i t i a l  attempts were 
made to purify  progastricsin from seminal f lu id  but our supply of 
gastrics in  was obtained as a g i f t .  Antisera to  gastrics in  were raised 
and used in studies of gastric  carcinoma and lymph node metastases. 
Subsequent studies on gastricsin  in the benign prostate were extended to 
prostatic  carcinoma. During th is  work the staining rack, described in 
Chapter 3, was devised. Attempts were made to purify  SMP from fe ta l  
stomach but, as some d i f f i c u l t y  was encountered, a ttention  was turned to 
another member of the aspartic  proteinase fam ily , cathepsin D, which was 
then thought to be possibly identical to SMP. In C a rd if f ,  under the 
supervision of Dr. J. Kay, M. J. V a l le r  and I p u rif ied  cathepsin D from 
human spleen, obtaining the most homogeneous form of the enzyme then
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av a ila b le .  Rabbit antiserum to cathepsin D was then raised and the 
d is tr ib u t io n  of the enzyme within human tissues was determined. 
Cathepsin D was also demonstrated in a var ie ty  of tumours, including 
gastr ic  carcinoma.
In April 1984 I spent three weeks in the laboratory of Professor
I.M . Samloff in Sepulveda, C a li fo rn ia ,  U.S.A. attempting to set up a 
radioimmunoassay fo r  cathepsin D. This proved unsuccessful, but a 
supply o f anti-SMP was given to us. I t  was thus possible to prove that  
cathepsin D and SMP were not identical and i t  was soon shown by 
Professor B. Foltmann, Copenhagen, using our anti-cathepsin D, that SMP 
was the enzyme known as cathepsin E.
I t  was suggested that the expression of pepsinogen, progastricsin  
and cathepsin D by neoplastic stomach might r e f le c t  the presence of the 
enzymes in the normal developing gastric  mucosa. A study of fe ta l  
stomachs was undertaken under my charge in 1983 -  1984 as part of a 
B.Sc. pro ject. Later th is  work was completed by inclusion of SMP 
(Chapter 7 ) .
In another B.Sc. project (1984 -  1985) which I supervised, the 
presence of progastricsin in gastric  carcinomas and d istant metastases 
was studied. This was subsequently expanded in a study of widespread 
metastases, with the aim of showing whether progastricsin is specific  to  
carcinoma of gastric  o r ig in .
Recently, the d is tr ib u t io n  of SMP in normal and neoplastic tissues 
has been determined and lo ca lis a tio n  of the enzymes at electron  
microscopic level has been attempted.
As much of the work to be described in the thesis presupposes some 
knowledge of the enzymes involved, i t  is with a b r ie f  review of th e ir  
biochemistry tha t th is  thesis begins (Chapter 1 ) .
CHAPTER 1 
INTRODUCTION
19
INTRODUCTION
NOMENCLATURE AND DEFINITIONS
In current l i t e r a t u r e ,  the terms protease, proteinase and 
pro teo ly t ic  enzyme are used synonymously. Protease is an older term 
than the others and has tended to become replaced by proteinase, which 
was adopted fo r the Enzyme Nomenclature (1982) L is t .  Enzymes may be 
acid , a lka l in e  or neutral proteinases according to optimal pH. Any of 
these types of proteinase may be an exopeptidase, which cleaves peptide 
bonds one or two residues from the ends of the p ro te in , or an 
endopeptidase, which mainly cleaves bonds d is tan t from the ends. 
Cathepsin is  a somewhat i l l -d e f in e d  generic name applied to  
endopeptidases of mammalian c e l ls  and tissues; most are acid 
proteinases, but some are neutral or a lka l in e  proteinases. The terms 
' t issue  proteinase1 and ' in t r a c e l lu la r  proteinase' are also rather  
i l l -d e f in e d  but are intended to describe the proteinases which are 
stored in lysosomes and other organelles and which act in t ra c e l lu la r ly  
and p e r ic e l lu la r ly ,  unlike those which are produced, usually as inactive  
precursors, and stored in secretory granules fo r  subsequent export 
(B a rre t t ,  1977b).
CLASSIFICATION OF PROTEINASES
P roteo ly tic  enzymes are c la s s if ie d  in to  four groups, according to  
th e i r  c a ta ly t ic  mechanism: serine, cysteine, m etallo- and aspartic  
proteinases (Kay, 1982). The aspartic  proteinases have been rather less 
well studied than many enzymes in the f i r s t  three groups (Kay, 1985) 
and, in p a r t ic u la r ,  th e i r  d is tr ib u t io n  in normal and abnormal human 
tissues is poorly documented.
The proteo ly tic  a c t iv i t y  of an aspartic  proteinase is dependent on 
the presence of an aspartic residue in positions 215 and 32 in the 
l in e a r  sequence. These react with the s i te -s p e c if ic  a f f in i t y  labels  
diazoacetyl norleucine methyl ester (DAN) and epoxy (p-nitrophenoxy)
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propane (EPNP) respective ly , the enzyme in e ith e r  case being 
inactiva ted . By d e f in i t io n ,  an aspartic proteinase must be inhib ited by 
both DAN and EPNP and also by pepstatin , an acylated pentapeptide
produced n a tu ra l ly  by various species of actinomycetes (Kay, V a lle r  &
Dunn, 1983).
CLASSIFICATION OF ASPARTIC PROTEINASES
The aspartic  proteinase group includes enzymes derived from the 
following sources:
1. Mammals -  pepsin, g as tr ics in , slow-moving protease, cathepsin D, 
cathepsin E, chymosin and renin .
2. Yeast -  proteinase A.
3. Fungi -  enzymes from the species Endothia pa ras it ic a ,  Penicillium
janthinellurn, Mucor pusillus and Rhizopus chinensis.
4. Plants -  proteinases from squash seeds and cucumber (Polanowski et 
a l , 1985), r ic e  seeds and wheat leaves (Foltmann, 1985a).
I t  may be noted that no bacteria l aspartic proteinases have yet  
been found.
Most of these enzymes have molecular weights of 35-42,000 Kd. Most 
are acid proteinases, being maximally active in acid conditions, but 
renin, which is a neutral proteinase in physiological conditions, is  
exceptional. The mammalian aspartic proteinases, unlike the microbial 
enzymes, are synthesized as precursors, termed zymogens, namely 
pepsinogen, progastricsin, prochymosin, prorenin (Kay, 1980) and 
possibly, though less well substantiated, cathepsinogen D (Puizdar & 
Turk, 1981).
In the nomenclature of the International Union of Biochemistry, 
enzymes are c lass if ied  according to c a ta ly t ic  a c t iv i ty  and fu rther  
separated by the substrates on which they ac t.  This system is d i f f i c u l t  
to apply to proteinases, as th e ir  substrate s p e c if ic i t ie s  overlap.
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These enzymes are more conveniently sub-c lass ified  according to the 
mechanism by which th e ir  active s ites  bind to various in h ib ito rs .  By 
these c r i t e r i a ,  the aspartic  proteinases occur in the group EC 3.4 .23  
and are fu r th e r  divided thus (Foltmann, 1985a):
3 .4 .23 .1  Pepsin A
3 .4 .2 3 .2  Pepsin B (pig only)
3 .4 .23 .3  Gastricsin
3 .4 .2 3 .4  Chymosin
3 .4 .2 3 .5  Cathepsin D
3 .4 .2 3 .6  Aspartic proteinases from fungi and yeasts
3 .4 .23 .15  Renin
Cathepsin E and slow-moving protease (SMP) are not yet c la s s if ie d .
Pepsin B (Ryle, 1970) occurs only in the pig and in the present 
work pepsin A w il l  be referred to simply as pepsin.
Pepsin
Pepsin was the f i r s t  enzyme ever id e n t i f ie d ,  fo llowing i ts  
extraction from human gastric  ju ic e  (Schwann, 1836). The early h istory  
of i ts  discovery and study is discussed by Wolf (1965). The enzyme is 
synthesised as the zymogen pepsinogen (Langley, 1882a), which is  
secreted from the gastric  mucosa and activated by the low pH in the 
gastric  ju ic e ,  where i t  is the main acid proteinase, i ts  concentration 
in humans being 400 mg/1 (Fruton, 1971). Although optimally active at 
pH 2 .0 ,  i t  is active up to around 5 .3 ,  at which i t  c lots m ilk. Above 
pH7 i t  is permanently inactivated and no longer functions, even i f  the 
pH is  lowered once more (Langley, 1882b). Pepsin survives 
lyoph ilisa t ion  but i f  stored in solution, even at 4°C, i t  digests i t s e l f  
rap id ly ,  although the fragments resulting  from i ts  autolysis may
continue to be active for some time.
Gastricsin
The second important acid proteinase of the human stomach, now 
called  gas tr ics in ,  was f i r s t  demonstrated in pig and dog gastric  mucosal 
ex trac ts , which were found to display a c t iv i ty  not explicable by the 
presence of pepsin alone (Takemura, 1909; Hirayama, 1910). The enzyme 
was found to be only weakly active at the optimal pH of pepsin. The 
enzyme was named cathepsin and was mistakenly thought to be derived from 
lymphocytes (W i l ls ta t te r  & Bamann, 1929; Freudenberg, 1940). The 
proteinase was found to have optimal pH 3-4 and was extracted from 
human duodenal as well as gastric  mucosa (Buchs, 1953; Buchs, 1954). As 
th is  enzyme is present in high amounts (150 mg/1, which is  20-30% of the 
p ro teo ly tic  a c t iv i t y  of the gastric  ju ic e ) ,  i t  seems c lear tha t i t  is a 
secretion product and does not r e a l ly  belong to the group of enzymes 
termed cathepsins. I t  was therefore renamed gastr ics in  when i t  was 
p u rif ied  in 1958 (Richmond et a l , 1958). Gastricsin is synthesised as 
the zymogen progastricsin and, l ik e  pepsinogen, is activated by exposure 
to gastric  acid. The optimum pH of gastricsin  is around 3 .0 ,  somewhat 
higher than tha t of pepsin. Gastricsin cleaves d i f fe re n t  peptide bonds 
from pepsin, but is s im ila r ly  inactivated by n eu tra lis a tio n .
Chymosin
In 1853 an acid proteinase was discovered in the in fant stomach of 
certa in  mammals: rennin (Heintz, 1853). Rennin was shown, l ik e  pepsin, 
to be secreted from the gastric mucosa as a zymogen (Langley, 1882a). 
Rennin is now called chymosin to avoid confusion with renin of the 
kidney. Chymosin is  an aspartic proteinase and has great importance in 
the manufacture of cheese but does not occur in the human stomach.
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Cathepsin D
■ Cathepsin D appears to have been responsible fo r  the acid 
pro teo ly t ic  a c t iv i t y  detected in autolysing t issues, such as l i v e r ,  
muscle, adrenal glands (Salkowski, 1890; Schweining, 1894; Biondi,
1896; Jacoby, 1900), thymus (Kutscher, 1901; Jacoby, 1902), spleen 
(Hedin & Roland, 1901a, Hedin, 1904), lymph node, l i v e r ,  kidney, 
skeletal and cardiac muscle, blood c e l ls  (Hedin & Roland, 1901b), 
inflammatory exudates, reactive  lymph nodes and bone marrow (Opie, 1906; 
Jobling & Strouse, 1912). The acid proteinase was thought to be of 
macrophage o r ig in ,  which would account fo r  i t s  wide d is tr ib u t io n  in 
t iss u e , and was found to have maximal a c t iv i ty  at pH 3-3 .5  (Dernby, 
1918). The term cathepsin was f i r s t  applied to an enzyme detected in 
gastr ic  mucosa, but i t  seems l ik e ly  tha t th is  enzyme was in fact  
gastr ics in  rather than cathepsin D. The term cathepsin is now reserved 
fo r  any of a group of pro teo ly tic  enzymes which are stored within c e l ls ,  
probably w ithin lysosomes, and act in t r a c e l lu la r ly .  Cathepsins vary in 
c a ta ly t ic  mechanism and include not only aspartic  proteinases such as 
cathepsin D, but also cysteine proteinases, such as cathepsins B, L and 
H and the serine proteinase, cathepsin G (Kay, 1982). Cathepsin D was 
named in 1960 (Press, Porter & Cebra, 1960).
By the above c r i t e r ia  the evidence fo r  the existence of a cathepsin 
in gastric  mucosa has un ti l  recently not been convincing and w il l  be 
discussed la te r  in th is  chapter.
Renin
Renin d i f fe rs  from other aspartic proteinases in that i t  is active  
physio logically  at neutral pH, although i ts  optimum in v i t ro  is 5 .5 -5 .6 . 
In addition , renin is highly substrate-specific  fo r the plasma protein  
angiotensinogen. Renin is  synthesised as the zymogen, prorenin, which 
is stored in the juxtaglomerular apparatus of the kidney and secreted 
into the blood. The enzyme has also been extracted from mouse
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submaxillary gland (Cohen et a l , 1972) and from ra t  and dog brain 
(F ischer-Ferraro et a l , 1971; Inagami et a l , 1982).
Cathepsin E
Cathepsin E is  an aspartic proteinase which has been id e n t if ie d  in 
rabb it  bone marrow (Lapresle & Webb, 1962), in ra b b it ,  ra t  and bovine 
spleen (Lapresle, 1971; Yamamoto, Katsuda & Kato, 1978; Yamamoto et a l , 
1980; Lapresle et a l , 1986) and in rabbit skin homografts (Jasani,
Jasani & Talbot, 1978). Cathepsin E has a molecular weight of 85-90,000 
Kd and consists of two subunits with molecular weights of around 45,000 
Kd (Yamamoto et a l , 1978; Lapresle, 1971). I t  has a pH optimum of 2.5  
(Jasani et a l , 1978) and is inh ib ited  strongly by the in h ib ito r  protein  
from Ascaris lumbricoides (Keilova & Tomasek, 1972). I t  is  known not to 
cross-react immunologically with antiserum to cathepsin D (B arre tt & 
Dingle, 1972; Yamamoto et a l , 1980; Lapresle et a l , 1986). I t  has been 
suggested tha t cathepsin E is a dimer of cathepsin D (Yamamoto et a l , 
1978) but recent studies have shown that the amino acid composition of 
cathepsin E is quite d i f fe re n t  from that of cathepsin D and that they 
cleave d if fe re n t  peptide bonds (Lapresle et a l , 1986).
ASSAY METHODS
Assay methods fo r pepsin, gastr ics in  and cathepsin D exp lo it  the 
a b i l i t y  of the enzymes to digest haemoglobin at certa in  pH optima to  
y ie ld  products which are not precip ita ted  by t r ic h lo ra c e t ic  acid (TCA) 
(Anson & Mirsky, 1932; Anson, 1938). Spectrometric measurement of the 
change in optical density allows accurate estimation of enzyme a c t iv i ty ,  
which is expressed in units compared with a standard specific  a c t iv i ty .
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The gas tr ic  and urine zymogens may be more c le a r ly  resolved by 
electrophoresis on polyacrylamide gel and more bands have been 
demonstrated than on agar. Even these can be shown by column 
chromatography to consist of subtypes (Samioff, 1985).
Slow moving protease (SMP)
Etherington & Taylor (1970 )1s zone 7 corresponds to a small early  
peak obtained by DEAE cellu lose chromatography and appears to correspond 
to PIV of Kushner et al (1964) and SMP of Samloff (1969) (Table 1 .3 ) .
The main property which distinguishes SMP from pepsin and gastricsin  is 
i t s  resistance to sequential acid activation  and n eu tra lisa tio n . An 
enzyme with such a property was isolated from normal human gastric  
mucosa and named a cathepsin (Mangla, Guarasci & Turner, 1974). I ts  
molecular weight, estimated by i ts  m obility  on Sephadex G-100, was 
40-50,000 Kd and i t s  pH optimum 3 .4 .  This is consistent with the 
suggestion that i t  is cathepsin D and not cathepsin E, which has a
molecular weight of about 90 Kd and pH optimum 2.5 (B a rre t t ,  1977a).
The id e n t ity  of th is  enzyme with SMP was not, however, established by 
zymography.
The non-pepsin proteinase isolated from human gastric  mucosa by 
Roberts & Taylor (1978) behaved l ik e  SMP on zymography and had optimal 
a c t iv i ty  at pH 2 .5 -3 .5 .  I t  cleaved p re fe re n t ia l ly  peptide bonds 
Leu-Tyr and Phe-Tyr, l ik e  pepsin and cathepsin E but unlike cathepsin 
D, which p re fe re n t ia l ly  cleaves Phe-Phe (Etherington & Taylor, 1972). 
These data supported th e ir  previous suggestion that normal gastric  
mucosa contains an enzyme with properties of cathepsin E and that i t  is
identical with SMP (Etherington & Taylor, 1972).
The previous authors found no evidence of cathepsin D i n  normal 
gastr ic  mucosa (Roberts & Taylor, 1978), although they had previously 
demonstrated i t  in gastric  adenocarcinomas. However, the non-pepsin 
proteinase purif ied  from normal gastric mucosa by Kageyama & Takahashi 
(1980) had properties s im ila r  to ,  but not identical w ith, those of
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Cathepsin D
Cathepsin D has only comparatively recently been p urif ied  (Table
1.1).
Slow moving Protease (SMP)
SMP was p a r t ly  purif ied  from human fe ta l  gastr ic  mucosa by 
acetone-ether extraction (Hirsch-Marie & Touboul, 1973). The method was 
somewhat crude and although the SMP obtained was used in immunological 
studies, i t s  purity  was not convincingly demonstrated. SMP has 
recently  been p urif ied  from human gastr ic  mucosa by chromatography 
(Sami o f f  et a l , 1987).
STRUCTURE 
Primary structure
The primary structure of various aspartic  proteinases has now been 
determined (Table 1.2 and Fig. 1 .1 ) .  There is considerable homology 
among a l l  the aspartic  proteinases, about 10% of th e i r  amino acid 
residues being at identical positions (Foltmann, 1985b). In most cases 
a propart, about 44 amino acids long, is attached to the N-terminal end, 
from which the active enzyme is numbered. The c a ta ly t ic  aspartic acids 
32 and 215 are present in a l l  the aspartic  proteinases, while f iv e  
clusters of residues around them are p a r t ic u la r ly  well conserved (F ig .
1 . 1  and 1 . 2 ) .
T h ir ty  to  fo r ty  of the approximately 375 amino acid residues of the 
zymogen carry negative charges, 1 0 - 2 0  carry positive charges and the 
rest are neutra l.  Differences in the numbers of these presumably 
account, at least p a r t ly ,  fo r  variations in e lectrophoretic  m obility  
among the members of the enzyme fam ily . The enzymes and zymogens are 
often coupled to a carbohydrate moiety to form a glycoprotein.
Cathepsin D, fo r  example, contains about 1% hexosamine and 5% hexose 
(B a rre t t ,  1980a). Variations in the size and charge of the carbohydrate 
may also a f fe c t  electrophoretic m ob ility .
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FIG. 1.2 Aspartic proteinases - three dimensional s tru c tu re .
The molecule has been folded open to show the ac t ive  
s i te  c l e f t ,  adjacent to which l i e  the f iv e  groups of  
conserved amino acid residues (Phe 31 to  Ser 36, Tyr 75 
to Gly 78, before Gly 122, Asp 215 to Gly 217 and 
around Gly 303), shown in yellow . The c a ta ly t ic  amino 
acids Asp 32 and Asp 215 normally l i e  close together  
and are hydrogen bonded (red dashes). The substrate  
f i t s  into the c l e f t ,  binding s ite  S4 being at the top. 
The N and C termini arp shown in blue. The arrows 
indicate beta-structures and the cylinders ind icate  
alpha-helices. In the zymogen, the propart is attached 
to the N-terminal end and occupies the c l e f t ,  blocking  
access by substrate.
,31
6,
THREE DIMENSIONAL STRUCTURE
The three dimensional structures of pig pepsin (Andreeva et a l ,
1985) and of the fungal aspartic  proteinases, pen icillopepsin  (dames & 
S ie leck i,  1983), endothiapepsin (Blundell et a l , 1985) and Rhizopus 
chinensis proteinase (Bott, Subramanian & Davies, 1982) have now been 
determined and are remarkably s im ila r .  The pig pepsin molecule consists  
of two lobes separated by a c le f t  (F ig . 1 .2 ) .  The N-terminal h a lf  
includes amino acids 1-175, while the C-terminal lobe includes residues 
176-327. About 35% of the residues in to p o lo g ica lly  s im ila r  positions  
are identical in the two lobes of the molecule of any one enzyme.
Each of the two lobes appears in turn to consist of two symmetrical 
halves. The active s i te  is  in the c le f t  and is  known as an extended 
s i te ,  indicating that t ig h t  binding of substrate requires in te rac tions  
with several side chains of e i th e r  side of the s c is s i le  bond, usually at  
least seven amino acids in the subsites, the bond between the
hydrophobic residues in the S^-S^‘ s ites being cleaved p re fe re n t ia l ly  
(Powers et a l , 1977).
Recently the t e r t ia r y  structure of the zymogen, pig pepsinogen, has 
been determined (James & S ie le c k i,  1986). The propart segment occupies 
the c le f t  of the pepsin part .
ZYMOGEN ACTIVATION
All the mammalian aspartic proteinases appear to  be synthesised 
as zymogens, although the evidence for a cathepsin D zymogen is less 
conclusive than fo r the others. The zymogen is in a c t iv e ,  because the 
propart occupies the substrate-binding c le f t  of the enzyme, blocking 
access to the two c a ta ly t ic  aspartyl residues. On a c id i f ic a t io n ,  the 
propart is detached by sequential removal of short peptides.
In pig pepsinogen the f i r s t  cleavage at Leu 16 -  H e  17 and 
the second at Phe 25 -  Leu 26 occur in tram olecu larly . The th ird  
cleavage, at Leu 44 -  H e  45 occurs in te rm olecu larly ,  as th is  bond is  
fa r  from the active s i te  of the molecule in which i t  is cleaved.
Removal of the propart thus exposes the active  s i te  o f the enzyme. The 
f i r s t  fragment removed is i t s e l f  a pepsin in h ib ito r  at or above pH 5 and 
may help protect the pepsin from inac tiva tion  when the pH of the gastr ic  
ju ice  rises (Kay, 1980).
At pH 4-4 .6  ac tiva tion  of pepsinogen is much slower than at pH 2 
and is au to ca ta ly t ic ,  i . e .  pepsin catalyses i ts  own production 
(H e r r io t t ,  1939).
EVOLUTION OF ASPARTIC PROTEINASES
The homology among the various aspartic  proteinases o f d i f fe re n t  
species suggests that the enzymes developed long ago, when fungi and 
mammals had a common ancestor (Foltmann, 1981). The bilobed structure  
and the symmetry within each of the lobes suggests tha t the aspartic  
proteinases evolved from a precursor gene which coded fo r  about 80 amino 
acids. Gene duplication and fusion led. to a gene coding fo r about 160 
amino acids and a second duplication and fusion led to an enzyme group 
with about 320 amino acids (Tang et a l , 1978; Andreeva & Gustchina,
1979; B lundell, Sewell & McLachlan, 1979; Foltmann, 1981). Sequence 
divergence would explain the non-homology between enzymes w ithin and 
between d i f fe re n t  species and is considered more l ik e ly  than convergence 
(Burt et a l ,  1985).
I t  has been speculated tha t cathepsin D might be the prim it ive  
ancestor of the aspartic proteinases and was the in t r a c e l lu la r  d igestive
enzyme of a u n ic e l lu la r  organism. On th is  basis, pepsin, gas tr ics in  and 
renin presumably evolved l a te r  (B a rre t t ,  1980a). I t  may be that the 
c r i t ic a l  step in evolution from fungal to mammalian proteinases was the 
acquis ition of the zymogens (Stepanov, 1985). The evidence suggests 
that the mammalian genes were derived from a common sequence around 
160 m il l io n  years ago and that the mammalian gene precursor and tha t  of  
the fungus Pen ic il lium  janthinellum  diverged about 1000 m il l io n  years 
ago (Burt et a l , 1985).
CATALYTIC MECHANISMS
The cleavage of a peptide bond by an enzyme involves at least three  
steps:
1 binding of substrate to the active  s i te  of the enzyme
2 cleavage of the peptide bond
3 release of the products from the active  s i te
The various aspartic proteinases d i f f e r  widely in th e i r  s e le c t iv i ty  fo r  
substrates. Natura lly  occurring proteins are generally  too complex for  
use in c a ta ly t ic  studies and much has been learned from experiments with 
synthetic substrates, such as
Pro-Thr-Glu-Phe - NC^Phe-Arg-Leu 
p4  p3 p2 pj px ' p2 ' p3 ' 
which is cleaved at the s c iss i le  bond between phenylalanine at position  
P^  and p-nitrophenylalanine in the P^' position . The s c is s i le  bond is  
orientated close to the c a ta ly t ic a l ly  essential aspartic  residues 32 and 
215. In most cases cleavage is at or between aromatic amino acids, 
which have hydrophobic groups, but the rate  of cleavage is a ltered  
considerably by the amino acid residues at the a n c il la ry  positions P^, 
P3 , P2 , P2 ' and P3 1. Moreover, the corresponding subsites in the enzyme 
vary between the d i f fe re n t  aspartic  proteinases. The s c is s i le  bond and 
the rate  at which i t  is cleaved depends therefore on the structure of
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the .substrate and of the p a r t ic u la r  aspartic  proteinase, as well as on 
the ion ic concentration of the solution (Pedersen, 1977). The 
mechanisms have been discussed in d e ta i l  elsewhere (Kay, 1985; Dunn et 
a l , 1985). Natura lly  occurring in h ib ito rs ,  such as pepstatin , and 
various synthetic in h ib ito rs  have also proved useful in such studies. 
Renin in h ib ito rs  have c l in ic a l  importance in the treatment of 
hypertension.
MOLECULAR VARIANTS OF ASPARTIC PROTEINASES
Because of th e i r  c l in ic a l  in te re s t ,  some of the aspartic  
proteinases have been fu rth e r  c la s s if ie d  by th e i r  e lectrophoretic  
m obility . In most studies electrophoresis was carr ied  out on 1 to  1.5% 
agar gel buffered at pH 7.3 to  8 . 6  in a slab around 1mm thick on a glass 
p late , kept cool during the run. More recently , polyacrylamide gel has 
been found to give bette r separation. Some studies have been carried  
out on urine, but most work has been performed on gastr ic  mucosal 
extracts , prepared from the supernatants obtained by centrifug ing  
homogenates of tissue in weak neutral or s l ig h t ly  a lka l in e  b u ffe r .  
Samples were placed in w ells , usually s l i t - l i k e ,  and an e le c t r ic  current 
was passed through the ge l. Most aspartic  proteinases are negatively  
charged and moved towards the anode. Enzyme a c t iv i t y  was demonstrated 
by the method of Uriel (U rie l & Scheidegger, 1955; Urie l & Grabar, 1956; 
U r ie l ,  1960), in which the gels are impregnated with protein , usually  
haemoglobin, buffered to suitable pH, usually around 2; the plate is  
then incubated, dried and stained fo r  protein with ami do black or 
Coomassie blue. Any enzyme a c t iv i ty  at the incubation pH is  marked 
by a c lear l y t ic  zone, where the protein has been digested. This 
technique is known as zymography. When electrophoresis is  performed 
as above, only the zymogens may be demonstrated, as any enzymes 
in the sample are inactivated at the neutral or a lka lin e  pH at
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which the electrophoresis is  carried  out. I f ,  however, electrophoresis  
is  performed at pH 5 .3 ,  the active enzymes are not denatured and so may 
be demonstrated.
The number o f isoforms of the zymogens detected depends on the 
conditions of electrophoresis, but the isoforms have usually been named 
in order of decreasing anodal m o b il i ty .  In several studies, four  
zymogens, P I, I I ,  I I I  and IV , were demonstrated in human g as tr ic  mucosa 
(Rapp et a l ,  1964) and in gastric  ju ic e  (H irsch-M arie , Conte & B urtin ,  
1965; Hirsch-Marie, 1968). Other workers, studying g as tr ic  mucosa from 
pig, human, rabbit and dog, obtained only three zymogens, named PGI, I I  
and I I I .  Sami o f f  (1969), on the other hand, found tha t human gas tr ic
mucosal extracts yielded no less than eight p ro teo ly t ic  bands. Like
Rapp et a l .  (1964), he found tha t a c id i f ic a t io n  and n eu tra lisa tio n  
abolished the a c t iv i t y  in the fastest seven bands, which he therefore  
considered to be pepsinogens and named Pg 1 to  7; a c t iv i t y  persisted in 
the eighth band, which he called slow-moving protease (SMP), as he 
considered i t  not to be a true pepsin. Pg 1-5 but not 6 and 7 or SMP 
were detected in the urine, whereas a l l  were present in the blood 
(Samioff & Townes, 1970). Seven p ro teo ly tic  f ra c t io n s ,  numbered 1 to  7,
were separated from human gastric  mucosa by Etherington & Taylor (1967;
1970).
A number of d i f fe re n t  zymogen fractions have also been separated 
from gastric mucosa by DEAE cellu lose chromatography, but these are 
often resolved fu rther  by electrophoresis (Turner et a l , 1970; Sami o f f ,  
1971a).
By the early  1970's the nomenclature of the gastr ic  zymogens and 
enzymes had become complex, as each group of authors accorded d i f fe re n t  
names or numbers to the fractions id e n t if ie d  (Etherington & Taylor, 
1967). The various terminologies are compared in Table 1 .3 .
Sami o f f  (1971a) showed the fastest 5 bands (Pg 1 to  5) to be
immunologically identical but d i f fe re n t  from the next two (Pg 6 and 7) 
and from SMP. He grouped Pg 1 to 5 together as Group I pepsinogens and 
Pg 6 and 7 together as Group I I  pepsinogens. An additional Group I 
zymogen, band 5a, cathodal to  5, has been found in the urine  
(Gedde-Dahl et a l , 1978). While c l in ic ia n s  tend to use these terms, 
biochemists usually ca ll the Group I pepsinogens simply pepsinogen and 
the Group I I  pepsinogens, progastrics in . In the l a t t e r  terminology, 
then, zymography separates gastr ic  mucosal extracts in to  1 ) pepsinogen, 
of which there are 5 or 6 isozymogens, 2) progastr ics in , of which 
there are 2 isozymogens and 3) SMP. These w il l  be considered in tu rn .  
Pepsinogen and progastricsin
The reasons fo r  the d i f fe re n t  bands are s t i l l  not understood. The 
molecular weights appear to vary from 43,800 to  34,600 Kd (Roberts & 
Taylor, 1972). Variations in the amount of phosphate or carbohydrate 
attached to the zymogen molecule could be important (Meitner & Kassell, 
1971; Kageyama & Takahashi, 1977; Ryle & Foltmann, 1985). I t  is also 
possible that the fractions are breakdown products of the same molecule 
(Hirsch-Marie, 1968). Differences in substrate s p e c if ic i ty  have 
apparently been demonstrated between the isozymogens but the 
significance of th is  is not c lear  (Walker & Tay lor, 1978; Roberts & 
Taylor, 1979).
The concentrations of the pepsinogen isozymogens vary gen e tica l ly .  
Indeed, about 14% of Caucasians in the U.S.A. lack pepsinogen band 5 on 
zymography of both urine and gastric  mucosal extracts (Samioff & Townes, 
1970) and are said to be of phenotype B. This is inherited  as an 
autosomal recessive t r a i t .  By contrast, a l l  indiv iduals of East Asian 
orig in  are of phenotype A, none lacking band 5 (Samioff, Taggart & 
Hengels, 1985). Altogether, nine phenotypes have been id e n t i f ie d ,  
explicable by the codominant expression of four a l le le s  at a single  
genetic locus (Taggart et a l , 1979).
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The gastr ic  and urine zymogens may be more c le a r ly  resolved by 
electrophoresis on polyacrylamide gel and more bands have been 
demonstrated than on agar. Even these can be shown by column 
chromatography to consist of subtypes (Samioff, 1985).
Slow moving protease (SMP)
Etherington & Taylor (1 9 7 0 ) 's zone 7 corresponds to a small early  
peak obtained by DEAE cellu lose chromatography and appears to correspond 
to PIV of Kushner et al (1964) and SMP of Samloff (1969) (Table 1 .3 ) .
The main property which distinguishes SMP from pepsin and gastricsin  is 
i t s  resistance to sequential acid activation  and n eu tra lis a tio n . An 
enzyme with such a property was isolated from normal human gastric  
mucosa and named a cathepsin (Mangla, Guarasci & Turner, 1974). I ts  
molecular weight, estimated by i ts  m obility  on Sephadex G-100, was 
40-50,000 Kd and i t s  pH optimum 3 .4 .  This is consistent with the 
suggestion that i t  is cathepsin D and not cathepsin E, which has a
molecular weight of about 90 Kd and pH optimum 2.5 (B a rre t t ,  1977a).
The id e n t ity  of th is  enzyme with SMP was not, however, established by 
zymography.
The non-pepsin proteinase isolated from human gastric  mucosa by 
Roberts & Taylor (1978) behaved l ik e  SMP on zymography and had optimal 
a c t iv i t y  at pH 2 .5 -3 .5 .  I t  cleaved p re fe re n t ia l ly  peptide bonds 
Leu-Tyr and Phe-Tyr, l ik e  pepsin and cathepsin E but unlike cathepsin 
D, which p re fe re n t ia l ly  cleaves Phe-Phe (Etherington & Taylor, 1972). 
These data supported th e ir  previous suggestion that normal gastric  
mucosa contains an enzyme with properties of cathepsin E and that i t  is
identical with SMP (Etherington & Taylor, 1972).
The previous authors found no evidence of cathepsin D in normal 
gastr ic  mucosa (Roberts & Taylor, 1978), although they had previously 
demonstrated i t  in gastric  adenocarcinomas. However, the non-pepsin 
proteinase purified  from normal gastric mucosa by Kageyama & Takahashi 
(1980) had properties s im ila r  to ,  but not identical w ith, those of
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cathepsin D from human l iv e r  and pig spleen. The enzyme consisted of 
two identica l monomers, covalently bound to form a molecule of weight
85.000 Kd. However, these workers did not convincingly demonstrate by 
zymography tha t th is  'cathepsin D - l ike  p rotease ', as they termed i t ,  
was SMP, which they had been attempting to p u r ify .  Soon afterwards, 
Pohl, Bure£ & Slavfk (1981) demonstrated two non-pepsin proteinases in 
normal gastric  mucosa. The f i r s t ,  which they termed 'protease 1 ' ,  
consisted of two polypeptide chains, of molecular weights 33,000 and
18.000 Kd, had optimal pH 3 .2 -3 . 6  and cleaved the Phe-Phe bond. On 
agar gel electrophoresis i t  moved cathodally, re f le c t in g  a higher 
proportion o f basic amino acid residues than are known to exist in 
pepsinogen or progastricsin . These and other properties supported the 
view that th is  enzyme was identica l to cathepsin D isolated from other 
t issues. The second enzyme, termed 'non-pepsin protease ', moved
e lec trophore t ica lly  l ik e  SMP. These results  suggest tha t normal 
gastric  mucosa contains cathepsin D and that SMP is a d i f fe re n t  
enzyme.
Recently a cathepsin D -l ike  proteinase has been demonstrated in 
the ra t  gastric  mucosa (Muto, Arai & Tani, 1983).
IMMUNOLOGICAL PROPERTIES OF THE ASPARTIC PROTEINASES
I t  has been recognised that pepsin is immunogenic since Northrop 
(1930) raised rabbit anti sera to his newly purif ied  c ry s ta l l in e  pig 
pepsin and demonstrated a p rec ip it in  l in e  between the anti sera and 
both active and denatured enzyme. The immunological non-identity of 
pepsinogen, progastricsin and SMP has been demonstrated by 
immunoelectrophoresis of human gastric mucosal extracts against rabbit  
antisera (Kushner et a l , 1964; Hirsch-Marie et a l , 1965; Samloff,
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1971a). There appears to be part ia l  immunological id e n t i ty  between the 
zymogens and th e i r  corresponding active enzymes (Kushner et a l , 1964; 
Kalinovsky & Okylov, 1978), suggesting that there  are shared antigenic  
determinants. As aspartic proteinases are normally inactivated at pH 
over 7 , they may, when used as immunogens, stim ulate production of 
anti sera which react be tte r  with the zymogen than with the active  
enzyme (Foltmann, 1981).
There is  immunological id e n t ity  among the f iv e  pepsinogen 
isozymogens (Pg 1-5) and between the two progastricsin fractions (Pg 6 
and 7) (Samloff, 1971a), presumably re f le c t in g  the strong corre la t ion  
known to ex is t between antigenic s im i la r i ty  and the extent of sequence 
homology (White, Ibrahimi & Wilson, 1978). S im ila r ly ,  pepsin, 
gastrics in  and chymosin from the same species are less closely re lated  
immunologically than is each enzyme to i ts  counterpart in d i f fe re n t  
species. I t  has been suggested that th is  indicates that development of 
separate genes fo r  these enzymes preceded the divergence of mammals 
(Foltmann, 1981).
COMMENT
Most work on the aspartic  proteinases has been carried  out by 
biochemists. Perhaps th is  p art ly  explains why the precise location of  
the enzymes in tissues is poorly documented and why th e i r  potential use 
in tumour diagnosis has not been examined. The immunohistochemical 
techniques used by pathologists can read ily  be applied to such problems 
and the answers may, in tu rn , be of biochemical as well as pathological 
in te re s t .  In the work described in th is  th es is , four human aspartic  
proteinases, pepsin, g as tr ics in , cathepsin D and SMP were selected. 
Before th e i r  immunolocalisation is discussed, however, certa in  
preliminary studies w il l  be described in Chapter 2.
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CHAPTER 2
BIOCHEMICAL AND IMMUNOLOGICAL STUDIES OF ASPARTIC
PROTEINASES
AO
INTRODUCTION
A prerequ is ite  of any immunohistological investigation is a supply 
of antibody and id e a l ly  some pure antigen, fo r  use in absorption control 
experiments. As there are no commercially ava ilab le  antibodies to any 
of the aspartic  proteinases, anti sera had to be prepared by immunisation 
of animals. However, the only enzymes or zymogens which are ava ilab le  
fo r  th is  purpose are pig pepsin and pepsinogen. I n i t i a l l y ,  therefore ,  
pig pepsin was used as an immunogen and the resu ltant anti serum was 
employed in immunohistological studies. Subsequently, due to doubts 
about the homogeneity of the commercial pepsin, i t  was considered 
desirable to  obtain a pure supply of th is  enzyme. In order to avoid 
problems due to autodigestion, the zymogen, pig pepsinogen rather than 
the active  enzyme was fu rth e r  p u r i f ie d ,  the aim being to use the 
p u rif ied  zymogen, and, i f  necessary, the derived enzyme, fo r  blocking 
experiments to ensure s p e c if ic i ty  of immune staining with the previously  
prepared antipepsin. Later, a small supply of human pepsin was donated 
to us.
The p u r if ic a t io n  of the other aspartic proteinases, progastricsin,  
cathepsin D and slow moving protease presents greater d i f f i c u l t i e s  than 
that of pepsinogen. As the advantage of a p a r t ia l ly  pure animal form of 
these enzymes did not e x is t ,  human tissues were used. Because of 
s im i la r i t ie s  between the enzymes, they are d i f f i c u l t  to  separate from 
one another and fo r  th is  reason sources other than gastric  mucosa, in  
which several members of th is  family are present, were chosen whenever 
possible. Progastricsin, for example, appears to be the only acid 
proteinase zymogen in seminal f lu id ,  which was therefore used as a 
source, although during the work we were given a supply of pure 
progastricsin . A small amount of human cathepsin D was also g ifted  to  
us but was thought in s u f f ic ie n t ly  pure for use as an immunogen. I t  was 
therefore decided to purify  cathepsin D anew from human spleen, which
k]
was read ily  ava ilab le  and known to be rich in th is  enzyme. When the 
present studies began, l i t t l e  was known about slow moving protease. The 
work of Hirsch-Marie et al (1976) suggested th a t  fe ta l  stomach was rich  
in SMP and poor in pepsin and gas tr ics in . For th is  reason, fe ta l  
stomach was i n i t i a l l y  used as a source of SMP. Later, SMP, purif ied  
from human gastr ic  mucosa, was g ifted  to us.
This chapter describes the p u r if ica t io n  of the various aspartic  
proteinases, the development of anti sera to the enzymes and the tests  
performed to  demonstrate the s p e c if ic i ty  of these an tisera , which were 
to be used fo r subsequent immunohistological work. Although pepsin, 
gastr ics in  and cathepsin D have been re la t iv e ly  well characterised,  
l i t t l e  is  known about SMP. In previous studies, there has been 
speculation th a t  i t  is identica l to  cathepsin D (Chapter 1 ) .
Experiments were therefore carried out in an attempt to c la r i f y  the 
nature of th is  enzyme.
kl
MATERIALS AND METHODS 
Sources of enzymes and zymogens
The sources from which the aspartic  proteinases and zymogens used 
in th is  study were obtained are l is te d  in Table 2 .1 .  Pig pepsinogen was 
fu r th e r  p u r if ied  as described below. The human pepsin obtained from Dr. 
A.P. Ryle had been purif ied  from gastr ic  ju ic e  (Ryle, personal 
communication). I t  had been shown to migrate as a single band on SDS- 
polyacrylamide gel electrophoresis. The human gastr ics in  obtained 
from Professor J. Tang had been p u r if ied  by the previously described 
method (Tang, 1970). I t  migrated as a single band on SDS-PAGE 
electrophoresis and on electrophoresis in 5.6% polyacrylamide gel. The 
human seminal progastricsin g ifted  by Professor Svasti had been prepared 
as described previously (Ruenwongsa & Chulavantnatol, 1975) and was 
activated at pH 2 to y ie ld  the enzyme, gastr ics in  (Surinru t, Svasti & 
S u ra r i t ,  1981). The human cathepsin D g if te d  by Dr. Barre tt had been 
purified  as previously indicated (B a rre t t ,  1977a). Attempts were made 
to purify  SMP from homogenates of fe ta l  gastric  mucosa. The supply of 
SMP g ifted  by Professor I.M . Sami o f f  was purif ied  from human gastric  
mucosa as described (Samloff et a l , 1987).
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TABLE 2.1
SOURCES OF ASPARTIC PROTEINASES AND ZYMOGENS
Enzyme/Zymogen Tissue of o rig in  Source
pig pepsin ( lyo ph il ised )  
pig pepsinogen M 
human pepsin
human gastric  gastr ics in
human seminal 
progastricsin
human cathepsin D
human cathepsin D 
human SMP
pig gastr ic  mucosa
ii  H ii
human " "
human gastr ic  mucosa 
human seminal f lu id
human spleen
human gastric  
mucosa
Sigma Chemicals Ltd
ii  ii ii
Dr. A.P. Ryle, 
Edinburgh
Prof. J. Tang 
Oklahoma
Prof. J. Svasti, 
Bangkok
Dr. A.J. B a rre tt ,  
Cambridge
purif ied  de novo
Prof. I .M . Samloff, 
C a lifo rn ia
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ENZYME ASSAY
Assay of pepsinogen, progastricsin and cathepsin D is  based on 
the a b i l i t y  of the active enzymes to digest haemoglobin at optimal pH 
2 .0 ,  3 .0 and 3 .5  respective ly . The methods described are fo r  pepsinogen 
but, with appropriate pH adjustments, are su itab le  fo r  estimation of the 
other two enzymes and zymogens.
1 . Anson's method
The method was that described previously (Anson & Mirsky, 1932; 
Anson, 1937, 1938; Berstad, 1970). Duplicate samples of bovine 
haemoglobin were kept at 37°C in a water bath. Proteolysis was started  
by addition to each tube of e i th e r  the unknown sample or a standard 
solution of pepsinogen, the mixture being buffered to  pH 2 .0 .  A fte r  10 
mins the reactions were stopped by addition o f 5% t r ic h lo ra c e t ic  acid 
(TCA). The TCA soluble s p l i t  products formed were estimated by 
measuring the optical density of the f i l t r a t e s  at 280 nm against the 
blanks. The amount of enzyme in each tube was proportional to the 
optical density and could be estimated by comparison with the optical 
density of the known standards.
2. Radial d iffus ion  assay
This is a convenient method fo r  assay of large numbers of samples 
and is ,  l ik e  Anson's method, based on haemoglobin digestion. The 
samples were allowed to d iffuse  ra d ia l ly  from c irc u la r  wells in agar 
impregnated with haemoglobin buffered to the optimal pH of the enzyme 
under assay. The agar gels were prepared as described previously 
(Samioff & Kleinman, 1969). I t  was found convenient to use glass 
microscope slides (7 .5  x 2 cm), on which a slab of gel 1 mm thick could 
be layered by addition of 1.8 ml of the agar mixture. The slides were 
stored in racks at 4°C in an a i r t ig h t  moist container. As o r ig in a lly  
described, the wells in the agar plate were 4 mm in diameter. I t  was 
found in the present studies, however, that wells as small as 2 mm could
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be used with sa t is fac to ry  resu lts .  In th is  way, up to 50 assays could 
be accommodated on one s l id e ,  although in practice about 30 per s lide  
suff iced . Into each well was placed a sample, pig pepsin or pepsinogen 
being used as standard. The slides were incubated in a humid chamber 
fo r 1 hr at 37°C and fixed in 5% acetic  acid in 50% ethanol to  stop the 
reaction and p rec ip ita te  undigested protein . Each slab was overlain  
with moist f i l t e r  paper to prevent cracking of the agar during drying. 
Slides were then stained fo r  protein with 1% ami do black (Urie l and 
Grabar, 1956). A c lear  zone developed round each well where there had 
been p ro teo ly tic  digestion of haemoglobin. The logarithm of the 
concentration of enzyme is l in e a r ly  re lated to the diameter of the c lear  
zone minus the diameter,of the well (Mancini, Carbonara & Heremans, 
1965). The concentration of enzyme in each sample could therefore be 
read o f f  a series of known pepsinogen standards.
3. M ilk c lo t t in g  assay fo r pepsin
Pepsin was assayed by the milk c lo t t in g  method at pH 5.3 (McPhie, 
1976).
4. Assay of cathepsin D
During p u r i f ic a t io n ,  cathepsin D a c t iv i t y  was assayed by digestion  
of the synthetic substrate Pro-Thr-Glu-Phe-(N0 2 phe)-Arg-Leu (Dunn, 
Kammermann & McCurry, 1984).
PROTEIN ASSAY
Protein was assayed e ith e r  by a standard Lowry method (Lowry et a l , 
1951) or by a Bio-Rad protein assay (Bio-Rad Laboratories -  Technical 
B u lle t in  1051E, A p r i l ,  1977).
PREPARATION OF GASTRIC MUCOSAL EXTRACTS
Stomachs which had been resected fo r  peptic ulceration or 
malignancy were collected fresh and washed in normal buffered saline.
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The mucosa was scraped o f f  with a glass microscope s l id e ,  homogenised in
0 .1 .  phosphate b u ffe r ,  pH 7.3 at 4°C and centrifuged at 18,000 rpm 
(Samloff, 1969). The supernatant was stored at -20°C.
ELECTROPHORESIS OF GASTRIC MUCOSAL EXTRACTS 
Agar gel electrophoresis
Agar gel electrophoresis was carried out by the method described by 
Samloff (1969). 1.5% Noble agar (D ifco) was made up in 0.05M Veronal
buffer pH 8.3 and poured over leve lled  glass plates to a uniform 
thickness of 1 mm. When the agar had s o l id i f ie d  samples were placed in  
slots 10 x 1 mm cut 2-3 cm from the cathodal end. The plates rested 
on a perspex box cooled by c irc u la t in g  water. Electrophoresis was 
carried out fo r  several hours at 11 volts per cm (constant vo ltage).
A fter electrophoresis the plates were incubated in  0.65% bovine 
haemoglobin (Sigma) in 0.06 N HC1, pH 1.6 fo r  10 min. The excess f lu id  
was poured o f f  and the plates were incubated in a humid chamber at 37°C
fo r  1 hr. The plates were then fixed fo r  at least 1 hr in 5% acetic
acid in  50% ethanol. Moist f i l t e r  paper was la id  on the agar surface to  
prevent cracking and the gels were dried and stained with 1% amido 
black, which stained the haemoglobin protein blue and l e f t  a c lear zone 
where there had been proteolysis .
Polyacrylamide gel electrophoresis (PAGE)
This was carried out by three d i f fe re n t  methods:
1. PAGE in the presence of sodium dodecyl sulphate (SDS). This was 
performed by a standard method as described previously (V a l le r ,
1986).
2. Horizontal slab PAGE. The separating gel consisted of 8% acrylamide
and 0.25% bisacrylamide in 0.42% Tris base ( f in a l ly  35 mM), pH 7 .5 .
The electrode buffer consisted of barbito l 22.08g and Tris  base 4.0g  
in  4 l i t r e s  of water, pH 7 .2 -7 .5 .  This was d ilu ted  1:2 fo r the
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cathode chamber. Electrophoresis was carried out at constant power 
2.5W.
3. Discontinuous ve rt ic a l  th in  layer PAGE. The stacking and separation 
gels were s im ila r  to those published (Taggart et a l , 1978). The 
electrode buffers were the same as those used in the horizontal slab 
PAGE.
Proteolytic  a c t iv i ty  in the gels was demonstrated by incubation in  
haemoglobin solution followed by staining with Coomassie blue (Taggart 
et a l , 1978).
PURIFICATION OF PIG PEPSINOGEN
Lyophilised pig pepsinogen (Sigma Chemical Co.) was fu rth e r  
p u rif ied  by ion exchange chromatography and gel f i l t r a t i o n ,  as described 
by Ryle (1970) and f in a l l y  by a f f in i t y  chromatography. A ll the  
procedures were carried out at 4°C. F o rty - f iv e  mg of pig pepsinogen in
0.02M phosphate b u ffe r ,  pH 6.9 was loaded on to a DEAE-cellulose column 
(2 .5  x 20 cm), which was then washed with 100 ml of bu ffe r .  The column 
was washed with an exponential gradient of 1M NaCl, 7.2 ml fractions  
being collected. The fractions containing the resultant optical density  
peak at were assayed fo r pro teo ly tic  a c t iv i t y  by the radial 
diffusion  and Anson's haemoglobin methods. The fractions with maximal 
proteo lytic  a c t iv i ty  were pooled and the to ta l  amount of pepsinogen 
estimated. The sample was concentrated, dialysed against phosphate 
buffer containing 0.1M NaCl and added to a G100 superfine Sephadex 
column (2 .5  x 40 cm), which was washed with Q.02M phosphate b u ffe r ,  pH 
6 .9 ,  8 ml fractions being collected. The fractions containing the 
resultant peak at E230  were assayed as before. The samples containing 
maximal proteolytic  a c t iv i ty  were pooled, dialysed against 0.Q5M 
phosphate bu ffe r ,  pH 6,5 and loaded on to an a f f in i t y  column (2 x 16 cm) 
of poly-L-lysine IB (Sigma catalogue P1886) coupled to Sepharose 4B.
This was washed with 0.05M phosphate buffer pH 6.5 and a l in e a r  gradient 
with 120 ml 1M NaCl applied. The fractions of the resu ltant peak at 
E-280 were assayed as before. The samples with maximal pro teo ly tic  
a c t iv i t y  were pooled, re-run on the washed p o ly - l - ly s in e  column and 
co llec ted , pooled and concentrated as before. The composition of the 
f in a l  sample was determined by amino acid analysis on a Locarte analyser 
following hydrolysis with 6M-HC1 in vacuo fo r  periods ranging from 24-72 
hrs. The sample was also examined by SDS-polyacrylamide gel 
electrophoresis and was also tested fo r  the presence of pepsin 
by milk c lo t t in g  assay at pH 5 .3 . These analyses were undertaken by Dr. 
J. Kay & M.J. V a l le r ,  Biochemistry Department, Univers ity  College, 
C a rd if f .
PURIFICATION OF SEMINAL FLUID ACID PROTEINASE ZYMOGEN
Samples of seminal f lu id ,  obtained from the i n f e r t i l i t y  and 
vasectomy c l in ic s ,  were pooled and stored at -20°C. The pooled seminal 
f lu id  was la te r  thawed and centrifuged at 25,000 rpm at 4°C for 30 mins. 
The supernatant plasma was fractionated by addition of ammonium 
sulphate to 40% saturation. A fte r  cen tr ifug ation , the resultant  
supernatant was assayed fo r  acid proteinase a c t iv i t y  by Anson's method. 
The supernatant was p u r if ied  by DEAE-cellulose by the method of 
Ruenwongsa & Chulavantnatol (1975) and then by a f f in i t y  chromatography 
as described above for pepsinogen. The fractions collected were assayed 
fo r  enzyme a c t iv i ty  by radial d iffus ion  assay and those with peak 
a c t iv i ty  were pooled.
PURIFICATION OF CATHEP5IN D
Cathepsin D was p u r if ied  from normal human spleen by a three step 
procedure as described by Afting & Becker (1981). Normal human spleen
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(6 4 .2 g ) , obtained at splenectomy and stored at -20°C, was homogenised in 
3 volumes of 30mM veronal bu ffer, pH 7.4 . The homogenate was spun at 
17,500 G fo r  15 min at 4°C and the supernatant reta ined. The p e lle t  was 
resuspended in buffer (1 ml per gram of t is s u e ) ,  homogenised and spun 
(31,000g, 20 min). Both supernatants were f i l t e r e d  through glass wool 
to remove fa t  and were pooled and assayed fo r  cathepsin D a c t iv i t y .  
Concanavalin-A-Sepharose CL4B (Pharmacia, 17-0440-01) was washed in a 
Buchner funnel with 30mM veronal bu ffer ,  pH 7.4 containing ImM Mn++ and 
ImM Ca++ and 0.6M NaCl. The combined supernatants were s t ir re d  gently  
at 10 mis per gram of the wet washed ConA-Sepharose fo r  30 mins and the 
gel was washed on a Buchner funnel with excess veronal/0.6M NaCl buffer  
containing ImM mercaptoethanol. The washed ConA-Sepharose was packed 
into a column (30 x 1.5cm) and washed with veronal/NaCl/mercaptoethanol 
until  the eluate had E23Q = 0. The column was washed with 0.1M sodium 
phosphate bu ffe r ,  pH 6.5 containing 0.6M NaCl/lmM mercaptoethanol and
0.2M alphamethyl mannoside (Sigma, M6882). Six bed volumes were 
collected, each volume being allowed to eq u il ib ra te  in the column for 20 
min at room temperature. The eluate fractions were assayed fo r cathepsin 
D a c t iv i ty  as above. The active fractions were pooled and concentrated 
to  10-15 mis with a PM-10 Ami con membrane. The concentrate was applied 
to a Sephadex G100 column (2 x 60 cm) in 0.1M sodium phosphate bu ffer,  
pH 6 . 5 / 0 . 6M NaCl/lmM mercaptoethanol. The cathepsin D a c t iv i ty  of the 
eluate fractions was assayed at pH 3.
Pepstatin-agarose was prepared as follows: isovaleryl pepstatin was 
covalently linked via i ts  carboxyl terminal to  aminohexyl Sepharose CL4B 
with 1 -e th y l- 3 - (3-dimethyl ami nopropyl) carbodiimide by the method of Kay 
& Dykes (1976).
The pooled eluate from the Sephadex column was adjusted to pH 4.0  
with 12N hydrochloric acid and passed through a column containing 5 ml 
of the pepstatin agarose, which had previously been equ ilibrated in
50 mM sodium c i t r a te  b u ffe r ,  pH 4.0 containing 0.6M sodium chloride.
The column was washed with 100 ml of th is  buffer containing 25 ml of 6M 
urea, followed again by 100 ml b u ffe r .  F in a l ly ,  cathepsin D was eluted  
with 50mM NaHC03 so lution , pH 8.2 containing 0.6M sodium ch loride.  
Fractions displaying a c t iv i ty  were pooled and dialysed overnight against 
2mM sodium phosphate bu ffe r ,  pH 6.5 and freeze dried . 40 pg samples 
were tested by SDS-PAGE as described above.
PURIFICATION OF SLOW MOVING PROTEASE
Attempts were made to purify  slow moving protease from fe ta l  
gastric  mucosa. Stomachs from fetuses of gestation age 21-36 weeks 
were collected at autopsy w ithin 24 hours of death and stored at -20°C. 
The stomachs were thawed and the mucosa scraped o f f  with a glass 
microscope slide  and homogenised in phosphate buffer as fo llo w s:-
1. Mucosae from 14 stomachs were separately homogenised in 1:10 volumes 
of 0.005M phosphate bu ffe r ,  pH 7.4 at 4°C at 16,000 rpm. The 
zymogens were extracted by the method of Hirsch-Marie & Touboul 
(1973), which en ta ils  acetone extraction  a t -35°C and ether 
prec ip ita tion  at 4°C. The specif ic  a c t iv i t y  of the resultant  
prec ip ita te  was calculated from the re la t io n  of acid proteinase 
a c t iv i ty  as measured by radial d iffus ion  assay to the protein  
content by Lowry assay. Agar gel electrophoresis of 4 of the 
extracts was carried out, normal adult gastric  mucosal extract being 
used as control. Five extracts were selected fo r  immunisation of  
rabbits .
2. Pooled mucosae from 8 , 5, 8 and 24 fe ta l  stomachs were homogenised 
in  5 vol/g of 20mM sodium phosphate b u ffe r ,  pH 7.2 and centrifuged  
at 20,000 rpm. The supernatants were assayed fo r pro teo ly tic  
a c t iv i ty  by Anson's method and the specific  a c t iv i ty  calculated. A
sample of the fourth homogenate of 24 fe ta l  gastric  mucosae was 
tested by agar gel electrophoresis with normal adult gastric mucosa 
as co n tro l.
PREPARATION OF ANTISERA
All the polyclonal antisera were prepared by in jec tion  of rabbits  
with enzyme or zymogen emulsified in complete Freund's adjuvant and 
boosted with subsequent in jec tio n s . F in a l ly  the rabbits were bled out. 
Sodium azide was added to the serum to in h ib i t  bacteria l growth and the 
serum was stored in aliquots at -20°C. The anti sera were tested for  
immunohistochemical r e a c t iv i ty  by a peroxidase-antiperoxidase (PAP) 
method on sections of paraffin-embedded gastric  mucosa or, in the case 
of anticathepsin D, spleen ( fo r  d e ta i ls ,  see Chapter 3 ) .
Pepsin and Pepsinogen 
A nti-p ig  pepsin
Three rabbits were in jected intramuscularly with 1 mg of pig pepsin 
and boosted with in jections of 0.5 mg at 2 week in te rv a ls .  A fter a 
fu r th e r  2 weeks, the rabbits were bled out.
Anti-p ig  pepsinogen
Antiserum to the highly purif ied  pig pepsinogen was prepared in a 
s im ila r  way to  anti pig pepsin except that there were 7 boosts at 10 day 
in te rv a ls .
Anti-human pepsin
This was prepared s im ila r ly  to anti pig pepsin except that the 
boosts were at monthly in te rv a ls .  Serum from 2 of the rabbits labelled  
normal gastric  mucosa by the PAP method; the rabbits with the higher 
t i t r e  was bled out.
Gastricsin
Antiserum to seminal f lu id  acid proteinase
Three rabbits were in jected with seminal f lu id  acid proteinase,
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50 pg in 2 doses, 1 in traderm ally , the other intram uscularly. Two weeks 
l a te r  a s im ila r  dose was given. A te s t  bleed 3 weeks la te r  showed no 
evidence of antibody to gastrics in  in serum from any of the rabbits and 
in view of the small amount of acid proteinase in the remaining extract  
(154 pg) no fu r th e r  rabbits were immunised.
Anti-human gastric  gastrics in
Three rabbits were immunised by intradermal and intramuscular 
in je c tio n  o f 50 pg ( to ta l )  of human gastric gas tr ics in .  This was 
repeated a f te r  4 weeks and a f te r  a fu rther  4 weeks a s im ila r  in jec tion  
of 37 pg was in jected intramuscularly. Two weeks la te r  a tes t  bleed 
gave positive la b e ll in g  of gastric  body mucosal sections by the PAP 
method with serum from 2 rabb its , the th ird  having died. A fter a 
fu r th e r  week, another intramuscular boost was given and the rabbits were 
bled out a f te r  a fu r th e r  week.
Anti-human seminal gastricsin
Three rabbits were immunised with 25 pg each of seminal gastricsin  
and boosted monthly fo r  2 months. Serum from a l l  3 rabbits was tested  
by the PAP method on normal human gastric  antrum. Only 1 serum labelled  
the glands and the rabbit was boosted twice more at monthly in terva ls  
before being bled out.
Cathepsin D 
Anti-cathepsin D
Three rabbits were injected intradermally and intramuscularly with 
a to ta l  dose of 50 pg of cathepsin D each. One month la te r  a s im ilar  
intramuscular dose was given. Two fu rth e r  intramuscular boosts of 37 pg 
were given a t 2 week in te rv a ls .  Test bleeds gave positive lab e ll in g  of 
para ff in  embedded sections of human spleen by the PAP method with serum 
from 2 rabb its . One of these died and the other was bled out.
SMP
Anti serum to fe ta l  gastric  zymogen
Extracts of 5 fe ta l  gastric mucosae, prepared as above, were
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in jected intradermally and intramuscularly into separate rabbits ( to ta l  
protein dose 5-7 mg) and boosted at 2 week in te rva ls  up to 8 in jec tions .  
The animals were bled out.
Anti-SMP
Rabbit anti-SMP was a g i f t  from Professor I.M . Samloff, VA Medical 
Center, Sepulveda, C a li fo rn ia ,  USA and had been prepared by in jec ting  
New Zealand white rabbits subcutaneously with 100 pg of SMP which had 
been dissolved in phosphate buffered saline and emulsified in complete 
Freund's adjuvant. Booster in jections in incomplete adjuvant were given 
at 4 ,  8 and 12 weeks.
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CHARACTERISATION OF ANTISERA
All rabb it sera were i n i t i a l l y  tested fo r  immune re a c t iv i ty  with 
paraffin-embedded h isto log ical sections. Subsequently, certa in  antisera  
were fu r th e r  tested by double d iffus ion  (Ouchterlony) and immune 
(Western) b lo t t in g .
1. Immune la b e l l in g  by anti sera
Immune la b e ll in g  was performed by the peroxidase-anti peroxidase 
(PAP) method, described in deta il  in Chapter 3. The anti sera were 
tested on formalin fixed para ff in  embedded sections of appropriate 
control tissues as follows:
Normal human gastric  body mucosa -  an t i-p ig  pepsin, an t i-p ig  
pepsinogen, anti-human pepsin, anti-human gastric  gas tr ics in , an t i­
human seminal f lu id  zymogen, anti-human seminal g as tr ics in , a n t i­
human fe ta l  gastric  zymogen, anti-human SMP.
Normal human spleen -  anti-cathepsin D.
The anti sera to fe ta l  gastric zymogen were also tested on sections 
of fe ta l  stomach and the following adult tissues:
Normal gastric  mucosa, colon, pancreas and endometrium.
Carcinomas of stomach, breast, colon, endometrium, ovary and 
pancreas.
An attempt to block non-specific lab e ll in g  was made by preincubating 
a n t i fe ta l  gastric  zymogen with lyophilised umbilical cord serum (1 
and 5 mg/ml) before incubation with sections of normal and 
carcinomatous stomach.
2. Double Diffusion (Ouchterlony)
Immunodiffusion was attempted between pepsin and pepsinogen and 
th e i r  anti sera and between fe ta l  zymogen extracts and th e ir  anti sera but 
not fo r  other aspartic proteinases, as only lim ited  quantities of these 
enzymes were ava ilab le  in pure form.
Immunodiffusion was performed on glass microscope slides layered
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with a 1 mm thick slab of 1.2% Noble agar (DIFCO) in 0.15M phosphate 
buffered sa line , pH 7 .3 ,  containing 4% polyethylene g lycol. Wells, 4 or 
8 mm in diameter, were cut. Commercial pig pepsin, pure pepsinogen and 
the pure pepsin prepared from i t  by acid activation  were tested against 
rabb it  antisera to pig pepsinogen and pig pepsin.
3. Immune(Western) b lo t t i  ng
Extracts of normal human gastric body mucosa (Samioff, 1969) were 
run by discontinuous vert ica l th in  layer PAGE, as described above. Two 
lanes of the gel were detached and enzyme a c t iv i ty  demonstrated as 
before (Taggart et a l , 1978). Protein was transferred to n itroce llu lose  
sheets by a Western b lot method (Towbin, Staehelin & Gordon, 1979). 
Strips corresponding to samples were incubated with anti sera to pig 
pepsin, human gastric  gastricsin  or human cathepsin D, a l l  at 1:20 and 
labe lled  by an ind irec t a lka line  phosphatase technique (Symington,
1984).
COMPARATIVE STUDIES OF CATHEPSIN D AND SMP
The properties of these two enzymes were compared by several 
methods: 1. Enzyme k in e t ic s , 2. Immune b lo tt in g , 3. Electrophoresis
The f i r s t  two were undertaken by Drs. M.J. V a lle r  and J . Kay, 
Biochemistry Department, University College, C a rd if f .
1. Kinetic studies
The hydrolysis of two chromogenic substrates, Pro-Thr-Glu-Phe- 
(N02 )Phe-Arg-Leu and Lys-Pro-Ala-Glu-Phe-(N02 )Phe-Arg-Leu, at th e ir  
Phe-(N02 )Phe bonds was followed spectrophotometrically at 300 nm as 
described previously (Dunn et a l , 1985; Dunn et a l , 1986).
The substrates were kindly supplied by Dr. B.M. Dunn, University of 
Florida College of Medicine. Kinetic parameters were obtained using 
ranges of substrate concentrations appropriate fo r  both enzymes. In a ll  
cases, Michaelis-Menten kinetics were observed and plots of S/v against
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S permitted the f i t t i n g  (by the method of unweighted sum of least  
squares) of unambiguous s tra igh t l in e s .  For each determination, i n i t i a l  
rates (v) were measured with at least f iv e  values of i n i t i a l  substrate 
concentretion (S ).
The active concentration of each enzyme was determined by t i t r a t io n  
against a solution i f  isova lery l-pepstatin  (k indly  supplied by Professor H. 
Umezawa, In s t i tu te  of Microbial Chemistry, Tokyo, Japan). The 
concentration of isova lery l-pepstatin  had been determined by amino acid 
analysis.
K inetic  constants (K^) fo r  the in te rac tion  of the in h ib ito r  from 
Ascaris lumbricoides with SMP and cathepsin D were determined as described 
previously (V a l le r  et a l , 1985). The in h ib ito r  was the kind g i f t  of Dr. T. 
Hofmann, Univers ity  of Toronto and Dr. R. Peanasky, Univers ity  of South 
Dakota.
2. Immunodot b lo tt in g
Immunological c ro ss -rea c tiv ity  between SMP and cathepsin D was 
examined using the immunodot-blot procedure described previously (Heath, 
Lewis & Kay, 1985). The antigens in a range of concentrations from 5 to 60 
g/ml were applied to n itroce llu lose  strips  and reacted with 1:500 and 
1:1000 d ilu tions  of th e ir  respective primary an tisera , heterologous 
anti sera, or with non immune rabbit serum fo r  2 hrs at room temperature. 
A fter washing, the str ips  were incubated with second antibody (sheep 
a n t i - ra b b it  IgG conjugated to horseradish peroxidase; Serotec L td .,  
Bicester, U.K.) fo r  1 hr at room temperature and then developed with 
diami nobenzidine.
3. E lectrophoretic studies
Cathepsin D and SMP were examined by horizontal slab polyacrylamide 
gel electrophoresis (PAGE). The gels were prepared as described above.
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Samples were run a f te r  incubation with th e ir  primary anti sera, heterologous 
anti sera or normal rabbit serum. Enzyme a c t iv i ty  was demonstrated by 
incubating the gels in haemoglobin solution and staining with Coomassie 
blue (Taggart et a l , 1978).
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RESULTS
PURIFICATION OF PIG PEPSINOGEN
The optical density peaks from the chromatography columns are shown 
in Fig 2 .1 ,  The p ro teo ly tic  a c t iv i t y  as estimated 
spectrophotometrically is also plotted and i l lu s t r a te s  that maximal 
a c t iv i t y  corresponded to the optical density peaks. Fractions from the 
DEAE ce llu lose  and Sephadex G100 columns were also estimated fo r  
p ro teo ly t ic  a c t iv i t y  by the radial d iffus ion  assay (Fig 2.2a and b) and 
the results  were in agreement with those shown in Fig 2.1a and b. Of 
the 45 mg of pepsinogen in the orig ina l sample, the amount remaining 
a f te r  each stage was as follows: DEAE ce llu lo s e , 9 mg, Sephadex G100 
3.25 mg and a f f i n i t y  chromatography 1.2 mg.
The amino acid composition of the sample was as follows:
Residues per mole of protein
Arginine 4
Lysine 10
H istid ine  3
Phenyl al anine 16
Tyrosine 15
This is in agreement with the calculated composition of the major 
pig pepsinogen A. No pepsin a c t iv i ty  was detected by milk c lo tt in g  at 
pH 5 .3 . The sample yielded a single l in e  by SDS-PAGE.
PURIFICATION OF SEMINAL FLUID ACID PROTEINASE ZYMOGEN
In 98 ml of pooled seminal plasma the estimated acid proteinase 
content was 12 mg. Following p u r i f ic a t io n ,  an estimated 450 pg was 
re tr ieved .
FIG. 2. PLOTS SHOWING RESULTS OF FURTHER PURIFICATION OF
COMMERCIAL PIG PEPSINOGEN
a. Ion exchange chromatography on DEAE c e llu lo s e . The 
volume of the mixing vessel was 2 l i t r e s  and the 
gradient 0 - 0 .45M NaCl. The resu lts  of rad ia l  
d iffu s io n  assay on the frac tions  of the optical  
density peak are shown in Fig. 2 .2a .
b. Gel f i l t r a t i o n  on Sephadex G100. The resu lts  of 
rad ia l d iffu s io n  assay on the frac tions  of the optical 
density peak are shown in Fig. 2 .2b.
c. A f f in i t y  chromatography on p o ly - l - ly s in e  Sepharose 4B 
f i r s t  run.
d. A f f in i t y  chromatography on p o ly - l - ly s in e  Sepharose 4B 
second run.
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FIG, 2 .2  Radial d iffus ion  assay on agar gel of frac tions  
( ind icated by numbers) which y ie lded the optical 
density peaks shown in Fig. 2 .1 .
a) Optical density peak from F ig . 2 .1a .
b) Optical density peak from Fig. 2 .1b.
Note the l y t i c  zone around each w e l l ,  the diameter 
being proportional to the log (concentration of 
enzyme), c) is the pepsinogen con tro l.
FIG. 2 .3  Antiserum to pig pepsin (8) shows a dense p re c ip i t in
l in e  with both samples ( la rge  and small wells) of pure 
pig pepsin (1 and 11) and both samples of commercial 
pepsin (3 and 10); one of the l a t t e r  (10) y ie ld s  two 
p rec ip ita t io n  l in e s ,  the denser of which shows 
id e n t i ty  with that of pure pepsin (1 ) .  Antipepsinogen 
(9) precip ita ted  with pure pepsinogen ( 5 ) ,  pure pepsin 
(6 and possibly 11) and commercial pepsin (4 and 
possibly 12). There is p a r t ia l  id e n t i fy  between 
pepsinogen (5) and pepsin (6 and 4 ) .
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FIG. 2 .4  IMMUNE (WESTERN) BLOT OF ZYMOGEN FRACTIONS OF GASTRIC 
MUCOSAL EXTRACT
Lanes 1 and 2 are zymograms (on PAGE) of gastr ic  
mucosal e x tra c t ,  neat (lane 1) and 1:5 (lane 2 ) .  The 
lane at the top (arrow) is  the marker dye, towards the  
anode, and the o r ig in  is aligned with the arrow at the 
lower r ig h t  (lane 5 ) .  The fastmoving pepsinogen 
fra c tio n s  (1 -5 ) ,  slower progastricsin bands (6 and 7) 
and SMP (8) show as c lear  l y t i c  zones. There is  a 
protein deposit ju s t  anodal to SMP. Lanes 3, 4 and 5 
are s tr ip s  of n i t ro c e llu lo s e ,  b lotted  from s im ila r  gel 
runs to that in lane 2. They have been labe lled  
respective ly  with antip ig  pepsin ( 3 ) ,  an t ig a s tr ic  
gas tr ics in  (4) and anticathepsin D (5 ) .  In 3, there  
is la b e l l in g  of pepsinogen fractions 2, 3, 4 and 5.
The eccentric deposit between 7 and 8 may be 
a r te fa c tu a l . In 4 there is la b e l l in g  of progastricsin  
f ra c t io n  7 and, apparently, of the SMP zone (8 ) .  In 5, 
there is  a f a in t  deposit near the o r ig in ;  th is  is  
equivocal, but fu r th e r  evidence (F ig  2 .6 ) suggests 
tha t  i t  may genuinely be cathepsin D.

FIG. 2.5 Immunodot-blot. Upper panel. Samples (0 .5  p i)  of
cathepsin D (s tr ip s  1 and 2) and SMP (s tr ip s  3 and 4) 
were applied to n itro c e llu lo s e  s tr ip s  at 
concentrations (from top to bottom) of 0, 60, 30, 15 
and 5 pg/ml. The s tr ip s  were immersed in anti serum to  
cathepsin D at d i lu t io n s  of 1:500 (s tr ip s  1 and 3) and 
1:1000 (s tr ip s  2 and 4 ) .  A fte r  washing, the s tr ip s  
were incubated with a second antibody (peroxidase- 
conjugated sheep a n t i - r a b b it  IgG) and stained with  
diaminobenzidine. Staining is observed with cathepsin  
D but not with SMP. Lower panel. Same as in upper 
panel except tha t  the s tr ip s  were immersed in  
anti serum to SMP at d i lu t io n s  of 1:500 (s tr ip s  1 and 
3) or 1:1000 (s tr ip s  2 and 4 ) .  Staining is observed 
only between anti-SMP and SMP.
FIG. 2.6 Zymogram run in  5% polyacrylamide gel (h o r izo n ta l)  at  
pH 7.5 of the fo llow ing samples:
1. Gastric mucosal ex trac t  and normal rab b it  serum
2. Gastric mucosal extract and anti-SMP
3. Gastric mucosal ex trac t and d is t i l l e d  water
4. Cathepsin D and d is t i l le d  water
5. Cathepsin D and anti-SMP
6. Cathepsin D and normal rabb it  serum
Cathepsin D is  more slow-moving than SMP and is s p l i t  
in to  6 or 7 bands.
The anti-SMP abolishes the SMP band in lane 2 (arrow) 
(compare controls 3 and 1) but not the cathepsin D 
bands in 5 (compare 6 and 4 ) .
The fas t  moving pepsinogen and progastricsin bands are 
fa in te r  than in F ig . 2 .4  because the gel was developed 
in  haemoglobin at pH 3.5 to show SMP and cathepsin D 
optim ally . Pepsinogen and progastricsin  are less  
active at th is  pH than at 2 .0 .
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PURIFICATION OF CATHEP5IN D
. The homogenate of spleen contained 16.85 mg of cathepsin D in  700 
ml. Of 11.28 mg bound to Con-A Sepharose, 4.63 mg was eluted and of 
4.52 mg bound to pepstatin agarose, 1.69 mg was e lu ted . The f in a l  
recovery of cathepsin D was 743 pg.
SDS-PAGE showed the enzyme to be pure and composed of two subunits
of molecular weights 28 and 14 Kd.
EXTRACTION OF ZYMOGEN FROM FETAL GASTRIC MUCOSAL H0M0GENATES
1. Electrophoresis of the 4 samples which contained most enzyme 
demonstrated that in  2 cases there was a band in the position of slow
moving protease while in the other 2 there was no p ro teo ly t ic  band. The
2 former samples were used as antigens fo r  immunisation of rabbits .
2. The to ta l  amount of zymogen in  the four extracts of pooled fe ta l  
gastr ic  mucosae was 2 .6 ,  8 .1 ,  5.2 and 79.8 mg respective ly . The 
amount in the f i r s t  3 was considered too low fo r  the intended fu rthe r  
p u r if ic a t io n  on DEAE ce llu lose  to be worthwhile. Electrophoresis of the 
fourth pooled homogenate yielded l y t i c  bands that corresponded to those 
present in the adult stomach contro l. As zymogens or enzymes other than 
SMP were present, i t  was considered that fu r th e r  attempts to purify  SMP 
from the sample were not worthwhile.
CHARACTERISATION OF ANTI5ERA
1. Immune la b e l l in g  by anti sera 
Antipepsin and antipepsinogen
Rabbit antisera to  pig pepsin and to the purif ied  pepsinogen gave 
strong la b e l l in g  of the glands of human gastric  body mucosa, the 
strongest of each group of rabbit sera being used subsequently. As the 
anti serum to pig pepsin gave stronger la b e l l in g ,  i t  was used in most 
subsequent experiments, ra ther than anti pepsinogen.
The anti serum to human pepsin from one rabb it gave stronger 
la b e l l in g  of gastr ic  mucosal glands than the others, although s t i l l  
weaker than the antisera to pig pepsin and pepsinogen.
D ilu tio n  experiments showed that a l l  three antisera at 1:100 fo r  30 
mins gave sa t is fa c to ry  la b e l l in g  of sections. Trypsinisation of 
sections markedly reduced or abolished la b e l l in g  and was not performed.
A ntigas tr ics in
Antiserum to  seminal f lu id  acid proteinase
A ll  three sera labe lled  weakly the connective tissue of the gastric  
mucosa and prostate. The glands were, however, negative. I t  was 
concluded tha t  the antibodies raised were against some connective tissue  
element which was present in the extract used fo r  immunisation. These 
sera were not used fo r  fu r th e r  experiments.
Anti human gas tr ics in
Antiserum to human gas tr ic  gastr ics in  gave la b e l l in g  of human 
gastr ic  mucosa, the strongest anti serum being used in subsequent 
studies. One rabb it anti serum to human seminal gastr ics in  also labelled  
gastr ic  mucosa s a t is fa c to r i ly .
Anticathepsin D
The rabb it  whose serum gave strongest la b e l l in g  of human spleen 
unfortunately died, and the second strongest anti serum was used 
subsequently.
AntiSMP
Anti sera to  fe ta l  gastr ic  zymogen
Antisera to fe ta l  gastric  zymogen a l l  gave strong non-specific  
la b e ll in g  of connective tissue and epithelium in a l l  the tissues tested.
Normal stomach, colon and pancreas and carcinomas of these s ites  and of 
endometrium a l l  showed strong la b e l l in g  in the cytoplasm and cell  
membranes of normal and malignant e p i th e l ia l  c e l ls .  Pre-incubation of 
antisera  with lyophilised umbilical cord serum reduced la b e ll in g  of 
connective t issue but not that of c e l ls .  The antisera  were considered 
not sp ec if ic  and were not fu r th e r  used.
AntiSMP
The antiSMP donated by Professor Sami o f f  gave la b e l l in g  of gastric  
body mucosa, the d e ta i ls  of which w il l  be described in Chapter 3.
2. Double D iffus ion (Ouchterlony)
The results  of double d iffus ion  between the preparations of pepsin 
and pepsinogen and th e i r  anti sera are shown in Fig 2 .3 .  The anti serum 
to pig pepsin contains an additional antibody which, however, does not 
appear to crossreact with pepsin or pepsinogen.
The fe ta l  gastr ic  zymogen a l l  y ielded several p rec ip it ing  lines  
with th e i r  corresponding an tisera , which were, there fo re , considered not 
to  be s p e c if ic .
3) Immune (Western) b lo tt in g
The results  of Western b lo tt in g  are shown in Fig 2 .4 .  Antipepsin 
reacted with the fa s t  moving pepsinogen fractions and an tigastr ics in  
with the zones corresponding to progastricsin and, apparently,, with a 
zone in the SMP position . The anticathepsin D resu lt  was equivocal.
COMPARATIVE STUDIES OF CATHEPSIN D AND SMP
1. K inetic  studies
K inetic  parameters (kcat and Km) fo r  the hydrolysis of
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Lys-Pro-Ala-Glu-Phe-(N02)Phe-Arg-Leu and Pro-Thr-Glu-Phe-(N02)Phe- 
Arg-Leu were obtained fo r  SMP and cathepsin D. Both enzymes gave 
comparable values fo r  the turnover number (kca^) of each substrate, but 
SMP exhibited considerably lower Km values than did cathepsin D (Table 
2 .2 ).
An even greater d is t in c t io n  between the two enzymes was observed 
with the protein in h ib i to r  from Ascaris 1umbricoides. The a c t iv i ty  of 
SMP was in h ib ited  very strongly, whereas that of cathepsin D was not 
affected  by concentrations of in h ib ito r  as high as 0 .6  M (Table 2 .2 ) .
2. Immunodot b lo tt in g
With th is  procedure (F ig . 2 .5 )  as l i t t l e  as 5 pg/ml of cathepsin D 
was detected read ily  with the anti-cathepsin  D antiserum. In contrast,  
as much as 60 pg/ml of SMP exhibited no r e a c t iv i t y .  Reciprocally, no 
c ro s s -re a c t iv i ty  was observed between anti-SMP and cathepsin D in 
amounts up to 60 pg/ml, while SMP was detectable with anti-SMP in  
amounts down to  30 pg/ml. Control incubations with normal rabbit serum 
gave negative resu lts  with both cathepsin D and SMP (not shown).
3. E lectrophoretic  studies
‘ The resu lts  of zymography are shown in Fig. 2 .6 .  The antiserum to  
SMP abolished the SMP band in normal gastr ic  mucosal extract but did not 
a f fe c t  the cathepsin D.
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TABLE 2.2
KINETIC CONSTANTS FOR THE HYDROLYSIS OF TWO SYNTHETIC CHROMOGENIC 
SUBSTRATES BY SMP AND CATHEPSIN D AND FOR THEIR INHIBITION BY THE 
PROTEIN FROM ASCARIS LUMBRICOIDES
Substrate Ascaris
I a I I b in h ib i to r0
Km ^cat *Sn ^cat ^i
Enzyme (uM) (sec~l) ( UM) (sec"-*-) (nm)
SMP 160 + 30 135 + 10 145 + 35 27 + 3 5 + 1
Cathepsin D 550 + 75 175 + 20 840 + 300 60 + 18 No in h ib i t i i  
at 600 nM
a -  Lys-Pro-Ala-Glu-Phe-(N02)Phe-Arg-Leu. 
b -  Pro-Thr-Glu-Phe-(N02)Phe-Arg-Leu.
c -  The Ascaris in h ib ito r  was preincubated with each enzyme fo r
5 min at 37°C before adding substrate I to  i n i t i a t e  the c a ta ly t ic  
reaction . A ll reactions were in 0.1 M sodium formate b u ffe r ,  
pH 3.1 a t  37°C.
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DISCUSSION
The p u r i f ic a t io n  of pig pepsinogen and human cathepsin D appears to  
have been successful. Preliminary attempts to p u rify  the seminal f lu id  
zymogen were not s a t is fa c to ry ,  judging by the resu lts  of immune 
la b e l l in g  with anti serum to i t ,  but a supply of pure enzyme and zymogen 
was g if te d  to  us before fu r th e r  attempts were made. Fetal stomach was 
expected to be a r ich  source of SMP. However, i t  appeared that the 
stomachs in ear ly  gestation contained so l i t t l e  th a t  p u r i f ic a t io n  was 
not worthwhile, while stomachs in la te  gestation contained other 
aspartic  proteinases, as w i l l  be more f u l l y  discussed in  Chapter 7.
Fetal stomach was therefore  not a practicable source of SMP. The 
anti SMP g if te d  to  us was prepared by rabb it in je c tio n  of SMP. This SMP 
was p u r if ie d  from adult gastr ic  mucosa on an a f f i n i t y  column, on which 
was adsorbed monoclonal antibody to SMP (Samloff et a l , 1987).
The resu lts  of Western b lo tt in g  support the view that anti pepsin 
and a n t ig a s tr ic s in  react with the expected components on the zymograms. 
Later immunolocalisation studies did not support the suggestion that  
a n t ig a s tr ic s in  was contaminated with anti SMP. Despite the additional 
antibody on double d if fu s io n ,  anti pig pepsin was used in subsequent 
work, but the s p e c if ic i ty  was confirmed by absorption controls and by 
la b e l l in g  with anti human pepsin on anti pig pepsinogen.
The studies of SMP and cathepsin D show conclusively that they are 
separate enzymes. This is supported by work which shows that th e ir  
d is tr ib u t io n  in tissues is d i f fe re n t  (see Chapters 3, 6, 8 and 10).
Since th is  work was completed, fu rthe r  investigations by others have 
shown th a t  SMP has properties s im ila r  to  those of cathepsin E (Tarasova, 
Sczecsi & Foltmann, 1986).
CHAPTER 3
THE DISTRIBUTION OF ASPARTIC PROTEINASES IN NORMAL HUMAN
STOMACH AND DUODENUM
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INTRODUCTION
Norrrial s tructure o f gastr ic  and duodenal mucosa
The morphology of the normal gastr ic  and duodenal mucosa is well 
documented at l ig h t  microscopic and u ltras tru c tu ra l  level (Rubin et a l , 
1968).
The surface epithelium is s im ilar  to tha t l in in g  the gastric  p i ts .  
In the gastr ic  body, the crypts contain, in order downwards, mucous 
neck, u n d iffe ren tia ted  neck, par ie ta l and chief c e l ls .  Some parieta l  
c e l ls  are intermingled with ch ie f c e l ls  deeper down the crypts.  
Occasional argyrophil c e l ls  are also present. I t  is thought tha t a l l  
these c e l l  types evolve from the und iffe ren tia ted  neck c e l ls .  In the 
antrum the glands are not as s tra ig h t as in the body, but are coiled and 
l ined by mucous c e l ls ,  scattered among which are variab le  numbers of  
parie ta l c e l ls  (Tominaga, 1975). The glands of the cardia are s im ilar
to those in the antrum. The duodenal mucosa is s im ila r  to that in other
parts of the small bowel, although Paneth c e l ls  are uncommon. The ce lls  
of the submucosal Brunner's glands are of s im ila r  morphology to those of 
the g a s tr ic ,  antral and cardiac glands.
U l t ra s t ru c tu ra l ly ,  there are six ce ll types (Rubin et a l , 1968);
1) ch ie f c e l ls ,  which contain cha ra c te r is t ic  2^m  diameter zymogen
granules, most prominent a p ic a l ly ,
2) par ie ta l  c e l ls ,  which include in t r a c e l lu la r  can a licu li  and 
abundant mitochondria,
3) mucous neck c e l ls ,  which contain mucous granules 0 .2 -2  u.m in 
diameter,
4) py loric  gland c e l ls ,  which resemble the mucous neck c e l ls  but 
include, in add ition , granules which resemble the zymogen granules
of the ch ie f  c e l ls ,
5) surface and p i t  c e l ls ,  with prominent m ic ro v i l l i  and
6) und iffe ren tia ted  neck c e l ls ,  in which organelles are less
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prominent than in  the other cell types.
The.Brunner's glands are u ltra s tru c tu ra l ly  s im ila r  to the c e l ls  of the 
antral glands (Leeson & Leeson, 1968).
D is tr ib u tio n  of aspartic  proteinases 
Pepsi nogen
The main zymogen of the human stomach, pepsinogen, has long been 
known to be a product of the ch ie f c e l ls  (Heidenhain, 1870), in which i t  
has been demonstrated biochemically (H o lte r  & Linderstrpfm-Lang, 1934) 
and by immunofluorescence (Samloff, 1971b). I ts  presence in the mucous 
neck c e l ls  was f i r s t  demonstrated by immunofluorescence in  the pig 
(Yasuda, Suzuki & Takano, 1966) and then in man (Samloff, 1971b; 
Hirsch-Marie et a l , 1976). I t  was found in the apical region of the 
cytoplasm of the mucous neck ce lls  in granules which have non- 
f luorescent centres. Pepsinogen has also been demonstrated in  granules 
of both ch ie f  and mucous neck ce l ls  by an in d ire c t  immunoperoxidase 
method (Wurster, Kuhlmann & Rapp, 1978). There has been no evidence of 
pepsinogen in the other ce ll  types of the gastr ic  body and i t  has not 
been demonstrated in the gastr ic  antrum or in the duodenum. The sub- 
c e l lu la r  location of pepsinogen has not been demonstrated in humans and 
while i t  appears l i k e ly  tha t pepsinogen is synthesised in the chief  
c e l ls ,  i t  is not c lea r  whether i ts  presence in mucous neck ce l ls  
re f le c ts  synthesis or uptake from the lumen of the glands.
Progastricsi n
Progastricsin  has been shown by immunofluorescence to  co-localise  
with pepsinogen in the c e l ls  of the gastric  body, in cytoplasmic 
granules with non-fluorescent centres (Samloff & Liebman, 1973).
Several e lectrophoretic  studies ( S e i j f f e r s ,  Segal & M i l le r ,  1963a; 
S e i j f f e r s ,  Segal & M i l le r ,  1963b; Kushner, Rapp & Burtin , 1964; Hanley, 
Boyer & Naughton, 1966; Hirsch-Marie, 1968; Cheret & Bonfils , 1968; 
Samloff, 1969) have demonstrated acid proteinase a c t iv i ty  in extracts of
antral and duodenal mucosa. This appears to be due not to pepsin but to 
g a s tr ic s in ,  the zymogen of which has been localised by 
immunofluorescence in the c e l ls  of the deep antral glands, duodenal 
Brunner's glands and ducts which open into the crypts of Lieberkuhn 
(Samloff & Liebman, 1973). The surface e p i th e l ia l  c e l ls  appear not to 
contain progastrics in . Progastricsin is probably located in the 
homogeneous granules demonstrable by electron microscopy in the antral 
and Brunner's glands, although th is  has not been proven by 
immunolocalisation studies. Hirsch-Marie et al (1976) found 
progastricsin and pepsinogen in only occasional fundic-type glands in 
the antrum and not in the typ ical antral deep glands. Their work is ,  
however, open to c r i t ic is m  because of the somewhat crude methods they 
used to purify  the zymogens to which they raised anti sera. The 
lo c a l is a t io n  of progastricsin in the gastric  antral glands has been 
confirmed by the immunoperoxidase method (Wurster, Kuhlmann & Rapp, 
1978), although the findings were only b r ie f ly  described. Progastricsin  
has also been demonstrated in the c e l ls  of the cardiac glands 
(Weinstein et a l , 1977).
Thus, progastricsin appears to  be more widely d is tribu ted  than 
pepsinogen, according to the published results  with immunofluorescence 
techniques. I t  appears not to have been localised  at subcellu lar  
1eve l.
Cathepsin D
Early l i t e r a t u r e  on gastr ic  ju ic e  cathepsin is  confused by the fact  
that some early  workers were c le a r ly  discussing the enzyme now termed 
gastricsin  ( W i l ls ta t te r  & Bamann, 1929; Freudenberg, 1940; Buchs, 1953; 
Buchs, 1954; Taylor, 1959). Recent evidence suggests that cathepsin D 
does indeed occur in the gastr ic  ju ic e  (B a r re t t ,  1977b) and mucosa 
(Pohl, Bure? & S lav ik , 1981). Cathepsin D is commonly supposed to be a 
lysosomal enzyme and i t  would be o f in te res t  to know whether i ts
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presence 1n gastr ic  ju ic e  re f le c ts  passive release from cell breakdown 
or active  secretion, possibly in the form of a zymogen (Puizdar & Turk, 
1981). Although lim ited  work on the lo c a l is a t io n  of cathepsin D in 
other s ites  has been undertaken in human (Matthews, Decker & Knight, 
1981; Whitaker, B ertorin i & Mendell, 1983) and animal (Poole, Dingle & 
B a rre tt ,  1972; B ird , Schwartz & Spaniar, 1977) t issues, there appears to  
be no information on the s ites  in which cathepsin D occurs in the 
gastr ic  mucosa.
Slow moving protease (SMP)
Slow moving protease (SMP) has been located by immunofluorescence 
(Hirsch-Marie et a l , 1976) by which there was weak re a c t iv i ty  in the 
gastric  body in the surface epithelium and strong re a c t iv i ty  in the 
antrum, in surface epithelium  and su p erfic ia l  glands. The fluorescence 
was often perinuclear but sometimes also present in the apical region of 
the c e l ls .  As noted above, the purity  of the SMP and, therefore , of the 
antiserum used in th is  study is open to doubt. There appears to  be no 
other published work on the lo c a l is a t io n  of SMP and i ts  function, too, 
is unknown.
Aim of present study
The work to be described in the present chapter was in i t ia te d  in 
order to lo c a lis e  the above four enzymes or zymogens in formal in -f ixed  
paraff in  embedded sections of stomach and duodenum by the peroxidase- 
anti peroxidase (PAP) method (Sternberger, 1970; Burns, 1978).
The aim was to  compare the d is tr ib u t io n  of pepsinogen and progastricsin  
with tha t obtained previously by immunofluorescence and to loca lise  for  
the f i r s t  time cathepsin D and SMP. In add ition , immunolocalisation 
studies were undertaken at u ltras tru c tu ra l  level in an attempt to 
id en t ify  the subcellu lar s ites  in which the enzymes or zymogens occur. 
Their presence on endoplasmic reticulum or in vesicles would indicate  
synthesis or storage respective ly  and i t  would be of in terest to
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determine whether the par ie ta l c e l ls  play a ro le  in zymogen or enzyme 
production. U ltra s tru c tu ra l  id e n t i f ic a t io n  of cathepsin D in secretory 
vacuoles would suggest a ro le  as an e x tra c e l lu la r  enzyme, whereas i ts  
presence in lysosomes would indicate that i t  is implicated in 
in t r a c e l lu la r  p ro teo lys is . The ro le  of SMP might l ikew ise be elucidated  
by determination of i ts  c e l lu la r  and subcellu lar locatio n .
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MATERIALS AND METHODS 
Anti sera
The antisera and d i lu t io n s  used are shown in Table 3 .1 ,  the optimal 
fo r  each being determined by t i t r a t i o n .  The secondary antibodies, swine 
a n t i - ra b b it  immunoglobulin (SAR) and peroxidase-antiperoxidase (PAP) 
were purchased from Dakopatts A/S, Denmark.
Immune-labelling procedure (Peroxidase-antiperoxidase (PAP) method)
Sections were deparaffin ised and endogenous peroxidase blocked by 
incubation in methanol containing fresh 0.5% hydrogen peroxide and 0.2% 
hydrochloric acid fo r  30 minutes. Sections were then washed in tap 
water. Subsequently, a l l  d i lu t ions  were in  0.05 M Tris-HCl bu ffer ,  pH 
7.6 (TBS) and a l l  washings were in 10% TBS. Sections were washed in 10% 
TBS and background staining was reduced by incubation with 20% normal 
human serum. Sections were then overlain with rabb it  antiserum, 
appropriate ly  d i lu te d .  Excess anti serum was washed o ff  and sections 
overla in  with 1:40 swine a n t i - ra b b it  immunoglobulin (SAR) fo r  30 
minutes. This was washed o ff  and the sections overlain with 1:100 
rabb it peroxidase-antiperoxidase (PAP) complex fo r 15 minutes. The dye 
reaction was developed with 0.03% 3,3* diamino-
benzidine tetrahydrochloride solution containing 0.05% hydrogen peroxide 
fo r  10 minutes. Sections were counterstained with haematoxylin or 
methyl green.
Slide rack
In the course of the work, large numbers of sections had to be 
labe lled  with an tisera . The tedium th is  enta iled  stimulated a search 
for a way of s im plify ing the procedure. This led to the design of a 
slide rack which was subsequently used in most of the immune labe lling  
work described in  th is  thesis (Reid et a l , 1985) (F ig . 3 .1 ) .
72
TABLE 3.1
ANTISERA AND DILUTIONS USED IN IMMUNOPERQXIDASE (PAP) METHOD
Anti serum to D ilu tion
Pig pepsin 1 : 200
Pig pepsinogen 1 : 100
Human pepsin 1 : 100
Human gas tr ics in 1 : 100 ( in  20% normal 
human serum)
Human progastricsin 1 : 100
Human seminal 
gastr ics in
1 : 100
Cathepsin D 1 : 100
SMP 1 : 100
Lysozyme 1 : 1000
SAR 1 : 40 ( in  20% normal 
human serum)
PAP 1 : 100
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Electron microscopic immunolocalisation
Sections were overlaid with neat normal swine serum (NSS) fo r  30 
mins and incubated in antiserum to pig pepsin, gas tr ics in  or cathepsin 
D at 1:20, fo r  e i th e r  1 hr at room temperature fo r  the frozen sections 
or 24 hrs at 4°C fo r  the resin embedded sections. Sections were then 
washed and incubated fo r 2 hrs in goat anti rabb it  immunoglobulin (G20) 
at 1:20 in  20mM TBS with 1% bovine serum albumin and azide, pH 8 .3 .
A fte r  fu r th e r  washes in TBS and d is t i l l e d  water, sections were 
counterstained with aqueous uranyl aceta te /lead  c i t r a t e  and coated with 
3% methyl ce l lu lo s e . All anti sera were microcentrifuged and the Tris  
was f i l t e r e d  with m il l ip o re .
Ti ssues
Prelim inary experiments with the PAP technique on p a ra ff in  embedded 
sections of gas tr ic  mucosa showed that la b e l l in g  of pepsinogen, 
progastricsin and cathepsin D was strongest with Bouin's f ix a t iv e  and 
only s l ig h t ly  less so with 10% formol sa line . SMP was most strongly  
labelled  in tissue fixed in 10% formol sa l in e ,  while Bouin's f ix a t iv e  
gave weaker re s u lts .  Other f ix a t iv e s  proved generally  less satis fac tory  
and fo r th is  reason Bouin's f ix a t iv e  or 10% formol saline were used.
Gastrectomy specimens, removed because of peptic u lceration or 
malignancy, were obtained fresh from the operating theatres of Glasgow 
Royal Infirm ary or the General Infirm ary at Leeds. The stomachs were 
opened along the greater curvature and the mucosal surface was washed 
with normal phosphate buffered sa l in e ,  pH 7 .6 .  Full thickness slices  
approximately 10 x 1 mm of stomach or duodenum were f ixed in Bouin's 
f ix a t iv e  or 10% formol sa lin e . The tissues were p ara ff in  embedded and 
6 pm sections cut.
A section, stained with haematoxylin and eosin, of each tissue  
sample was examined to check fo r  i ts  s u i t a b i l i t y  for immune la b e l l in g .  
Samples which included malignant tumour or inflammation were excluded.
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For the studies on cathepsin D and SMP and those on normal duodenum 
f ixod tissue from the f i l e s  was used.
For electron microscopic studies, small pieces of mucosa were 
removed from fresh gastrectomy specimens and fixed immediately in  3% 
glutaraldehyde and a f te r  3 hrs were transferred  to 10% formol sa line .
For lo c a l is a t io n  of pepsinogen and progastricsin in par ie ta l c e l ls ,  
s tr ip s  of gastr ic  w a ll ,  obtained as above from fresh gastrectomy 
specimens, were snap frozen in solid  carbon d iox ide /a lcoho l. Serial 
frozen sections were cut, f ixed in Bouin's f ix a t iv e  and labe lled  with 
anti-human pepsin, the a lte rn a te  sections being stained H&E to  
f a c i l i t a t e  id e n t i f ic a t io n  of the par ie ta l c e l ls .
Absorption controls  
A n ti-p ig  pepsin
A n ti-p ig  pepsin was incubated with ser ia l d i lu t io n s  of pig pepsin 
from 1 mg/ml to  0.5 pg/ml and used in the PAP method to label gastric  
mucosa. As contro ls , a n t i -p ig  pepsin was also incubated with bovine 
t ry p s in ,  ribonuclease and diastase, a l l  at 1 mg/ml. S im ilar experiments 
were performed by pre-incubation of a n t i-p ig  pepsin with seria l  
d ilu t io n s  of p u r if ied  pig pepsinogen at 1:2 -  1:10 (600-120 pg/ml). In 
p ara l le l  experiments, pepsinogen was activated by addition of a 
calculated volume of HC1, so that the pH would f a l l  to  2 .0 ,  thus 
ac tiva t ing  the zymogen to pepsin. A fte r  15 min the acid was neutralised  
by addition of s u f f ic ie n t  NaOH to ra ise the pH to  7 .3 ,  at which pepsin 
has no enzymic a c t i v i t y .  The d ilu tions  with Tris  bu ffer  were such that  
iden tica l amounts of pure pepsinogen and pepsin were used fo r incubation 
with the an ti-peps in . Serial d ilu t ions  of pepsinogen and pepsin were 
used at a range of concentrations between 1:5 and 1:100 (240 and 
12 pg/ml). A f te r  incubation fo r 15 mins at room temperature, the 
solutions were used to label normal gastr ic  mucosa by the PAP method.
An attempt was made to  block immunoreactivity by pre-incubating
a n t i -p ig  pepsin (1:200) with pig in tr in s ic  fac tor (Armour Pharmaceutical 
Co.) 2 mg/ml.
In add it ion , sections of gastric  mucosa were labelled with a n t i­
pepsin, pre-incubated with seria l solutions of pepsin from 1 mg/ml -  
0.5 pg/ml in order to  determine i f  lab e ll in g  of chief and parietal ce lls  
was blocked at d i f fe re n t  d i lu t io n s .
A n ti-p ig  pepsinogen
Blocking experiments s im ila r  to those with an ti-p ig  pepsin were 
performed.
Anti-human pepsin
Because pure human pepsin was scarce, only lim ited  blocking 
experiments were performed with anti-human pepsin (1:200) and human 
pepsin (0 .5  mg/ml) .
A n ti-g as tr ics i  n
Blocking of a n t i -g a s tr ic s in  1:100 was performed with gastricsin  
(100 pg/ml) and the various pepsinogen and pepsin preparations. 
Experiments s im ila r  to  those with zymogen and enzyme were performed with 
seminal f lu id  progastricsin and the gastricsin prepared from i t  by 
a c id i f ic a t io n  to  pH 3 followed by neutra lisation  to pH 7.
Anti-cathepsin D
The cathepsin D g ifted  by Dr. Barrett was used for blocking 
experiments, as even less of the cathepsin D purified  by us was 
ava ilab le . The cathepsin D was used at 1 pg/ml -  0.1 pg/ml and the 
antiserum to  cathepsin D was diluted at 1:200. Sections of normal 
spleen were used as positive controls.
Anti-SMP
Blocking experiments could not be performed as insu ffic ien t pure 
SMP was ava ilab le  to us fo r  th is  purpose.
RESULTS 
GASTRIC BODY 
Pepsinogen
The pattern of la b e ll in g  in the gastric  body was s im ila r  with the 
antisera to pig pepsin, pig pepsinogen and human pepsin, although a n t i ­
pepsinogen gave weaker results than anti-pepsin, both in tissue fixed in 
Bouin's f ix a t iv e  and in that fixed in formol sa line . In a l l  10 cases 
there was strong lab e ll in g  of a l l  the chief ce l ls  in the gastric crypts 
(F ig . 3 .2 ) .  Reaction product appeared granular and was present 
throughout the cytoplasm of the ce lls  and on high power examination was 
noted to be in vesicles with clear centres (F ig . 3 .4 ) .  Marked granular 
re a c t iv i ty  fo r  pepsinogen was also present in the cytoplasm of the 
mucous neck c e l ls ,  although the in tensity  and d is tr ibu tio n  was less 
constant than in the ch ie f c e l ls .  In some cases the surface ep ithe lia l  
c e lls  appeared to contain pepsinogen. In most cases the majority of the 
parie ta l c e l ls  were negative. However, some specimens included a few 
parie ta l c e l ls  in which there was d e f in ite  re a c t iv i ty .  Usually th is  was 
fa in te r  than in the ch ief ce lls  but in some parietal ce lls  i t  was 
marked. Although some positive parieta l ce lls  were adjacent to strongly 
labe lled  ch ie f or mucous neck c e l ls ,  in some cases these parietal ce lls  
were negative while isolated parieta l ce lls  higher up the crypt were 
pos it ive . In four cases the parieta l ce lls  were strongly labelled , even 
in the absence of adjacent positive chief ce lls  in the sections. The 
pattern of la b e l l in g  in the cytoplasm of the parietal ce lls  was not 
granular, but was e ith e r  d iffuse or in the shape of tubular structures 
(F ig . 3 .5 ) ,  the l a t t e r  being thought most l ik e ly  to be the in tra c e llu la r  
c a n a lic u l i .  Frozen sections of fresh stomach obtained at gastrectomy 
showed d e f in i te  lab e ll in g  of some parieta l c e l ls  fo r  pepsinogen m  3 of 
4 cases studied.
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Progastricsin
. Labelling fo r  progastricsin appeared in a l l  10 cases to be s im ilar  
in in te n s ity  and d is tr ib u t io n  to that fo r pepsinogen (F ig . 3 .2 ) .  The 
parie ta l c e l ls  were s im ila r ly  labe lled .
Cathepsin D
Cathepsin D was strongly labelled  in nearly a l l  the parietal ce lls  
in the 26 cases studied (F ig . 3.6a and b). In most specimens the chief
c e l ls  were negative but in occasional cases there was d iffuse p o s it iv ity
which was weak compared with that in the parie ta l c e l ls .  In the mucous 
neck c e l ls  there was a granular reaction, most marked on the luminal 
side of the nucleus, but often deep to the mucus globule (Fig . 3 .7 ) .  A 
few mononuclear c e l ls ,  probably macrophages, in the lamina propria were 
also strongly p o s it ive .
Slow moving protease
In a l l  7 cases there was weak or moderate cytoplasmic labelling  of 
the surface e p i th e l ia l  c e l ls  (F ig . 3 .8 ) .  There was weak re a c t iv ity  with 
mucous neck c e l ls  in 1 case and some parieta l ce l ls  in 2 cases, but in 
a l l  specimens the ch ie f ce l ls  were negative. In a l l  cases there was
strong la b e l l in g  of red blood cell membranes.
GASTRIC ANTRUM 
Pepsinogen
The coiled deep antral glands of 10 cases studied were mainly 
pepsinogen negative, although occasional ce lls  in some glands labelled  
strongly. S im ila r ly ,  although occasional mucous neck ce lls  contained 
pepsinogen, most were negative.
Progastricsin
The c e l ls  of the deep antral glands in 10 cases labelled strongly 
for progastricsin  (F ig . 3 .9 ) .  The apparent granular d is tr ibution  was 
in part due to  coexistence in the cytoplasm of droplets of mucin. 
Progastricsin appeared also to be present in  the mucous neck cells
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Cathepsin D
In the 14 cases studied, the e p ith e l ia l  ce l ls  of the deep antral 
glands showed strong granular re a c t iv i ty  for cathepsin D (Fig . 3 .10 ) .  
Labelling of mucous neck, parie ta l and mononuclear ce lls  was s im ilar  in 
in te n s ity  and d is tr ib u t io n  to that in the body of the stomach.
Slow moving protease
The antral glands were weakly positive in 4 specimens out of 11 
In 2 specimens there was fa in t  la b e ll in g  of some parieta l ce lls  and in 2 
cases the surface e p i th e l ia l  ce lls  were weakly positive .
DUODENUM
Pepsinogen
In 3 fresh cases and 7 from the f i l e s ,  pepsinogen was absent from 
most sections of duodenum. However, occasional ce lls  in the mucosal 
crypts and in  the submucosal Brunner's glands were strongly positive  
(F ig . 3 .1 1 ) .
Progastricsin
Three fresh cases and 7 from the f i l e s  were examined. There was a 
strong reaction fo r  progastricsin in occasional ce lls  in the mucosal 
crypts and in  most c e l ls  of Brunner's glands (3 .1 2 ) .
Cathepsin D
In the duodenum, cathepsin D was predominantly localised to the 
cytoplasm of mononuclear c e l ls ,  probably macrophages, of the lamina 
propria in  the 10 cases examined (3 .1 3 ) .
Slow moving protease
In 8 cases studied, the surface e p ith e l ia l  ce lls  were in 7 
specimens weakly pos it ive . The mucosal crypts were weakly reactive in 1 
case only, and the Brunner’ s glands were in a l l  cases negative.
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ABSORPTION CONTROLS 
Anttpepsin
In a l l  cases la b e l l in g  of gastr ic  mucosa was abolished by prior  
incubation of anti pig-pepsin 1:200 with pig pepsin at 40 pg/ml. When 
the concentration of pepsin was lowered to 4 pg/ml the ch ief ce lls  
became p o s it iv e ,  but the p ar ie ta l c e l ls  remained unlabelled until the 
pepsin was d i lu ted  to  1 pg/ml. In tr in s ic  fa c to r ,  t ryp s in , ribonuclease 
and diastase a l l  f a i le d  to block la b e l l in g  by antipepsin. Labelling was 
only s l ig h t ly  weakened by incubation of anti pig pepsin with pure 
pepsinogen a t  600 pg/ml. By contrast, pure pepsin was e ffe c t iv e  in  
blocking immunoreactivity even when d ilu ted  to 24 pg/ml. Labelling by 
anti human pepsin was only p a r t ia l l y  blocked by p rio r incubation with 
human pepsin at 100 pg/ml.
A n tigastr ics in
Immune la b e l l in g  by an tig as tr ics in  1:100 was completely blocked by 
p rio r  incubation with gastr ics in  at concentrations of 5 pg/ml or more 
but not by any of the preparations of pepsinogen or pepsin. 
A n tigastr ics in  was also blocked by seminal gastricsin  or progastricsin  
at 10 pg/ml. However, progastricsin at 1 pg/ml fa i le d  to reduce the 
in te n s ity  of la b e l l in g ,  whereas gastr ics in  at the same concentration 
completely blocked r e a c t iv i t y .
Anticathepsin D
Cathepsin D a t 1 mg/ml blocked almost a l l  immune re a c t iv ity  of anti 
cathepsin D with spleen, whereas 100 pg/ml reduced lab e llin g  only 
si ig h t ly .
ELECTRON MICROSCOPIC IMMUN0L0CALISATI ON
The ch ie f  c e l ls  of the gastr ic  body were shown to  contain 
pepsinogen and progastricsin w ithin the secretory vacuoles and rough 
endoplasmic reticulum , but the zymogens could not be convincingly
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demonstrated in  the par ie ta l  c e l ls  (Figs 3 .14 , 3.15 and 3 .1 6 ) .  
Cathepsin D was loca lised  to the p a r ie ta l  c e l ls  and appeared to be in  
in t r a c e l lu la r  organelles , possibly lysosomes (Fig 3 .1 7 ) .
FIG. 3.4 Pepsinogen in vesicles of ch ie f  c e l ls  in normal human 
gastr ic  mucosa. Each ves ic le  has a c lear centre and a 
lab e lle d  rim.
Anti pig pepsin, PAP method. xl600.
FIG. 3 .5  Pepsinogen in p a r ie ta l  c e l l ,  apparently w ith in  a
tubu lar  s tructure  (T ) ,  thought to be the in t r a c e l lu la r  
cana licu lus . Most of the pepsinogen is  in ch ie f  c e l ls ,  
but at leas t  one other p a r ie ta l  c e l l  is lab e lle d  (P ) ,  
while another (N) is  negative.
Antip ig  pepsin, PAP method. xl600.

FIG. 3.6 a) Cathepsin D in  normal gastric  body mucosa. There
is granular la b e l l in g  of p ar ie ta l c e l ls  but the ch ie f
c e l ls  are negative.
Anticathepsin D, PAP method. x l80 .
b) Cathepsin D in normal gastr ic  body mucosa. The
cytoplasm of the par ie ta l c e l ls  (P) is  strongly
pos it ive  but the ch ie f c e l ls  (C) are negative.  
Anticathepsin D, PAP method. x520.
FIG. 3.7 Cathepsin D in mucous neck c e l ls  of gas tr ic  body
mucosa. Labelling  is cytoplasmic and granular and 
predominantly supranuclear.
Anticathepsin D, PAP method. x520.

FIG. 3 .8  SMP in the normal gas tr ic  body. I t  is loca lised  in the 
surface epithelium  and in the epithelium  of the g as tr ic  
p i ts .  The mucus globule towards the lumen is ,  
however, negative.
Anti SMP, PAP method. x l80 .
FIG. 3 .9  Progastrics in  in the gas tr ic  antra l glands The upper 
part of the glands ( to  the l e f t  of the p ic ture) is  
negative.
A n t ig a s tr ic s in ,  PAP method. x!80.
FIG. 3.10 Cathepsin D in the deep glands of the gas tr ic  antrum. 
Note the g ran u la r ity  of la b e l l in g .
Anticathepsin D, PAP method. x520.

FIG. 3.11 Pepsinogen in occasional c e l ls  of duodenal Brunner's 
glands. (Luminal surface to  l e f t . )
Anti human pepsin, PAP method. x!88.
FIG. 3.
FIG. 3.
12 Progastrics in  in duodenum, mainly in Brunner's 
but also in mucosal glands.
A n tig a s tr ic s in ,  PAP method. x70.
13 Cathepsin D in  mononuclear c e l ls  o f the lamina 
propria , duodenum.
PAP method. x288.
glands

FIG. 3.14 Pepsinogen in zymogen vacuoles (Z) of gastric  mucosal 
c h ie f  c e l l .  The gold reaction product is seen as 
black granules. Note that some granules are present 
over the par ie ta l ce l l  (P ) ,  possibly in th is  case due 
to  d iffu s io n  of zymogen.
In d ire c t  immunogold method, u lt ra c ry o s ta t  frozen 
section , labe lled  with anti pig pepsin, e lectron  
micrograph x3000.
FIG. 3 .15 Progastricsin  g as tr ic  c h ie f  c e l ls .  The gold reaction  
product is seen as black granules in the secretory  
vacuoles (Z) and rough endoplasmic reticulum  (R) but 
not in the nucleus (N) or in the adjacent p ar ie ta l  
c e l l  (P ) .
Embedded in LR w hite , la b e lle d  with a n t ig a s tr ic s in ,  
in d ire c t  immunogold method, e lec tron  micrograph 
X7500.
"N

FIG. 3.16 Electron micrograph including parts of a g as tr ic  ch ie f  
ce ll  (lower) and par ie ta l  ce ll  (upper). P rogastrics in  
is  lab e lle d  with 20 nm gold p a r t ic le s ,  which are 
located with secretory zymogen vesicles (Z) and rough 
endoplasmic reticulum  (R) of the ch ie f  c e l l  and in  
luminal secretion (S ) .  Note tha t the p a r ie ta l  c e l l  
(P) is negative.
Embedded in  LR w hite , labe lled  with a n t ig a s t r ic s in ,  
in d ire c t  immunogold method, e lectron micrograph 
X15000.
FIG. 3.17 Cathepsin D in  g as tr ic  body mucosal p a r ie ta l  c e l l .
The black gold p a r t ic le s  appear to  be lo ca lis ed  over 
electron  dense organelles, possibly lysosomes. Part 
of the in t r a c e l lu la r  canaliculus (C) is present in 
th is  sec tion .
U ltra c ry o s ta t  frozen section, lab e lle d  with  
anticathepsin  D, e lectron micrograph x8200.
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DISCUSSION
The d is tr ib u t io n  of pepsinogen and progastricsin in stomach and 
duodenum obtained with the immunoperoxidase method appears s im ilar  to 
that demonstrated by immunofluorescence (Sami o f f ,  1971; Sami o f f  & 
Liebman, 1972a, 1973). The lab e ll in g  of both zymogens in some parieta l  
c e l ls  has not previously been described. One obvious p o s s ib il i ty  is  
tha t the anti sera contained more than one antibody. However, the 
zymogens, especia lly  pepsinogen and progastricsin and at least some of 
the enzymes, such as gas tr ics in , to which anti sera were raised, were 
highly pure and any contaminant could have been present in only small 
amounts. Moreover, the contaminant would have to be closely related to  
the enzymes or zymogens, as f iv e  d i f fe re n t  enzyme or zymogen 
preparations a l l  yielded anti sera which gave s im ilar  lab e ll in g  of 
parie ta l c e l ls .
The p o s s ib i l i t ie s  of cross-reaction between an tigastr ics in  and SMP, 
or of contamination of an tigastr ics in  by anti SMP were raised in Chapter 
2 on the basis of the Western blot re s u lt ,  but immunolocalisation sites  
d i f f e r ;  an t igas tr ics in  did not react w ith, for example, red blood cell 
membranes.
Another explanation fo r the staining of parieta l ce l ls  is diffusion  
of zymogen or enzyme from the chief c e l ls .  This might explain labe lling  
of par ie ta l ce lls  adjacent to the chief c e l ls ,  but not of those some 
distance away from pepsinogen-producing c e l ls .  As parieta l ce lls  were 
s t i l l  labelled  in frozen sections of fresh t issue, d iffus ion  seems not 
to be a complete explanation. I t  is ,  however, possible that the 
antisera were bound by a cross-reacting tissue constituent other than 
the antigen, but th is  applies to a ll  immunohistology and is a 
theoretica l l im ita t io n  of the technique.
F in a l ly ,  i t  may be that zymogen or even active enzyme is present 
within the parieta l c e l ls ,  possibly within the in t ra c e l lu la r  
canaliculus.
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Electron microscopic studies have so fa r  fa i le d  to demonstrate 
progastricsin in the parieta l c e l ls ,  except when d iffusion  from adjacent 
ch ie f  c e l ls  could explain i ts  presence.
The d is tr ib u t io n  of cathepsin D in the stomach favours i ts  being a 
lysosomal enzyme and th is  is supported by the electron microscopic 
f ind ings . I t  is d i f f i c u l t  to exclude f u l ly  the p o s s ib i l i ty  that i t  is 
secreted as an e x tra c e llu la r  enzyme, but i ts  absence from most ch ief  
c e l ls  does not support th is ,  and i t  has not been located 
u lt ra s tru c tu ra l ly  in secretory granules and on rough endoplasmic 
reticulum . Unlike pepsinogen, progastricsin and SMP, cathepsin D is  
present in ce lls  of the lamina propria. Morphologically, these are most 
probably h istiocytes but further studies with known so-called markers of 
such c e l ls  have not been undertaken.
The p o s s ib i l i ty  that d iffusion of SMP from gastric  ju ice  could 
account fo r  i t s  demonstration in surface epithelium (see Chapter 4) 
seems u n l ik e ly ,  because pepsin and gastr ics in , which account fo r about 
99% of acid proteo ly tic  a c t iv i ty  in the gastric ju ice  (Samloff, personal 
communication) were not so localised. Indeed, there may be no SMP in 
the gastr ic  ju ice  (Kay, personal communication). SMP, l ik e  cathepsin D, 
could be lysosomal, but electron microscopic immunolocalisation has not 
yet confirmed th is  and i ts  presence on red blood ce ll membranes might 
suggest some other ro le .
The p o s s ib il i ty  was considered that unbuffered f ixa tives  such as 
Bouin's f ix a t iv e  could, because of the low pH, activate  pepsinogen in 
the gastric  mucosa to active pepsin. As pepsinogen and pepsin have 
immunologically only part ia l  id en tity  (Chapter 2 ) ,  the antipepsin would 
be expected to react be tte r  with the l a t t e r .  I f  th is  were the case, 
antipepsinogen should give poorer results with tissue fixed in Bouin s 
f ix a t iv e  than those fixed in non-acid f ix a t iv e s ,  as the zymogen would
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have been activated to  pepsin. Repeat labe lling  with antipepsinogen 
however, showed a s im ila r  pattern of results to those with anti pepsin. 
Zymogen activa tion  could not, therefore , explain the d if fe re n t  results  
with d i f fe re n t  f ix a t iv e s .
8k
CHAPTER 4
THE EFFECT OF DIFFUSION ON THE IMMUNOLOCALISATION OF ANTIGEN
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INTRODUCTION
A well-recognised problem with any immunohistochemical technique is 
that fa ls e  positive results may be generated during the staining  
procedure (Burns, 1978) and appropriate controls are generally included 
with each batch of slides stained. False p o s it iv i ty  may, however, also 
occur i f  the antigen is correctly  labelled  in the section but has moved 
from the s i te  of i t s  normal location in vivo into other areas prior to  
f ix a t io n  of the t issue. Although such a cause of fa lse  
immunolocalisation has been recognised previously (Isaacson et a l , 1980; 
Mason et a l , 1980; Isaacson et a l , 1981), the extent to which i t  occurs 
in practice  has received scant a tten tion . In the investigations  
discussed in Chapter 3, i t  was noted that antibody to pepsin sometimes 
labe lled  connective tissue and ce lls  adjacent to those in which 
pepsinogen was known to occur in v ivo; d iffusion  was suggested, without 
evidence, as a possible explanation. In the present study the extent to  
which the zymogens pepsinogen and progastricsin can diffuse from th e ir  
normal s ites  in gastric  mucosa prior to f ix a t io n  has been examined. The 
d iffus ion  hypothesis has been further tested by introduction of a 
mixture of antigens into tissues in which they do not normally occur.
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MATERIALS AND METHODS 
Human Gastric Mucosa
Five gastrectomy specimens, three of which had been removed fo r  benign 
conditions and two fo r carcinoma, were obtained fresh from the operating  
th ea tre .  From the gastric  body d istant from any obvious les ion , f u l l  
thickness s tr ips  approximately 10 mm long and 2 mm wide were cut. One 
piece was fixed immediately in Bouin's f ix a t iv e .  Each of the others was 
placed in a universal container, along with a small piece of moist 
f i l t e r  paper to prevent dessication. The l id s  were f i t t e d  and the 
specimens were kept at room temperature. Bouin's f ix a t iv e  was added to  
the containers in turn a f te r  10, 20, 30, 40, 50, 60, 90 minutes and 2,
3, 4 , 6, 12, 24, 48 hours.
A fte r  addition of f ix a t iv e  to the f in a l  specimen, a l l  pieces of 
tissue were l e f t  to f i x  for a fu r th e r  48 hours and then embedded in 
p ara ff in  wax. Sections (6um) were labelled by the PAP method with 
anti sera to pig pepsin or to human gastricsin  as described previously.
Mouse Tissues
Fresh murine small in testine was washed through with 0.05M 
TRIS-HCL buffer pH7.6 and then a solution of pig pepsin (10 mg/ml) 
(obtained from Sigma Chemical Co.,Poole, UK) in normal human serum was 
in s t i l le d  into the lumen. The bowel was t ie d  o f f  into 2 cm segments. One 
segment was removed immediately and fixed in 10% formol sa line . The 
other segments were removed and fixed a f te r  1, 6, 12 and 24 hours. 2 mm 
cubes of mouse spleen and l iv e r  were placed in a s im ilar mixture in 
universal containers, a piece of each being removed for f ixa tio n  at the 
same time as the bowel segments. Controls with TRIS buffer in place of
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the serum mixture were performed fo r  a l l  t issues. A fte r  f ix a t io n ,  
sections of l i v e r ,  spleen and transverse sections of small bowel were 
embedded in para ff in  wax. 6/*m sections were labelled  by the PAP method 
with antisera to pepsin, IgG, lambda and kappa chains. Antipepsin was 
used as described above and the other primary antibodies, obtained from 
Dakopatts A/S, Denmark, were used at 1:1000.
Assessment of D iffusion
Each section of stomach was examined microscopically to  ascertain  
that i t  was orientated perpendicular to the gastric  mucosal surface and 
included a suitable  amount of connective tissue surrounding gastric  
glands which contained labelled  ch ief c e l ls .  Sections which did not 
f u l f i l  these c r i t e r ia  were deemed uninterpretable and excluded. The 
maximum distance between the chief ce lls  and the edge of the zone 
labe lled  fo r pepsinogen in the lamina propria was measured with an 
eyepiece micrometer. The presence of lab e ll in g  of connective tissue  
c e lls  was also noted. Sections labelled for progastricsin were 
s im ila r ly  examined but not measured.
In the experiment on murine tissues,the extent to which antigens 
had diffused from the surface into the l i v e r ,  spleen and small in tes tin e  
was noted.
RESULTS
Human gastric  mucosa
As described previously (Chapter 3 ) ,  pepsinogen and progastricsin  
were strongly labelled  in the c h ie f ,  mucous neck and occasional parieta l  
c e l ls  of the gastric  glands in tissues that had been immersed in 
f ix a t iv e  immediately (Fig 4 .1 a ) .  Labelling of the lamina propria 
extended progressively further from the ch ie f  c e l ls  as the duration o f  
f ix a t io n  delay increased (Figs 4 .1 b -c ) ,  the distance by 3 hours usually  
being more than 180 \±m (Table 4 .1 ) .  A fter longer time in te rv a ls ,  the 
edge of the zone became less easy to define and the distance sometimes 
appeared less than in specimens fixed e a r l ie r .  Cells in the lamina 
propria, including lymphocytes, plasma ce lls  and macrophages, became 
strongly pos it ive , often to an extent greater than tha t observed in the 
surrounding connective tissue (Fig 4 . Id ) .  By 24-48 hours, considerable 
autolysis had occurred in most cases and the in ten s ity  of the immune 
reaction product was weaker than at 12 hours.
Mouse Tissues
Antigens were also demonstrated in sections o f  the mouse tissues  
with which they had been l e f t  in contact. In tissues fixed immediately, 
there was la b e ll in g  of the outer surface of the l i v e r ,  spleen 
and in tes tina l mucosa with anti sera to pepsin, IgG, kappa and lambda 
chains (Fig 4 .2 a ) .  In a ll  tissues there was a progressively widening 
zone of la b e ll in g  (Fig 4 .2b -d ) .  This was of simlar extent with each 
antiserum and by 12-24 hours the tissues were d if fu s e ly  labe lled .
All anti sera fa i le d  to label sections of control tissue in contact 
with TRIS buffer.
TABLE 4.1
DISTANCE DIFFUSED BY PEPSINOGEN AFTER DIFFERENT PERIODS OF 
AUTOLYSIS OF GASTRIC MUCOSA
PERIOD OF
AUTOLYSIS DISTANCE (pm)
(hrs)
Case: 1 2 3 4 5
0 - 90 90 0 45
1 135 90 315 270 90
3 180 90 270 270 450
6 360 225 - 135 225
12 - 135 - 90 315
24 - 135 - 225 540
Several slides in Case 1 could not be s a t is fa c to r i ly  assessed ( 
Materials and Methods). Case 3 was studied up to  3 hours only.
FIG. 4.1 Pepsinogen in normal gas tr ic  mucosa f ixed  immediately
(a) and a f te r  auto lysis  of 1 hour (b) and 4 hours ( c ) .
Note the halo of pepsinogen in the lamina propria
around the crypts in b and c. Id  is  a higher 
power view of the area of Fig 4.1c marked and shows 
focal d is t r ib u t io n  of pepsinogen in lymphoid c e l ls  
adjacent to intensely pos itive  ch ie f  c e l ls .  (PAP method 
a x60, b & c x 53; d x 350)
msBSt.
FIG. 4 .2  IgG in mouse l i v e r  f ixed immediately (a) and a f te r  1 
hour (b) and 12 hours (c) au to lys is . There is  
progressive d if fu s io n  of immunoglobulin in to  the l i v e r .  
Higher power (d) shows IgG a t  the edge of the d iffu s io n  
rim at 12 hours. Note the g ra n u la r ity  of la b e l l in g .  
(PAP method; a, b & c x 53; d x 540)

90
DISCUSSION
In human stomach there was a time-dependent increase in the 
distance between the ch ie f ce l ls  and the edge of lab e ll in g  of connective 
tissue and ce l ls  of the lamina propria fo r both pepsinogen and 
progastricsin . This is consistent with the hypothesis that a f te r  
removal of tissue from the body, the zymogens d iffuse  into the 
surrounding tissues from th e i r  normal s i te .  The appearances seen in the 
autolysing mouse bowel, l iv e r  and spleen can only be explained by 
d iffus ion  of serum immunoglobulins and pepsin into the tissues since the 
controls not in contact with these antigens were negative.
The distance between the normal s i te  of an antigen and the edge 
of the d iffus ion  zone in surrounding tissues is dependent upon 2 
factors:
1. The rate  of d iffus ion  of f ix a t iv e  into the tissues, which is 
approximately proportional to the square root of time (Bancroft & 
Stevens, 1982).
2. The rate  of d iffusion  of antigen through the tissues, which 
decreases with time, although in a more complex way than (1) (Harris ,  
1972).
The increasingly long time in tervals  chosen re flec ted  the expected 
decreasing rate  of d iffusion  of antigen. The apparent diminution in the 
distance diffused a f te r  autolysis of 6 hours or more in some samples 
probably re f le c ts  d i f f i c u l t y  in defining the d iffusion  edge c learly  and 
differences in concentration of pepsinogen in ch ie f c e l ls ,  plane of 
section and f ix a t io n  times.
An additional factor which might accelerate d iffusion  is tissue  
digestion. This might be s ign ifican t i f  an antigen were an enzyme or 
colocalized with an enzyme. This was considered unlikely  to be the case 
with pepsin and gastricsin which are inactive at the physiological pH at 
which the above experiments were carried out.
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I t  is  important to  note the short time, often less than 1 hour, in  
which a d iffus ion  e f fe c t  may be noted. This has implications fo r  immune 
lo c a lis a t io n  of antigens in tissues not fixed immediately. Moreover, 
most f ix a t iv e s  in common use penetrate tissues at less than 1 mm per 
hour (Bancroft and Stevens, 1982). In large pieces of tissue, complete 
f ix a t io n  of antigens may be delayed fo r  several hours and hence 
s ig n if ic a n t  d iffus ion  may occur.
Falsely localised antigen due to d iffus ion  is l ik e ly  to occur 
adjacent to s ites containing high antigen concentration, as in Fig 
4 . Id .  However, d iffus ion  w il l  occur not only from tissue but also from 
bathing f lu id  such as plasma, and ce l ls  may take up tissue f lu id  during 
autolysis or even during l i f e .  This problem has been noted by Mason et 
a l , 1980 and by Isaacson et al (1980, 1981), who, in complementary 
experiments to those described above, demonstrated synthesis of antigen 
by c e l ls  in which i t  had previously been localised immunohistologically. 
Their c r i t e r ia  fo r  recognising uptake of antigen, in th is  case 
immunoglobulin and albumin from permeating plasma were that reaction  
product in the c e l ls  was d if fu s e , non-granular and often in the nucleus 
as well as in the cytoplasm. While th is  may often be tru e ,  i t  can been 
seen from Fig 4.2d that d iffusion  cannot be ruled out because labe lling  
is granular, presumably because prominent cytoplasmic organelles such as 
mitochondria would s t i l l  cause such a pattern on l ig h t  microscopy, even 
i f  antigen had diffused into the c e l l .
The focal d is tr ib u t io n  of labe lling  seen in Fig 4 . Id is of in terest  
as i t  could read ily  be mistaken for genuine in vivo lo ca lis a tio n . There 
are several possible explanations fo r  such a pattern: f i r s t l y ,  uptake
of antigen by c e l ls  may vary, as differences in the survival time of 
ce lls  in tissue removed from the body could lead to active ingestion of 
antigen by l iv e  c e l ls  or passive uptake by dead ones. Moreover, some 
antigens could be imbibed or bound se lec t ive ly ,  although in the case of
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pepsinogen and progastricsin th is  is un like ly  as there are no natura lly  
occurring in t r a c e l lu la r  protease inh ib ito rs  with which these zymogens 
might form complexes (Kay, 1985). Secondly, antigen may be 
p re fe re n t ia l ly  washed out of e x tra c e llu la r  tissue during processing. 
T h ird ly , there may be masking of e x tra c e llu la r  antigen; with formalin  
f ix a t io n ,  formation of cross-links between immunoglobulin and other 
e x tra c e llu la r  proteins may reduce the an tigen ic ity  of the 
immunoglobulins and a s im ila r  mechanism might operate in the present 
experiments (Brandtzaeg, 1982). Whatever the explanation i t  is 
important to recognise that fo c a l i ty  of immunostaining does not 
necessarily exclude d iffus ion  of antigen.
The degree to which a substance diffuses depends, amongst other 
th ings, on i ts  molecular weight, which in the above experiments varied 
from 42 kd for pepsinogen and progastricsin to 150 kd for IgG. Other 
factors such as charge and s ite  o f attachment in tissue w il l  vary and 
some antigens w il l  remain in th e ir  orig inal s i te  even a f te r  considerable 
autolysis has occurred. However, in lo ca lisa tio n  studies the 
p o s s ib i l i ty  of artefactual lab e ll in g  due to d iffus ion  should always be 
taken into account, especially  when autopsy material is used or when the 
f ix a t io n  time of surgical biopsy material is not known. As 
immunohistochemical and other loca lis a tio n  techniques become more 
sen s it ive , such arte facts  are l ik e ly  to lead to an increased number of 
fa ls e  positive resu lts .
CHAPTER 5
IDENTIFICATION AND ORIGIN OF SEMINAL FLUID ACID PROTEOLYTIC
ACTIVITY
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INTRODUCTION
A zymogen, activated at optimal pH 2 .5 ,  was f i r s t  demonstrated in 
human seminal plasma by Lundquist & Seedorff (1952). Later, the 
charac te r is t ics  of th is  zymogen were shown by chromatography, 
electrophoresis and immunochemistry to be s im ila r  to those of a zymogen 
found in extracts of gastric  and duodenal mucosa ( S e i j f f e r s ,  M i l le r  & 
Segal, 1965; Hirsch-Marie & Conte, 1967; Hirsch-Marie, 1968). These 
authors used d i f fe re n t  terminologies but a l l  appeared to be describing 
progastricsin . Sami o f f  & Liebman (1972a) purif ied  two zymogen fractions  
from seminal f lu id  and demonstrated that they were e lectrophoretica lly  
and immunochemically indistinguishable from the two progastricsin  
fractions known to be present in gastroduodenal mucosa. The zymogen was 
also purif ied  by Ruenwongsa & Chulavantnatol (1975), who found that i ts  
c a ta ly t ic  a c t iv i ty  on some substrates, such as haemoglobin, resembled 
tha t of pig pepsin, but that i t  was less e f fe c t iv e  than pepsin in 
hydrolysing synthetic substrates. The seminal f lu id  zymogen is 
i r re v e rs ib ly  denatured at neutral pH; so i t  cannot be cathepsin D or E 
(B a rre t t ,  1977a).
Thus, although the seminal f lu id  zymogen is s im ilar  to 
progastricsin of gastroduodenal mucosa, d e f in ite  proof of id en tity  has 
s t i l l  not been furnished. Moreover, the o rig in  of the zymogen is not 
c lear .  Lundquist & Seedorff (1952) claimed that i t  originated in the 
seminal vesicles. The process of e jaculation  has been studied by x-ray  
cinematography (Mitsuya et a l , 1960) and the find ings, combined with 
those of biochemical marker studies of epididymis, prostate and seminal 
vesicle appeared to show that acid proteolytic  a c t iv i ty  was confined to 
the la te r  part of the e jacu la te , which originated in the seminal 
vesic le , while there was no a c t iv i ty  in the early  e jaculate , which came 
from the prostate (MacLeod & Hotchkiss, 1942; Glezerman & Lunenfeld,
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1975). The zymogen was therefore  considered to be derived from the
seminal vesicle and not the prostate. On the other hand, Hirsch-Marie &
Delafontaine (1978) found equal amounts of a c t iv i ty  in fractions of  
s p l i t  ejaculates and concluded that the zymogen originated in both 
seminal vesic le  and prostate. The most convincing evidence that
prostate is  one, i f  not the only, source is that a zymogen, considered
to be progastricsin , was isolated from homogenates o f prostate (Chiang 
et a l , 1981). Thus, while biochemical data favour an orig in  in prostate 
and perhaps in seminal ves ic le , other sources in the male genital t ra c t  
have not been excluded. The precise c e l lu la r  loca lis a tio n  of the 
seminal f lu id  zymogen is unknown.
In the present study, the biochemical properties of the seminal 
f lu id  enzyme were compared with those of gastricsin  and pepsin from 
human gastric  mucosa and the s i te  of o r ig in  of the zymogen was 
determined immunohistochemically.
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MATERIALS AND METHODS
IMUNQHISTQCHEMICAL STUDIES 
Anti sera
The rabb it  anti sera and human enzymes and zymogens used are shown 
in Table 5 .1 .  All anti sera were d ilu ted  in Tris  buffered saline (TBS) 
except fo r  an t ig as tr ic  gastrics in  which was d ilu ted  in 10% normal human 
serum in TBS. The antiserum to seminal gastrics in  was raised in rabbits  
by ser ia l in jec tio n  of the enzyme in Freund's adjuvant (Chapter 2 ) .
Absorption control experiments were performed by incubation of 
anti sera with enzyme or zymogen for 1 hr at room temperature before 
use.
Ti ssues
A ll  tissues were from the routine surgical histology f i l e s  of the 
Pailtology Department, Glasgow Royal Infirmary and had been fixed in 10% 
f@rw@1-sal ine and paraffin-embedded. 6pm sections were cut. Ninety-six  
c m e s  ©f benign prostatic enlargement were studied. In 85 the prostate 
ted been removed transure th ra lly  as curettings and in the other 11 cases 
toy fuipratpubic enucleation. Other normal male genital t ra c t  tissues 
studiied1 (number of cases in brackets) were te s t is  (1 6 ) ,  epididymis (12 ),  
vas deferens(1 1 ) ,  seminal ves ic le(3) and bladder tra n s it io n a l mucosa
iwh
A selected group of 19 benign prostates was also labelled with
awtii pepsi n.
A lte r n a te  seria l sections from 10 of the cases of benign nodular 
ltypefp>1asi;a were labelled for progastricsin and prostatic acid 
|pte§ptotase.> The extent of co loca lisation  was determined by examination
WTti a comparison microscope.
a l l  staining runs a section of normal gastric  body mucosa
TABLE 5.1
ANTISERA AND ZYMOGENS OR ENZYMES
Anti sera to: Source D ilu tion
Gastric gastr ics in See Chapter 2 1:100
human
in 10% normal 
serum in TBS
Human pepsin See Chapter 2 1:100 in TBS
Prostatic  acid phosphatase Miles Lab. Ltd. 1:500
Seminal gastr ics in See Chapter 2 1:100
Blocking controls
Seminal progastricsin Prof. J. Svasti, Bangkok
Seminal gastr ics in  "
Gastric gastr ics in  Prof. J. Tang, Oklahoma
Pig pepsin Sigma Chemicals Ltd.
Pig pepsin "
10 |ig/ml
1 mg/ml
labe lled  with anti gastr ic  gastricsin  was included as a positive control.  
Sim ilar sections were labe lled  with anti serum to gastric  gastricsin  and 
seminal gastr ics in  and controls in which both antisera were preincubated 
with seminal gas tr ics in  (10 ^g/ml) fo r  1 hr at room temperature were 
i ncluded.
The s p e c if ic i ty  of immune la b e ll in g  of the prostate was also 
demonstrated by attempts to block staining by prior incubation of 
a n tig as tr ics in  with gastr ics in  (10 ug/ml) or pig pepsin (10 pg/ml or 
1 ug/ml) fo r  1 hr. For th is  purpose the most strongly positive 13 cases 
were selected. As human pepsin was in short supply, pig pepsin, which 
is immunologically s im ila r ,  was used fo r  absorption experiments.
BIOCHEMICAL STUDIES
These experiments were carried out by Drs. M.J. V a lle r  and J . Kay, 
Biochemistry Department, University College, C a rd if f .  The inh ib itors  
iso va le ry l-  and 1actoyl-pepstatins were g i f ts  from Professor T. Aoyagi, 
In s t i tu te  of Microbiological Chemistry, Tokyo. The preparation of the 
l a t t e r  has been described previously (Kay et a l , 1982). The synthetic  
peptide substrate Pro-Thr-Glu-Phe-(N02)Phe-Arg- Leu was a g i f t  from Dr. 
B.M. Dunn, University of F lorida . The hydrolysis of th is  substrate by 
the various acid proteinases was followed at 300 nm in formate bu ffer,  
pH 3.1 at 37°C as described previously (Kay, V a l le r  & Dunn, 1983). Km 
values for the enzymes were obtained with substrate concentrations of 
10-100 um for pepsin and 50-300 |im for gas tr ics in . Michaelis-Menten 
kinetics were observed in a l l  cases and s tra ig h t lines were f i t t e d  to 
plots  o f  S/v vs S by the method of unweighted sum of least squares. For 
each: determination i n i t i a l  rates v were measured with at least f iv e  
valuer (estimated to be precise +5%) of the i n i t i a l  substrate 
ee^eentifation S w ithin these ranges.
With Pro-Thr-Glu-Phe-(NO2 )Phe-Arg-Leu at concentrations between 40
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and 130 pM as substrate, k in e t ic  constants (Ki) fo r  the in h ib it io n  of 
the enzymes by is o v a le ry l-  and lactoyl-pepstatins were determined. The 
in h ib ito rs  were used at 0.03-1 pm and 2-20 pM respectively with the 
seminal and gastr ic  gas tr ics in . Both inh ib ito rs  were added at 
concentrations between 5-25 nM to pepsin. For t igh t-b ind ing  inh ib ito rs  
Ki values were obtained by the method of Goldstein (1943), while for  
weaker-binding in h ib ito rs  plots of 1/v vs in h ib ito r  at d i f fe re n t  
substrate concentrations were used.
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RESULTS
IMMUNOHISTOCHEMICAL STUDIES
S ix ty -s ix  of the 96 cases of benign prostatic  enlargement gave a 
positive reaction fo r  progastricsin in the cytoplasm of the c e l ls  
l in in g  the a c in i .  Labelling was in most cases confined to  a few acini 
but was invariab ly  strong (F ig . 5.1 and 5 .2 ) .  In some cases labe lling  
was widespread, but even then was fo ca l.  Often the supranuclear 
secretion in the t ip s  of ce l ls  was positive (F ig . 5.3 and 5 .4). There 
was no difference in la b e ll in g  between prostates removed in ta c t and 
those removed by transurethral resection. There was no evidence o f 
progastricsin in any of the sections of normal t e s t is ,  epididymis, vas 
deferens, or bladder tra n s it io n a l mucosa. Spermatozoa in the te s tis  
were negative. The epithelium of the seminal vesic le  was rich  in 
l ipofusc in  which, being brown and granular, could have been mistaken fo r  
reaction product. However, the granules were no more intensely brown in  
sections labelled  fo r  progastricsin than in control sections stained 
only with haematoxylin and were therefore considered to  be progastricsin 
negative.
Serial sections from 10 cases of progastricsin positive prostates 
were labe lled  fo r acid phosphatase, which gave a strong reaction in  
nearly a l l  acinar c e l ls .  Comparison microscopy showed tha t none of the 
few acid phosphatase negative ce lls  contained progastricsin* AH 19 
prostates labelled  for pepsin were negative.
Controls
There was strong lab e ll in g  of prostate with antigastrics in  
preincubated with pepsin at both concentrations used* but not when 
preincubated with gastricsin  (Fig 5.5a and b ) .
Preincubation with seminal gastricsin  abolished staining of gastric 
mucosa by an tig as tr ic  gastricsin  but not by anti pepsin (Fig S*6a»d)*
FIG. 5.
FIG. 5.
1_ Progastricsin  in the acinar epithelium of the benign 
prostate .
Note th a t  progastrics in  appears to  be fo c a l ly  d is tr ib u te d  
even w ithin ind iv idual a c in i .
Labelled with a n t ig a s tr ic s in ,  PAP method. x76.
2  Progastricsin in the acinar epithelium of the benign 
prostate . In th is  case most acinar e p i th e l ia l  c e l ls  
are stained.
Labelled with a n t ig a s tr ic s in ,  PAP method. x76.
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FIG. 5.
_1 Progastricsin  in the acinar epithelium of the benign 
prostate.
Note tha t  progastrics in  appears to be fo c a l ly  d is tr ib u te d  
even w ith in  ind iv idual a c in i .
Labelled with a n t ig a s tr ic s in ,  PAP method. x76.
2 Progastricsin  in the acinar epithelium of the benign 
prostate . In th is  case most acinar e p i th e l ia l  c e l ls  
are stained.
Labelled with a n t ig a s tr ic s in ,  PAP method. x76.
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3 Progastrics in  in the acinar c e l ls  of the benign prostate .  
Labelling  is most intense towards the luminal end of the  
c e l ls .
Labelled with a n t ig a s tr ic s in ,  PAP method. x350.
j4 Progastrics in  in p ro s ta t ic  acinar ep ithe lium , in which 
i t  is  located at the luminal end of the c e l ls  and in  
secretion (S ) .
Labelled with a n t ig a s tr ic s in ,  PAP method. x420.
X

FIG. 5.5 Prostate lab e lle d  with a n t ig a s tr ic  g a s tr ics in  (a) without 
and (b) with p r io r  incubation of anti serum with seminal 
g as tr ics in  (10 pg/ml) fo r  1 hr at room temperature.
PAP method. x90.

FIG. 5.6 Stomach la b e lle d  with anti human pepsin (a and b) or 
antihuman gas tr ic  gas tr ics in  (c and d ) .  In b and d 
each anti serum was preincubated with seminal g as tr ics in  
(10 pg/ml) fo r  1 hr at room temperature.
PAP method. x90.
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BIOCHEMICAL STUDIES
I t  can be seen from the data in Table 5.2 th a t  Pro-Thr-Glu-Phe- 
(N02)Phe-Arg-Leu has a lower Km value with human pepsin than fo r  gastri  
gas tr ics in . I t  would appear tha t the seminal enzyme behaves more l ik e  
gastr ics in  than a pepsin. This conclusion is confirmed by the 
in h ib it io n  constants obtained with the two pepstatins (Table 5 .2 ) .  In 
keeping with previous observations with animal pepsins (Kay, V a lle r  & 
Dunn, 1983) lac to y l-p ep sta tin  is  equally as e f fe c t iv e  an in h ib ito r  of  
human pepsin as is  the isovalery l d e r iv a t iv e .  By con trast, la c to y l -  
pepstatin in h ib its  gastr ic  gastr ics in  very weakly.
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TABLE 5.2
KINETIC CONSTANTS FOR THE HYDROLYSIS OF PRO-THR-GLU-PHE-(NOo)PHE- 
ARG-LEU BY HUMAN PEPSIN, GASTRIC GASTRICSIN AND THE SEMINAL ENZYME. 
AND FOR THE INHIBITION OF THESE REACTIONS BY ISOVALERYL-AND LACTOYL- 
PEPSTATINS
Substrate 
Km (mM)
Isovalery l-  Lactoyl- 
pepstatin Q pepstatin 
^  (xlOa )M
Human pepsin 0.11 *0.05 0.04
Gastric gastr ics in 0.42 10 580
Seminal enzyme 0.60 16 400
All reactions were in 0.1M sodium formate bu ffe r ,  pH 3.1 at 37°
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DISCUSSION
The immunohistochemical results demonstrate c lea r ly  that  
progastricsin is present in and presumably synthesised and secreted by 
the c e l ls  l in in g  the prostatic ac in i .  This is supported by the 
observation that the zymogen was located in the t ips  of c e l ls .  There is 
no evidence of i ts  presence in seminal vesicle epithelium, although, as 
th is  tissue was obtained postmortem, i t  is possible that loss of zymogen 
due to autolysis could explain the negative resu lts . There was no 
evidence of progastricsin in any of the other tissues studied from the 
male gen ito -urinary  t r a c t .  The spermatozoa are known to contain an 
acrosomal acid proteinase (Polakoski, Williams & McRorie, 1973) but 
showed no evidence of progastricsin.
As la b e ll in g  with antigastr ics in  was blocked by prior incubation 
with gastr ics in  of gastric  origin and by gastricsin and progastricsin of 
seminal f lu id  o r ig in ,  but not by pepsin, even at high concentration 
(1 mg/ml), the zymogen labelled must be progastricsin and not 
pepsinogen. This is supported by the finding that the prostate did not 
label with anti pepsin.
The biochemical data, too, show that the seminal f lu id  zymogen 
behaved more l ik e  a gastricsin than a pepsin. F i r s t ly ,  the Km value of 
the seminal zymogen for hydrolysis of the synthetic substrate Pro-Thr- 
Giu-Phe-(NO2 ) Phe-Arg-Leu is closer to that of gastricsin than of pepsin, 
which is much lower. Secondly, both pepstatins, especially  
lac to y l-p e p s ta t in ,  are weak inh ib itors  of gastricsin and the seminal 
enzyme and strong inh ib itors  of pepsin.
Biochemically and immunohistochemically, therefore, the seminal 
enzyme behaves l ik e  gastricsin and not l ik e  pepsin and appears to be 
produced by the e p ith e l ia l  ce lls  which l in e  the prostatic ac in i.
I t  is tempting to speculate on i ts  function. As progastricsin is 
not activated to gastricsin at the pH of semen, normally around 7.4,
1 0 4
i t  cannot have any pro teo ly tic  role before ejaculation (Polakoski & 
Zaneveld, 1976). In the vagina, however, the pH can f a l l  to  4, low 
enough to ac t iva te  the zymogen and within the range of proteolytic  
a c t iv i t y  of gas tr ics in ,  which may be implicated in digestion of vaginal 
protein or mucoprotein a f te r  ejaculation (S e i j f fe r s ,  M i l le r  & Segal, 
1965; Hirsch-Marie & Delafontaine, 1978). The presence of other acid 
proteinases in acrosomal extracts of spermatozoa from various mammals, 
including humans, supports th is  suggestion (Polakoski, Williams & 
McRorie, 1973). Presumably pepsin, optimally active at even lower pH 
than g a s tr ic s in ,  is  less suited to such a function.
E ffo rts  have been made to correlate  the concentration of seminal 
gastr ics in  with sperm count and a tendency towards an inverse 
re la tionsh ip  was found, but proved not to be s ta t is t ic a l ly  s ign ificant  
(Hirsch-Marie & Delafontaine, 1978).
The findings in the above study have since publication (Reid et a l , 
1984, 1985) been confirmed (Reese et a l , 1987) and progastricsin 
demonstrated mainly in the central zone of the prostate, with a sharp 
boundary at the junction with the peripheral zone. This is the f i r s t  
evidence th a t  these two zones may serve d if fe re n t  biological functions. 
In the same study, progastricsin was also found in seminal vesicle 
epithelium; the discrepancy between th is  observation and that of the 
present study could be due e ith e r  to differences in the avid ity  of the 
anti sera or to  erroneous in te rp re ta tion  of brown lipofuscin granules as 
positive s ta in ing .
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CHAPTER 6
t i X S P M & m m t i F  ASPARTIC PROTEINASES IN NORMAL TISSUES 
OTHER THAN STOMACH
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INTRODUCTION
I t  has been established in Chapter 3 that pepsinogen is normally 
present and presumably produced in stomach and progastricsin in 
stomach, duodenum and prostate. In th is  chapter, the d is tr ibu tio n  of 
cathepsin D and SMP in other sites in the body w il l  be considered.
Although cathepsin D is known to be widely d is tr ibu ted , the sites  
from which i t  orig inates have not been determined. B io tin -labe lled  
pepstatin has been used to loca lise  cathepsin D in cultured human 
synovial c e l ls  (Matthews, Decker & Knight, 1981) and the same cells  in 
rabb it have been immunocytochemically labelled (Poole, Dingle & 
B a rra tt ,  1972). Cathepsin D has also been localised in rat skeletal 
muscle by electron microscopic detection of enzyme reaction product 
(B ird , Schwartz & Spanier, 1977) and in human skeletal muscle and 
phagocytes by electron microscopic immunocytochemistry (Whitaker, 
Bertorin i & Mendel 1 , 1983). Cathepsin D has, however, been purified  
from human gastr ic  mucosa as described in Chapter 1, although the cells  
which produce i t  were not then known.
The d is tr ib u t io n  of slow moving protease has been even less 
c le a r ly  defined. The tissues in which i t  occurs have not been 
determined, apart from gastric  mucosa (Chapter 3) and i ts  role is  
unknown. The present study was undertaken to localise  cathepsin D and 
SMP in  normal human tissue by the immunoperoxidase (PAP) method.
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MATERIALS AND METHODS 
Anti sera
Anticathepsin D was used at 1 : 100 fo r  1 hr. Sections were 
counterstained with methyl green or haematoxylin but the Prussian blue 
reaction was performed on the lung sections instead of a counterstain, 
so th a t  the brown haemosiderin granules commonly seen in alveolar  
macrophages would not be confused with the brown reaction product of 
the PAP technique.
Rabbit antilysozyme (Dakopatts A/S, Denmark) at 1 : 1000 in 0.05M 
TBS, pH 7.6 was used on selected tissues so that the d is tribution  of 
lysozyme might be compared with that of cathepsin D.
Anti-SMP was used at 1 : 100 as in labe lling  experiments on 
gastr ic  mucosa.
Tissues studied
Tissues studied were from the routine surgical f i le s  of the 
Pathology Departments, Glasgow Royal Infirmary and the General 
In firm ary at Leeds. All tissues were fixed in 10% formol saline and 
p a ra f f in  embedded. 6 pm sections were used in the immunoperoxidase 
PAP method.
Tissues examined for cathepsin D (number of cases in brackets) 
were:- spleen (7 ) ,  l iv e r  (5 ) ,  small bowel (5 ) ,  large bowel (6 ) ,  lung 
( 6 ) ,  prostate ( 7 ) ,  lymph nodes (6 ) ,  brain (5 ) ,  jo in t  synovium (2 ) ,  
kidney (5) and placenta (7 ) .
Tissues stained fo r lysozyme included normal spleen (7 ) ,  l iv e r
(5 ) ,  colon (7 ) .
Tissues examined for SMP were jejunum (5 ) ,  colon (6 ) ,  l iv e r  (7 ) ,  
spleen (6 ) ,  bone marrow (5 ) ,  pancreas (5 ) ,  prostate (6 ) ,  kidney (5 ) ,  
brain (1 1 ) ,  lung (12 ) ,  breast (6 ) ,  endometrium (6 ) ,  fa llop ian  tube (6 ) ,  
te s t is  ( 7 ) ,  vas deferens (6 ) ,  placenta (6 ) .  Six cases of nasal polyps 
were also examined so that plasma ce lls  could be studied for SMP.
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RESULTS
Cathepsin D 
Spleen
In the spleen cathepsin D was shown in the l i t t o r a l  ce lls  l in ing  
the sinusoids (F ig . 6.1a and c ) .  There was also intense re a c t iv ity  
with s ingle large c e l ls  in the Malpighian bodies; these had abundant 
cytoplasm, often containing vacuoles, and appeared morphologically to 
be macrophages (F ig . 6 .1 a ) .  The pattern observed with anticathepsin D 
in spleen was d i f fe re n t  from that obtained with antilysozyme, which 
reacted strongly with numerous ce lls  in the red pulp (F ig . 6.1b and d) 
but with only occasional l i t t o r a l  ce lls  and with very few cells  in the 
white pulp.
Liver
L iver showed widespread labe lling  of cathepsin D in hepatocytes 
but in only a small number of Kupffer ce l ls  (F ig . 6 .2a ) .  In contrast, 
lysozyme was present in most Kupffer ce l ls  and a few hepatocytes (Fig . 
6 .2b ).
Lymph nodes
Ting ib le  body macrophages within germinal centres were 
consistently strongly positive for cathepsin D (F ig . 6 .3 ) ,  as were 
occasional s te l la te  c e l ls ,  which seemed to be dendritic  reticulum 
c e l ls .  Sinus l in in g  ce l ls  showed a s im ilar but weaker reaction pattern 
to those in the spleen. Most sinus histiocytes were weakly positive. 
Bowel
In the duodenum and small and large bowel cathepsin D was most 
strongly labe lled  in the cytoplasm of mononuclear c e l ls ,  probably 
macrophages, of the lamina propria. In the colon these cells  
containing cathepsin D tended to l i e  just below the surface epithelium 
(F ig . 6 .4 a ) ,  whereas those containing lysozyme were widely distributed
109
throughout the lamina propria (F ig . 6 .4b ) .  There was weak labe lling  of 
the surface epithelium fo r  cathepsin D in some cases, but the cells  in 
the crypts were negative, although in three cases the duodenal 
Brunner's glands showed weak p o s it iv i ty .
Lunfl
Of the sections from the six lungs studied, f iv e  contained 
abundant a lveo lar macrophages, a l l  of which were rich in cathepsin D 
(F igs . 6 .5  and 6 .8 ) .  Counterstaining of PAP labe lled  sections with 
Prussian blue showed haemosiderin in the ce lls  containing cathepsin D; 
at leas t some of the haemosiderin was in d if fe re n t  granules, although 
the intense brown reaction of the DAB may have obscured some of the 
blue sta in ing haemosiderin. Less commonly, a lveolar l in ing  ce lls  were 
p o s it iv e .  Where present, the respiratory epithelium lin ing  the 
bronchioles showed granular cytoplasmic labe lling  near the luminal 
aspect (F ig . 6 .7 ) .
Brain
The mononuclear phagocytes of the brain (the microglia) were 
negative, as were the as trog lia .  Neurones of the cerebral and 
cerebe lla r  cortex, however, showed granular cytoplasmic reac t iv ity  for  
cathepsin D (F ig . 6 .6 ) .  Two cases of brain included choroid plexus, 
the surface epithelium of which gave a positive reaction for cathepsin 
D.
Other tissues
In the four cases of normal kidney cathepsin D was mainly confined 
to proximal and d is ta l tubular epithelium, although in two cases there 
was also focal glomerular re a c t iv i ty .  Prostate has already been shown 
to contain gas tr ics in , and although cathepsin D was present in several 
cases, la b e ll in g  was weak and was shown in only a small proportion of 
acinar l in in g  ce lls  and occasional stromal c e l ls .  The 
syncytiotrophoblast of the placental chorionic v i l l i  exhibited granular
cytoplasmic r e a c t iv i ty  (F ig . 6 .9 ) ,  but the Hofbauer c e l ls ,  which are 
the mononuclear phagocytes of the placenta, were negative. Both 
specimens of jo in t  synovium were negative fo r cathepsin D. In the bone 
marrow la b e l l in g  was confined to non-haemopoietic c e l ls ,  apparently 
h is t io c y te s ,  with no cathepsin D in megakaryocytes, or in erythroid, or 
myeloid c e l ls .  In p a r t ic u la r ,  neutrophils were negative.
SMP
The presence of SMP in red blood cell membranes (F ig . 6.10) acted 
as a useful in ternal contro l, as they were found to label strongly in 
most sections.
Bowel
In 4 of the 5 samples of jejunum and 3 of 6 colons the surface 
epithelium stained but the pattern resembled that noted in d iffusion. 
The crypt epithelium was fo ca lly  positive.
Lymph nodes
Occasional c e l ls ,  apparently macrophages, were weakly positive in 
4 cases. ?
Brain
Weak staining of neurones was noted in 2 cases only (Fig . 6 .11 ).
In 1 case the choroid plexus was labelled  (F ig . 6 .12 ) .
Lung
In 3 cases the t ip s  of the c i l i a  of bronchial respiratory  
epithelium were fo ca lly  positive , where they were in contact with red 
blood c e l ls  (F ig . 6 .1 3 ) .  Alveolar macrophages were weakly positive in 
3 cases.
PIacenta
The apical microvillous membrane of the syncytiotrophoblast 
was labe lled  in 2 cases (Fig . 6 .14 ) .
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Prostate
The surface membranes of a few acinar ce lls  were stained in 5 of 
the 6 cases.
Kidney
Occasional tubules were positive in 1 of the 5 cases studied. 
Nasal polyps
Plasma c e l ls  and respiratory  epithelium appeared weakly labelled  
in  2 cases but were otherwise negative.
There was no convincing evidence of SMP in l iv e r ,  spleen, bone 
marrow, endometrium, fa l lo p ian  tube, vas deferens, te s t is  or breast 
( inc luding apocrine epithelium ).
FIG. 6.1 a and b.
Normal spleen labe lled  fo r  (a) cathepsin D and (b) 
lysozyme. Cathepsin D is present in l i t t o r a l  
c e l ls  and in  the c e l ls  of the Malpighian bodies. 
Lysozyme is widely d is tr ib u ted  in the red pulp and is  
generally  absent from the white pulp.
PAP method. x47.
A 7/ V  p * .. .
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FIG* 6,1 (c) Normal spleen lab e lle d  fo r  cathepsin D. Cathepsin
D is  present in l i t t o r a l  c e l ls  (S) l in in g  the sinusoids 
and in c e l ls  (M) in the white pulp.
PAP method. x340.
(d) Normal spleen la b e lle d  fo r  lysozyme. Lysozyme is  
absent from white pulp (W) and l i t t o r a l  c e l ls  (S) 
although present in many other c e l ls  of the red pulp. 
PAP method. x340.

FIG. 6 2 (a) Normal l i v e r  lab e lle d  fo r  cathepsin D, seen mainly
in the hepatocytes.
PAP method. x340.
(b) Normal l i v e r  lab e lle d  fo r  lysozyme, which is  
present mainly in the Kupffer c e l ls .
PAP method. x340.

FIG. 6 .3  Cathepsin D in  the germinal centre of a reac tive  lymph 
node, where i t  is  mainly in t in g ib le  body macrophages 
and d e n d r it ic  reticulum c e l ls .
PAP method. x340.

FIG. 6 .4  a) Cathepsin D in  colonic mucosa, in which i t  is
located in mononuclear c e l ls  in the lamina propria near 
the luminal surface.
PAP method. x72.
b) Lysozyme in colonic mucosa, in which i t  is located  
in  mononuclear c e l ls  throughout the lamina propria .
PAP method. x72.

FIG. 6
FIG. 6
5 Cathepsin D in  a lveo la r  macrophages of lung. 
PAP method. x210.
6_ Cathepsin D in neurones of normal b ra in .  
PAP method. x210.
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FIG. 6.7 Cathepsin D in bronchiolar epithelium , lung. Reaction 
product is v is ib le  as brown granules towards the  
luminal side of the nuc le i.
PAP method. x72.
FIG. 6 .8  Cathepsin D in  lung. Brown reaction product and black 
carbon p a r t ic le s  are present in the same a lveo la r  
c e l ls ,  which are there fo re  macrophages.
PAP method. x !88.
FIG. 6 .9  Cathepsin D in  syncytotrophoblast of chorionic v i l l i .  
PAP method. x72.
C - - * '  *
FIG. 6.10a SMP on red blood c e l l  membranes, w ith in  a small blood 
vessel.
PAP method. x!88.
FIG. 6.10b Control section, incubated with normal rabb it  serum.
The red blood c e l ls  are negative, showing th a t  the  
brown la b e l l in g  in  (a) is  not endogenous peroxidase. 
PAP method. x l88 .

FIG. 6.11 SMP in  neurones o f b ra in .  
 ! ‘ PAP method. x288.
FIG. 6. Granular la b e l l in g  o f SMP in  epithelium of choroid 
plexus.
PAP method. x470.

FIG. 6.13 SMP on surface of c i l i a ,  bronchial resp ira tory
epithelium and on the membranes of red blood c e l ls  in 
the lumen.
PAP method. x470.
FIG. 6.14 a) SMP on surface of syncytiotrophoblast of chorionic  
v i l l i .
PAP method. x !88.
b) High power of a ) .  
PAP method. x470.

DISCUSSION
The results  confirm that cathepsin D is  widely distributed in 
human tissues. I ts  presence in synovial ce lls  (Poole et a l ,  1972; 
Matthews et a l , 1981) has not been confirmed but in the kidney i t  was 
found in the same s i te ,  namely in the renal tubular epithelium, as was 
reported previously in the ra t  (Baricos & Shah, 1984). Cathepsin D 
appears to be found mainly in ce lls  of the mononuclear phagocyte 
system. Like lysozyme (muramidase) (Mason & Taylor, 1975) i t  seems 
more prominent in reactive histiocytes, as in lymph node and spleen, 
than in resting phagocytes in l iv e r ,  brain and placenta. I ts  presence 
in epithelium , for example of bronchi and bowel, shows that i t  does not 
ind icate phagocytic a c t iv i ty ,  but that i t  may play a role in more 
general metabolic a c t iv i ty .
Cathepsin D is  generally regarded as a lysosomal enzyme (B arre tt,  
1980). I ts  d is tr ib u tio n  in the body would be consistent with th is ,  as 
would i ts  granular appearance in c e l ls ,  although the poss ib il ity  of i ts  
being w ithin other subcellular structures, for example in the gastric  
mucosa, cannot be excluded.
The present study has c lear ly  established that the d is tribution  of 
cathepsin D is d if fe re n t  from that of lysozyme (Mason & Taylor, 1975; 
Klockars & Reitamo, 1975) and, according to published accounts, from 
that of a i  proteinase in h ib ito r  (antitrypsin) (Isaacson et a l , 1981; 
Tahara et a l , 1984), although i t  seems to be s im ilar to that of 
cathepsin B (Crocker, Burnett & Jones, 1984; Howie, Burnett & Crocker, 
1985), a biochemically unrelated enzyme in the cysteine proteinase 
category.
The SMP results  did not y ie ld  convincing evidence of SMP in most 
cases studied. One problem in interpretation of the results is the 
e f fe c t  of adjacent red blood c e l ls ,  which were usually strongly 
pos it ive . This appeared to explain the staining on the surface of the
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bronchial epithelium and could explain that on the surface of the 
syncytiotrophoblast, which is normally in contact with blood. The 
la b e l l in g  of choroid plexus is less easy to explain in th is  way and 
could be genuine, although further cases attempted were negative.
Other c i l ia te d  e p ith e l ia  of fa llop ian  tube and vas deferens were 
negative. S im ila r ly ,  the staining of neurones is not convincing and is 
under fu r th e r  study. The staining in the bowel could be genuine or 
could be due to d iffus ion  of red blood cell products or gastric ju ice  
from higher up the bowel. Further study of the colonic mucosa would be 
worthwhile. I t  is not clear whether staining of the plasma cells  is 
genuine, although plasma cells  in malignant lymphomas were sometimes 
strongly pos itive  (see Chapter 10).
The wide d is tr ib u t io n  of cathepsin D and to a lesser extent, SMP 
is in strong contrast to that of the other aspartic proteinases, 
pepsin, gastr ics in  and renin. Why th is  is so is not c lear.  Because of 
the structural s im ila r i ty  between the aspartic proteinases a common 
evolutionary orig in  has been suggested. I t  could be that cathepsin D 
is the least highly evolved and that i ts  d is tr ibution  re flec ts  an 
orig in  in u n ic e l lu la r  organisms (B arre tt ,  1980b).
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CHAPTER 7
THE LOCALISATION OF ASPARTIC PROTEINASES IN THE DEVELOPING STOMACH
INTRODUCTION
I t  w i l l  be shown that about 5% of gastric carcinomas contain 
pepsinogen; by contrast, the corresponding values fo r progastricsin, SMP 
and cathepsin D are 30%, 54% and 100% respectively (Chapter 8 ) .  By 
analogy with other oncofetal antigens, such as carcinoembryonic antigen, 
alpha fe topro te in  (P u rt i lo  & Yunis, 1971) and more recently, CL-187 
(Bleday et a l , 1985), the aspartic proteinases found in the neoplasms 
might be expressed by the corresponding normal fe ta l  t issues. I t  is also 
possible tha t the enzymes produced most frequently by gastric carcinomas 
appear e a r l ie s t  embryologically and i t  was thus considered of interest  
to determine the time course in which the zymogens appear in the 
developing fe ta l  stomach.
116
MATERIALS AND METHODS 
Antisera
Polyclonal rabbit anti sera to pepsin, gastr ics in , cathepsin D and 
slow moving protease were used as described in detail previously.
Ti ssues
Stomachs were collected from fetuses of known gestational ages as 
assessed by crown-to-foot and crown-to-rump measurements. Whenever 
possible, the stomachs were sectioned long itud ina lly  to include the body 
and antrum. The slices were paraffin  embedded and 4 pm sections were 
cut, one being stained with haematoxylin and eosin for preliminary 
study. Only those cases which showed well preserved tissue and well 
orientated sections were used for immunohistochemical investigations. 
Twenty-three cases were collected from post mortem material which had 
been fixed and stored in neutral buffered formalin at the Leeds 
Maternity Hospital. Additional stomachs were collected from autopsies, 
conducted within 24 hours of death in the General Infirmary and St 
James's Hospitals, Leeds (8 cases) and Aberdeen Maternity Hospital (12 
cases) and were fixed in 10% neutral buffered formalin. Paraffin blocks 
from 8 fu r th e r  fe ta l  stomachs were kindly provided by Dr J W Keeling, 
Department of Pathology, John Radcliffe  Infirmary, Oxford and blank 
sections from 2 cases by Dr G G Williams, Department of Pathology, 
Univers ity  Hospital of Wales, C ard if f .  Thus a to ta l of 53 fe ta l  
stomachs were examined. The gestational ages ranged from 10 to 38 
weeks.
Immunohistochemical methods
Immunohistochemical labe lling  of the four antigens was performed by 
the peroxidase-antiperoxidase (PAP) method as previously. Antisera to 
pepsin and gastricsin  were diluted 1 in 200 and those to cathepsin D and 
SMP, 1 in 100 in 0.05 M TRIS - buffered saline, pH7.6. Sections were
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overla in  fo r  24 hours at 4°C with d i lu te  anti sera. With every batch of 
slid es , a positive control section was included, th is  being normal human 
spleen fo r  cathepsin D and normal human adult gastric mucosa fo r  the 
other enzymes. Swine a n t i - ra b b it  immunoglobulin (1 in 25) and rabbit 
peroxidase-antiperoxidase complexes (1 in 50) (Dakopatts A/S, Denmark) 
were used as secondary antibodies. Sections were developed in 3 ,3 ‘ 
diami nobenzidine (Sigma Chemical Co, Poole, Dorset) and counterstained 
with haematoxylin. In selected cases, antisera were pre-incubated with 
the appropriate antigen fo r 1 hour at room temperature before 
application  to the sections.
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RESULTS
There was no evidence of aspartic proteinases in the fe ta l stomach 
u n t i l  12 weeks, when SMP was id e n t if ie d  in some cells  of the surface 
epithelium and progastricsin in a few cells  at the base of developing 
glands. At 14-16 weeks SMP was the more prevalent enzyme of the two and 
appeared in occasional ce l ls  in the glands. At 17-18 weeks pepsinogen 
and cathepsin D began to appear. Pepsinogen was present in the basal 
part of the surface epithelium ce lls  and in the cytoplasm of occasional 
c e l ls  at the base of the glands, the pattern being sim ilar to that of 
progastrics in . Cathepsin D was f i r s t  seen in ce lls  at the base of the 
glands, where there was d iffuse cytoplasmic la b e ll in g , sometimes with 
more intensely reactive cytoplasmic granules. By th is  stage SMP was 
labe lled  strongly in surface epithelium and, in some cases, in the 
glands (Fig 7 .1 ) .
A fte r  17 weeks a l l  four aspartic proteinases were identif ied  in 
most cases (Figs 7 .2 -7 .4  and Table 7 .1 ) .  From 17-24 weeks pepsinogen 
and progastricsin were less strongly labelled in surface epithelium than 
before, while positive ce lls  in the gastric glands became more numerous. 
Progastricsin was present in and pepsinogen absent not only from the 
gastr ic  antrum, but also from several cases of gastric body, although 
both were equally present in the body from 34 weeks onwards. SMP was 
id e n t if ie d  in almost a ll  cases until term, although the intensity of 
staining appeared to diminish somewhat a f te r  22 weeks. Cathepsin D was 
also present in most cases and i ts  pattern and d istribution  did not 
s ig n if ic a n t ly  change. Pre-incubation of antisera to pepsin and 
gastr ics in  with th e ir  respective antigens resulted in complete abolition
of sta in ing.
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TABLE 7.1
ASPARTIC PROTEINASES IN THE EARLY DEVELOPING STOMACH
Number of positive cases 
(equivocal cases in brackets)
Gestation
(weeks)
Total Pepsinogen Progastricsin Cathepsin D SMP
e10 2 0 0 0 0
12 2 0 1 0 2
14-16 8 1 1(2) 0 4(3)
17-18 8 6 6 4(1) 7(1)
19-20 7 2(1) 5(1) 4 3
N o te :a fte r  20 weeks a l l  four aspartic proteinases were present in most 
cases studied
FIG. 7.1 Slow moving protease in glands and surface epithelium in 
fe ta l  g as tr ic  mucosa at 18 weeks gestation .
(PAP method x 215).
FIG. 7.2 Progastricsin  in the deeper parts of the glands in fe ta l  
gastr ic  body at 17 weeks gestation .
(PAP method, x 330).

FIG. 7
FIG. 7
3 Cathepsin D in c e l ls  of the glands in fe ta l  gastr ic  
mucosa at 34 weeks gestation.
(PAP method x 215).
4 Pepsinogen in the deeper parts of the glands in fe ta l  
gastr ic  mucosa at 35 weeks gestation .
(PAP method, x 330).
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DISCUSSION
I t  has long been known th a t ,  from as early as 16 weeks of gestation 
(Keene & Hewer, 1924; Keene & Hewer, 1929) the fe ta l gastric juice of 
various species, including humans, has acid proteinase a c t iv ity ,  
presumed to be due to pepsin (Langendorff, 1879). In previous 
investigations , immunoelectrophoresis of fe ta l gastric mucosal extracts 
suggested that progastricsin appeared during the th ird  month of 
gestation and pepsinogen by the fourth month, although in histological 
sections both zymogens could only be detected by immunofluorescence 
a f te r  5 months.
The present results indicate that SMP and progastricsin both appear 
in the developing stomach at 12 weeks, soon a fte r  the glands are formed 
( 6 - 9  weeks) and just before the parietal cells  become discernible (12 
-  15 weeks) (Salenius, 1962) with the production of hydrochloric acid 
(16 weeks) (Deren, 1971). Progastricsin is ,  however, only occasionally 
present u n t i l  17-18 weeks, around the time the chief cells  d iffe ren tia te  
(15 -  23 weeks) (Salenius, 1962), a f te r  which a ll  four aspartic 
proteinases are normally detectable.
The amniotic f lu id  also appears to contain zymogens; 
immunoelectrophoresis yields progastricsin at 32 weeks and pepsinogen at 
11 weeks, although the possib ility  that these are of maternal origin  
cannot be excluded (Liebman & Sami o f f ,  1978). SMP, however, was noted 
by immunoelectrophoresis of fe ta l gastric mucosa from approximately 8 
weeks of gestation onwards (Hirsch-Marie et a l , 1976). In a separate 
study, SMP was proposed as main acid proteinase in the human stomach at 
b ir th  (Foltmann & Axelsen, 1980). Clearly, there is some inconsistency 
in the findings reported in these e a r l ie r  investigations and much of 
th is  may be explained by the d iffe ren t techniques and conditions, such 
as exposure to acid pH, employed in the various studies. The present
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investigation  was carried out to resolve these discrepancies and, by 
including cathepsin D, to consider a ll the aspartic proteinases now 
known to be present in the human stomach (Kay et a l , 1987). The results 
support the e a r l ie r  suggestions of Hirsch-Marie et a l , 1976.
In animals, the gastric aspartic proteinases d i f fe r  from those in 
the human. The stomachs of fe ta l piglets and calves express not pepsin 
or gastr ics in  but the milk c lo tting  aspartic proteinase, chymosin 
(rennin) (Foltmann & Axelsen, 1980). Unlike the other enzymes, chymosin 
cannot digest immunoglobulins. The neonate can thus develop immunity by 
ingestion and absorption of antibodies from maternal colostum until 
chymosin production is replaced by that of pepsin approximately 4 weeks 
a f te r  b ir th  (Foltmann, 1981). A sim ilar protection mechanism for  
antibodies cannot exist in the human stomach as four enzymes, a l l  of 
which can digest immunoglobulins, are present in gastric mucosa long 
before b ir th  and postnatal immunity is maintained by placental transfer  
of antibodies.
The aspartic proteinases, including chymosin, a l l  show a remarkable 
homology in structure and probably evolved from a common precursor 
(Foltmann, 1981). I t  has been suggested that cathepsin D might be the 
p rim it ive  in tra c e l lu la r  enzyme of un icellu lar organisms (Barrett,
1980b). Cathepsin D appears to be a ubiquitous enzyme, and has been 
detected in almost a ll  normal and neoplastic tissues so fa r  studied 
(Reid et a l , 1986). On the other hand pepsinogen, progastricsin and 
SMP, are mainly produced by the gastric mucosa and by neoplasms of the 
stomach. The present study suggests that SMP is ontogenetically more 
prim it ive  than progastricsin and pepsinogen. The distribution of 
staining for progastricsin, which was more widespread and intense than 
that of pepsinogen, tends to suggest that progastricsin may develop 
before pepsinogen, although the number of cases studied over the 
c r i t ic a l  gestational age range (12 - 18 weeks) is too small to allow
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d e f in i te  conclusion. The descending order of frequency with which SMP, 
progastricsin  and pepsinogen occur in the epithelium of gastric 
carcinomas is also consistent with the hypothesis that this reflects  
t h e i r  order of appearance in the evolution of the human gastric mucosa.
. .
123
CHAPTER 8
ASPARTIC PROTEINASES IN PRIMARY CARCINOMA OF STOMACH^
v  d f .
4^ ftp#/ ilfr.
INTRODUCTION
The p o s s ib i l i ty  that gastric carcinomas may produce aspartic 
proteinases appears to have been somewhat neglected until recently, 
possibly because biochemical analysis of tumour extracts revealed no 
trace of acid proteo ly tic  a c t iv i ty  (Greenstein & Stewart, 1942; Dixon & 
Webb, 1964). Proteolytic  a c t iv i ty ,  optimal at pH around 3.5 but almost 
absent at 2 .0 ,  was demonstrated in extracts of 6 gastric carcinomas 
(Tay lor, 1960a). I t  is not clear whether th is  was due to cathepsin D,
which is  inactive  at pH 2 .0 , or to gastricsin which is s t i l l  active at
th is  pH or to  a mixture of the two enzymes. Similar proteolytic  
a c t iv i t y ,  maximal at pH 3.3 was found in extracts of adenocarcinomas
from a l l  parts of the in testine (Taylor, 1960b), which would also f i t
with e i th e r  cathepsin D or gastricsin. Later, two enzymes were detected 
in gastr ic  carcinomas and on the basis of chromatographic and 
electrophoretic  properties were considered to be cathepsins D & E 
(Etherington & Taylor, 1972).
Kalinovsky & Parshin (1975) demonstrated uptake of tyros ine-I-  
C14 and serine-3-C14 into homogenates of gastric cancer and detected 
small amounts of radioactive pepsinogen in the tumour tissue. On 
electrophoresis of extracts of gastric carcinoma from 18 patients, 
Kalinovsky, Melnikov & Seits (1977) noted 3 fast-moving anode fractions, 
the positions of which were s im ilar to those of pepsinogen and pepsin 
from normal gastric  mucosa. These fractions proved to have proteolytic  
a c t iv i ty  fo r  ge la tin  at low pH. Similarly situated inactive pepsinogen 
bands were found in the metastases in para-aortic , omental and 
supraclavicular lymph nodes from these patients.
In an in teresting  study, Hirsch-Marie et al (1976) demonstrated by 
standard and bidimensional immunoelectrophoresis that pepsinogen and 
progastricsin appeared to be e ither absent or present in markedly 
smaller amounts in acetone extracts of 5 gastric carcinomas than in
125
normal mucosa. On the other hand, slow moving protease (SMP) was 
present in a l l  5 cases, usually in almost as great amounts as in normal 
mucosa.
Immunofluorescence studies confirmed the presence of progastricsin 
in one well d if fe re n t ia te d  carcinoma but pepsinogen could not be located 
in any of the tumours. SMP, on the other hand, was strongly labelled in 
ded iffe re n tia ted  mucosal glands and in some isolated neoplastic ce l ls .
The present study was undertaken in order to determine whether 
aspartic proteinases could be demonstrated immunohistochemically in 
gastr ic  carcinoma. As preliminary experiments indicated that a ll  the 
zymogens were well preserved in tissues fixed in 10% formol saline, 
material from the surgical f i l e s ,  fixed in th is  way and paraffin  
embedded, was used. This permitted retrospective examination of tissue  
which would otherwise take years to accumulate.
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MATERIALS AND METHODS 
Antisera
Antisera to pig pepsin and pepsinogen, human pepsin and gastricsin, 
cathepsin D, SMP and lysozyme were used as described in Chapter 2. All 
d ilu t io n s  were in 0.05M Tris  -  HCL buffered saline (TBS) pH 7.6 except 
a n t i -g a s tr ic s in ,  which was diluted in 20% normal human serum in TBS. 
A nti-p ig  pepsin was used at 1:200, anti-lysozyme at 1:1000 and all  
others at 1:100.
Ti ssues
Blocks of gastric carcinoma removed by gastrectomy were selected 
from the routine surgical histology f i le s  of the Pathology Departments, 
Glasgow Royal Infirmary and the General Infirmary at Leeds. All tissues 
had been fixed in 10% formol saline and paraffin  embedded. Altogether, 
125 cases from Glasgow Royal Infirmary were examined for the presence of 
pepsinogen and 114 for progastricsin. Cases examined from the General 
In firm ary at Leeds included 19 which were studied for cathepsin D, 28 
fo r  SMP and a fu r th e r  62 carcinomas with metastatic lymph node deposits 
in the gastrectomy specimen which were examined for progastricsin.
In a l l  cases 4-6 pm were cut and labelled by the peroxidase 
anti-peroxidase (PAP) method as described in Chapter 3. Sections were 
counterstained with haematoxylin or methyl green.
Controls
Wherever possible blocks were chosen to include non-neoplastic 
gastr ic  mucosa adjacent to the carcinoma. In addition, a section of 
normal gastric  body mucosa served as a control for pepsinogen, 
progastricsin and SMP while a section of normal spleen was used as
pos itive  control for cathepsin D.
Sections of carcinomas were also incubated with antisera,
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preincubated with the corresponding enzymes or zymogens, as in Chapter 
3. The supplies of pure cathepsin D and SMP were too small to allow 
absorption experiments to be performed on the carcinomas, but
experiments on selected strongly positive cases have been described in 
Chapters 3 and 10.
Selected carcinomas were also incubated with normal rabbit serum or 
with preimmune serum from the rabbit in which the antiserum had been 
ra ised.
C lass if ic a t io n  of tumours
G astric carcinomas which contained e ither pepsinogen or 
progastricsin were c lass if ied  1) according to the degree of 
d i f fe re n t ia t io n  and 2) into diffuse and in testinal type by the system of 
Lauren (1965). The pepsinogen positive cases were c lassified by Dr. J. 
Jass, Histopathology Department, Central Middlesex Hospital, London and 
the progastricsin cases independently by Dr. M.F. Dixon, Department of 
Pathology, University of Leeds and by the author.
Case d e ta i ls
The case notes of the pepsinogen positive cases were reviewed to 
determine a) the s i te  of origin of the carcinomas in the stomach and b)
the duration of survival.
The duration of survival of patients with gastric carcinoma in the 
General Infirmary at Leeds (LGI) was obtained by courtesy of Mr. D.
Ward, Department of Surgery, LGI. The survival times of the patients 
with progastricsin-containing carcinomas was compared with those with 
progastricsin-negative carcinomas. S ta t is tica l analysis was performed 
by computer with a BMDP software package analysis (LOGRANK) program 
(BMDP L ife  Tables and Survival Functions, BMDP S ta tis tica l Software, 
Copyright 1983 Regents of Californ ia) (Peto et a l , 1977). Analysis was 
performed in collaboration with the Department of Medical S ta tis tics ,  
University of Leeds.
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RESULTS
Pepsinogen
Seven (5.6%) of the 125 gastric carcinomas examined labelled with 
both a n t i-p ig  pepsin and anti-p ig  pepsinogen. In a ll cases staining was 
fo c a l ,  being present in some tumour acini and not others and often in 
only some c e lls  of an acinus (Figs. 8.1 -  8 .3 ) .  In areas of tumours 
where there was no acinar formation, staining was also focal, although 
often present in large numbers of ce lls  (Fig. 8 .4 ) .  All 7 cases showed 
the same pattern of labe lling  with both anti-pepsin and anti-pepsinogen. 
The reaction product was generally intense and often granular and was 
present in the cytoplasm of the malignant ep ithe lia l ce lls ;  none of the 
stromal ce l ls  were positive.
In most cases there was non-neoplastic gastric mucosa adjacent to 
the tumour. Mucosa of body type was always positive, even when there 
was severe inflammation, but areas of intestinal metaplasia were 
negative.
Two fu rther cases gave equivocal results with only weak, diffuse  
staining in tumour c e l ls .  There was no evidence of pepsinogen in any of 
the other carcinomas, although the gastric body mucosa was always 
pos it ive .
Controls
In a l l  7 cases labe lling  of tumour cells  was abolished by prior 
incubation of antipepsin with commercial pig pepsin or of antipepsinogen 
with pure pepsinogen. As in the normal stomach (Chapter 3) the enzyme 
was found to be more e f f ic ie n t  than the zymogen in blocking staining.
In a l l  cases sections incubated with normal rabbit serum in place of 
anti serum were negative, both in the carcinoma and non-neoplastic 
stomach.
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C la s s i f ic a t io n of pepsinogen-containing gastric carcinomas
a) by degree of d i f fe re n t ia t io n
Five of the 7 cases were moderately d ifferentia ted  adenocarcinomas 
and 2 were poorly d iffe ren tia te d  carcinomas.
b) by the Lauren c lass if ica tio n
Three o f the carcinomas were of the so-called intestinal type and 2 
of d if fu se  type. The other 2 were d i f f i c u l t  to c lassify .
Case d e ta i ls
The case notes of only 4 of the 7 patients with pepsinogen- 
containing gastric  carcinomas could be traced.
a) S ite  of tumour
One of the tumours was an ulcer-cancer of the antrum and 1 arose 
around the lower oesophagus, but the s ite  of origin of the others could 
not be found in the case records.
b) Survival
One patient died 3 months a fte r  gastrectomy, but the outcome in the 
other cases was not known.
Progastricsin
T h ir ty -th ree  (29%) of the 114 gastric carcinomas from Glasgow Royal 
Infirm ary and 26 (42%) of the 62 cases from the General Infirmary at 
Leeds showed evidence of progastricsin in the cytoplasm of the malignant 
c e l ls  (F igs. 8.5 and 8 .6 ) .  In addition, the la t te r  series included 4 
cases in which there was only fa in t  diffuse labelling  of the tumour 
c e l ls ;  the resu lt  in these cases was considered equivocal. In 4 cases 
from Glasgow Royal Infirm ary, the malignant cells  close to the normal 
mucosa were labelled  for progastricsin, but those further away were 
negative. This was considered to be an effect of diffusion and these
cases were therefore considered negative.
Like pepsinogen, progastricsin was usually focally distributed  
within each tumour (F ig . 8.7) and most malignant cells were eithe
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negative or strongly positive . The reaction product was often granular 
(Fig-. 8 .8 ) .  Sometimes there appeared to be cloning, with most cells in 
some parts of a given tumour being positive while other areas were 
negative (F ig . 8 .9 ) .  In some cases the number of positive tumour cells  
lessened with the depth of invasion into the gastric wall, but in most 
cases malignant ce lls  throughout the stomach wall and extraserosal fa t  
were pos it ive .
Controls
In a l l  sections, any non-neoplastic mucosa of gastric body or 
antrum or duodenum gave strongly positive labelling  of progastricsin in 
the c e l ls ,  even when the carcinoma was progastricsin negative.
Labelling of tumour cells  was blocked in a ll  cases by prior 
incubation of antigastr ics in  with gastricsin or progastricsin. The 33 
p o s it iv e ly  id e n t if ie d  cases were divided into two groups for absorption 
experiments with gastricsin derived from two d ifferent human s ites , i . e .  
stomach and seminal f lu id .  In the f i r s t  group of 16 the labelling by 
an tig as tr ics in  was completely abolished by prior incubation with gastric  
gastr ics in  (10 pg/ml). In the second group, which included the 17 most 
strongly positive carcinomas, absorption experiments were performed with 
seminal progastricsin or gastricsin at 1 pg/ml. Seminal gastricsin was 
e f fe c t iv e  in abolishing labelling  by the anti serum to the gastric enzyme 
whereas in only 2 cases did seminal progastricsin block labelling  
completely. In the other 15 cases labelling  was either not reduced or 
only p a r t ly  diminished on incubation with the seminal zymogen.
Twelve of the gastricsin-positive cases of gastric carcinoma 
labe lled  with preimmune serum were a ll  negative.
A ll sections incubated with normal rabbit serum or with preimmune 
serum showed no evidence of labelling in e ither the carcinomas or the 
normal gastric  body of antral mucosa.
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C la s s if ic a t io n  of progastricsin-containing carcinomas
a) by degree of d i f fe re n t ia t io n
The 33 progastricsin-containing gastric carcinomas from GRI were of 
a ll  degrees of d i f fe re n t ia t io n .  Three were p ap il la ry , 12 moderately 
d i f fe re n t ia te d ,  11 poorly d iffe ren tia ted  with some acinar formation and 
7 poorly d if fe re n t ia te d  without acinar formation (Fig. 8 .9 ) .  There thus 
appeared to  be no predilection for any one histological type.
b) by the Lauren c lass if ica t io n
The 33 gastrics in  positive cases, c lass if ied  according to the 
Lauren c la s s i f ic a t io n ,  were grouped as follows:
Diffuse: 13 (including 4 with some in testina l areas)
In te s t in a l :  16 (including 2 with some diffuse areas)
Mixed: 4
Comparison between pepsinogen- and progastricsin-containing carcinomas 
Four of the pepsinogen-containing carcinomas were strongly positive 
fo r  progastrics in , 1 was weakly positive and 2 others were negative.
The other progastricsin-containing carcinomas did not contain 
pepsinogen.
Case d e ta i ls
Whether or not the type of surgical operation was taken into 
account, there was no s ign ifican t difference in survival time between a 
group of patients with progastricsin-containing gastric carcinomas and 
that in which the tumours were progastricsin-negative.
Cathepsin D
In a l l  19 cases there was granular labe lling  of the cytoplasm of 
ce lls  in the gastric  carcinomas. In some tumours, labelling was 
predominantly in ep ith e l ia l  ce lls  (Fig. 8 .1 0 ) ,  in some, in the non 
neoplastic stromal ce lls  (F ig . 8 .11), while in others both types of 
were labelled  (F ig . 8 .1 2 ) .  The stromal ce lls  were mononuclear and may
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have been macrophages but detailed  study was not undertaken to establish  
th is  with c e r ta in ty .  Tumours of a l l  degree of d i f fe re n t ia t io n  contained 
cathepsin D (F ig . 8 .1 3 ) .
Lysozyme, on the other hand, was present mainly in stromal ce lls  
and was seen in fewer neoplastic e p ith e l ia l  ce lls  than cathepsin D.
Slow moving protease
Of 28 cases examined, 21 showed lab e llin g  of tumour ce lls  for SMP. 
The number of positive ce lls  in each case varied from few to many and 
stain ing was usually strong (Figs. 8.14 and 8 .1 5 ) .  As was observed with 
progastr ics in , both moderately and poorly d iffe ren tia te d  carcinomas were 
posit ive  and staining was fo ca l.  Stromal ce lls  were negative, apart 
from red blood c e l ls ,  which were usually strongly positive and 
polymorphs which, in some of the cases where they were present, were 
weakly reac tive .  In 4 SMP positive cases where there was tumour in 7 
out of 12 lymph nodes, 6 of the deposits were also SMP positive.
FIG. 8.1 Pepsinogen in moderately d i f fe re n t ia te d  gas tr ic
adenocarcinoma. The secretions w ith in  some of the  
acini are p o s it iv e .
Antipig pepsin, PAP method. x54.
FIG. 8 .2  Pepsinogen in moderately d i f fe re n t ia te d  g as tr ic
adenocarcinoma. Some acini are strongly pos it ive  but 
many others are negative.
Antipig pepsin, PAP method. x !15.

FIG. 8 .3  Pepsinogen in moderately d i f fe re n t ia te d  gas tr ic
adenocarcinoma. Labelling is notably fo c a l ,  even 
w ith in  ind iv idual tumour a c in i .
Anti pig pepsin, PAP method. x284.
FIG. 8 .4  Pepsinogen in poorly d i f fe re n t ia te d  gas tr ic  
adenocarci noma.
Anti pig pepsin, PAP method. x284.
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FIG. 8 .5  Progastricsin  in gas tr ic  carcinoma at o r ig in  in mucosa 
and in tumour c e l ls  invading through submucosa and 
muscle.
A n tig a s tr ic s in ,  PAP method. x30.
FIG. 8 .6  Progastricsin in gas tr ic  adenocarcinomas. In th is  case 
the tumour in lymphatic channels (L) is  not expressing 
progastricsin  while the c e l ls  elsewhere are.  
A n tig as tr ic s in ,  PAP method. x72.
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FIG. 8 .7  Progastrics in  in moderately d i f fe re n t ia te d  g a s tr ic
adenocarcinoma invading the muscularis propria of the  
stomach. Note th a t  the sta in ing is fo c a l .  
A n tig a s tr ic s in ,  PAP method. x!12.
FIG. 8 .8  Progastricsin fo c a l ly  lab e lle d  in gastr ic
adenocarcinoma. In some c e l ls  the sta in ing is c le a r ly  
granular.
A n t ig a s tr ic s in ,  PAP method. x348.

FIG. 8 .9  Progastricsin  in poorly d i f fe re n t ia te d  g as tr ic
carcinoma, including c e l ls  in a lymphatic channel. 
A n tig a s tr ic s in ,  PAP method. x470.
FIG. 8.10 Cathepsin D in  g as tr ic  adenocarcinoma. There is  focal 
la b e l l in g ,  often granular, of neoplastic epithelium  and 
of c e l ls  in the stroma.
Anticathepsin D, PAP method. x340.
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FIG. 8.11 Cathepsin D in  g as tr ic  carcinoma, in th is  case mainly 
in the stromal c e l ls  rather than in neoplastic  
ep ithe lium , which is mostly negative.
Anticathepsin D, PAP method. x340.
FIG. 8.12 Cathepsin D in  gas tr ic  adenocarcinoma showing focal 
la b e l l in g  o f neoplastic e p i th e l ia l  c e l ls  (N) and of  
some stromal c e l ls  (S ) .
PAP method. x340.
FIG. 8.13 Cathepsin D in  poorly d i f fe r e n t ia te d  g as tr ic  carcinoma, 
mainly in neoplastic  e p i th e l ia l  c e l ls .
Anticathepsin D, PAP method. x510.
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FIG. 8.14 SMP in  g as tr ic  adenocarcinomas invading subserosal 
stomach.
Anti SMP, PAP method. x74.
FIG. 8.15 SMP in  g as tr ic  adenocarcinomas invading submucosa. 
Anti SMP, PAP method. x340.

DISCUSSION
The resu lts  show that gastr ic  carcinomas contain aspartic  
proteinases. Presumably, pepsinogen and progastricsin are present in  
the tumour c e l ls  as zymogens, as in normal stomach, although th is  is  
d i f f i c u l t  to prove by immunohistochemical la b e l l in g  with anti sera that  
react with both zymogen and active enzyme (Chapter 2 ) .  The p o s s ib i l i ty  
of se lective  uptake- by d iffus ion  has been considered in Chapter 4 and 
was taken into  account in assessment of the immune la b e l l in g .
Presumably the malignant ce l ls  which arise in the stomach re ta in  the 
capacity to  synthesize the zymogens of the c e l ls  from which they a r is e .  
I t  is  not yet c lea r  whether cathepsin D and SMP are also produced as
zymogens or as active  enzymes, although a precursor of cathepsin D has
been postulated (Puizdar & Turk, 1981).
There are two possible reasons why biochemical studies have fa i le d  
to demonstrate acid proteinase a c t iv i t y  in gastr ic  carcinomas. The 
f i r s t  is  tha t the zymogens are not present throughout the tissue but are 
only in the malignant ce l ls  and even then fo c a l ly ,  so that i f  the t issue  
were homogenized they might well be d ilu ted  below the l im i t  of detection  
by enzyme assay. The second is that the zymogens might not be normal.
I t  is  well known that hormones produced by tumours may d i f f e r  
s tru c tu ra lly  and fu n c tio n a lly  from those produced normally (Robbins, 
Cotram & Kumar, 1984). I t  is  possible tha t at least some malignant 
ce lls  produced abnormal molecular forms of pepsinogen or progastricsin,  
some of which may be inac t ive . Such a p o s s ib i l i ty  has previously been 
suggested by detection of inactive forms of pepsinogen in gastric
carcinoma (Kalinovsky, Melnikov & S e its , 1977).
Pepsinogen appears to be a much less common product of gastric  
carcinoma than is  progastricsin. E ig h ty -f ive  per cent of carcinomas of
the stomach a r ise  in the antrum, where progastricsin but not pepsinogen 
is normally produced and the predominance of progastricsin  in carcinomas 
could r e f le c t  t h is .  I t  would be of in te res t to know whether the 
pepsinogen-containing tumours in the present study arose in the gastr ic  
body but the case records were in s u f f ic ie n t ly  complete to allow th is  to  
be determined. Moreover, th is  might be d i f f i c u l t  to prove 
re tro spec tive ly  as the precise orig in  of any given carcinoma is l ik e ly  
to be obscure by the time the tumour is  large enough to be c l in ic a l l y  
apparent. As pepsinogen-producing c e l ls  in the normal gastr ic  body also 
produce progastr ics in , i t  might be expected that th is  would also apply 
to carcinomas. Of three carcinomas which were strongly positive fo r  
pepsinogen, one was only weakly positive fo r  progastricsin and two were 
negative. Possible explanations fo r  th is  include deletion of the 
progastricsin  gene or translocation to a region where i t  is no longer 
transcribed.
A second possible explanation fo r  the higher prevalence of 
progastricsin  than pepsinogen in gastr ic  carcinomas is that the former 
might be the more p r im it ive  zymogen embryologically and might be more 
l i k e ly  to occur as an oncofetal antigen. There is evidence from 
comparative biochemical studies in animals that th is  is the case 
(Foltmann & Axelsen, 1980; Foltmann, 1981; Foltmann et a l , 1981) and 
th is  is  supported by the observation that progastricsin appears e a r l ie r  
in gestation in the developing human stomach (Chapter 7 ) .  These two 
possible explanations fo r  the higher prevalence of progastricsin than 
pepsinogen are not, of course, mutually incompatible.
The focal d is tr ib u t io n  of pepsinogen and progastricsin is analogous 
to th a t  noted fo r  many other tumour products, fo r  example the aspartic  
proteinase renin in malignant tumours of kidney (Lindop & Fleming,
1984) and prealbumin in carcinoids (M i l la r  et a l , 1984).
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While production by some c e l ls  of small amounts of product, below the 
l im i t  of detection by the PAP method, might resu lt  in a focal pa tte rn ,  
the resu lts  of q u a n tita t iv e  immunohistochemical studies suggest that  
there would be va r ia t io n  in the in te n s ity  of the sta in ing reaction  
( M i l l a r  & W illiam s, 1982). In the present study th is  was not observed; 
most c e l ls  were e i th e r  negative or strongly p o s it iv e .  I t  seems most 
l i k e ly ,  th e re fo re ,  tha t the fo c a l i ty  is because zymogen production is  
e ith e r  switched on or not. Zymogen production could be switched on at a 
number of le v e ls ,  but is most l ik e ly  to happen before gene tra n scr ip tio n  
(A lberts et a l , 1983). The absence of progastricsin from some 
pepsinogen-containing carcinomas suggests tha t the two genes may become 
uncoupled in neoplastic c e l ls .
Whether these c e l ls  secrete zymogen into  the blood is not known, 
but there was evidence of secretion in to  the lumen of some tumour a c in i .
The prognosis of gastr ic  carcinoma does not appear to be re lated  to  
the presence or absence of progastricsin in the tumour c e l ls .  The 
numbers were too few and case records too incomplete to permit a s im ila r  
corre la tion  with the presence or absence of pepsinogen. In te re s t in g ly ,  
parie ta l ce ll  d i f fe r e n t ia t io n  in gastric  carcinoma has been said to be 
associated with a favourable outcome in the few cases described 
(Capella et a l , 1984; Gaffney, 1987).
Although cathepsin D was found in a l l  gastr ic  carcinomas studied, 
i ts  expression seems not to be a specific  property of the neoplastic  
e p ith e l ia l  c e l ls ,  as i t  was also found in the stromal c e l ls .  I ts  
presence may therefore  r e f le c t  some non-specific functional a t tr ib u te  of 
the c e l ls ,  such as high metabolic a c t iv i t y ,  re la ted  to requirement fo r  
lysosomal enzymes. This has not yet been investigated experimentally as 
cathepsin D has not previously been localised w ithin tumours.
Since the results  of the studies described in th is  chapter were 
published (Reid, Thompson & Kay, 1983; Reid & Kay, 1983; Reid, V a l le r  & 
Kay, 1985; Reid, V a l le r  & Kay, 1986), they have been confirmed by 
Stemmermann, Samloff & Hayashi (1985), who in a series of 64 gastr ic  
carcinomas found pepsinogen in 3.1% and progastricsin in 29.7% of cases. 
In the in te s t in a l  types pepsinogen was found in 4.5% and progastricsin  
in  36.3%, whereas in the d iffuse  types pepsinogen was found in none and 
progastricsin  in  15%.
Busby-Earle, Williams & P ir is  (1986) also found both zymogens in  
both in te s t in a l  and d iffuse  types of carcinoma, but th e i r  anti serum to  
pepsinogen labe lled  a higher proportion of carcinomas (75%) than t h e i r  
an tip rogastr ics in  (22%). The reason fo r  the discrepancy is not c le a r  
but differences in antibody a v id ity  and the p o s s ib i l i ty  of d iffus ion  
could be part of the explanation.
I t  has been suggested that the presence of progastricsin indicates  
a higher degree of malignancy, as i t  correlates with the depth of  
invasion of the gas tr ic  wall and with the presence of lymph node 
metastases (Fiocca et a l , 1987).
In the present study, SMP was found in a higher proportion of 
gastr ic  carcinomas than were pepsinogen and progastrics in . This is in  
accord with the results  of a recent study of 74 gastr ic  carcinomas, in  
which SMP was found in  54%, compared with progastricsin in  31% and 
pepsinogen in 5% (Shira ish i et a l , 1987). In the same study i t  was 
found that some cancer ce l ls  expressed both SMP and progastrics in ,  
unlike normal gastr ic  mucosal c e l ls ,  none of which express both 
enzymes.
A low pepsinogen concentration (*20 ng/ml) in the serum was found 
in about a th ird  of Japanese men with gastr ic  cancer and in only 6.3% of  
controls and i t  has been suggested that i t  is a useful subclinical 
marker of increased r isk  (Nomura, Stemmermann and & Samloff, 1980). The
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serum pepsinogen to gas tr ics in  r a t io  was of greater p red ic t iv e  value,  
although i t  detected mainly advanced carcinoma and was of l i t t l e  value 
in detecting ear ly  gastr ic  cancer (Stemmermann et a l , 1987). Whether or 
not SMP has c l in ic a l  s ignificance remains to be determined.
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CHAPTER 9
PROGASTRICSIN IN CARCINOMA OF PROSTATE
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INTRODUCTION
The enzyme acid phosphatase is  produced by normal p ro s ta t ic  ac inar  
epithelium . When carcinoma develops in the p rosta te , the malignant 
ce lls  also secrete th is  enzyme (Jobsis et a l , 1978), o ften in  such large  
amounts tha t the serum level is ra ised . As demonstrated in Chapter 5, 
the normal p rosta tic  epithelium also contains progastr ics in  and i t  might 
be expected th a t  th is  zymogen would also be found in carcinomas a r is in g  
in prostate. This p o s s ib i l i ty  is  supported by the demonstration 
(Chapter 8) th a t  progastricsin  is found not only in normal gas tr ic  
mucosa but also in carcinomas of the stomach. A series of cases of 
prosta tic  carcinoma was there fore  studied in order to determine whether 
progastricsin could be demonstrated in the malignant e p i th e l ia l  c e l ls .
1*lO
MATERIALS AND METHODS 
Anti sera
Rabbit antisera to human pepsin, gastr ics in  and prostatic  acid 
phosphatase were used in the peroxidase-anti peroxidase method with
controls as described in Chapter 5.
Tissues
F i f ty - fo u r  cases of prostatic  adenocarcinoma from the routine  
surgical histology f i l e s  of the Pathology Department, Glasgow Royal 
In firm ary were studied. In 44 cases the prostate had been removed by 
transurethral resection and in the remaining 10, by suprapubic 
enucleation.
Nine o f the carcinomas were fu r th e r  studied by la b e ll in g  a lte rn ate  
seria l sections with rabb it antisera to progastricsin and to prostatic  
acid phosphatase (Miles Laboratories L im ited). Sections were examined 
with a comparison microscope and the d is tr ib u t io n  of the two enzymes was 
compared.
The s p e c if ic i ty  of the immune la b e l l in g  was studied as before
(Chapter 5 ) ,  12 cases of prostatic carcinoma being examined.
Twenty-four prostatic  carcinomas were also labe lled  with rabbit  
a n t i -p ig  pepsin.
With a l l  staining runs a section of normal gastr ic  body mucosa was 
included as a positive control for progastricsin or pepsinogen. The 
sections o f prostate being examined fo r  the presence o f acid phosphatase 
served as th e i r  own contro l.
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RESULTS
Progastricsin was id e n t i f ie d  in the cytoplasm of the malignant 
c e l ls  in  21 (39%) of the 54 cases of prostatic  carcinoma studied. As in 
gastr ic  carcinomas, progastricsin was present fo c a l ly ,  the number o f  
positive  c e l ls  varying from a few in some cases to many in others.  
Despite i t s  focal d is t r ib u t io n ,  la b e l l in g ,  where present, was always 
intense (Fig 9 .1 ) .  All pos itive tumours included at least some areas 
with a microacinar pattern , typical of p rosta tic  carcinoma (Fig 9 .2 ) .
In 9 cases there were und iffe ren tia ted  areas; in  4 of these cases 
progastricsin tended to be in the less well d i f fe re n t ia te d  areas (Fig  
9 .3 ) ,  but in the other 5 cases no such tendency was noted.
The 9 p rosta tic  carcinomas in which progastricsin  was most 
extensive were also labe lled  for acid phosphatase. In a l l  9 cases there  
was strong la b e l l in g  fo r  acid phosphatase in most of the tumour c e l ls .  
Comparison microscopy of seria l sections labe lled  a l te rn a te ly  fo r  
progastricsin and acid phosphatase showed that most c e l ls  which 
contained progastricsin also contained acid phosphatase but that many 
ce lls  contained acid phosphatase but not progastrics in .
FIG. 9 .1 a ) Progastrics in  in moderately d i f fe re n t ia te d  adeno­
carcinoma of prostate . There is strong but focal 
la b e l l in g  o f neoplastic epithelium .
Labelled with a n t ig a s tr ic s in ,  PAP method. x210.
b) High power of area of Fig. 9 .1 (a )  showing granula 
la b e l l in g  of the cytoplasm in some malignant c e l l
Labelled with a n t ig a s tr ic s in ,  PAP method. x540.
Cr*.,
FIG. 9.2 Progastrics’i n fo c a l ly  d is tr ib u te d  in moderately 
d i f fe re n t ia te d  adenocarcinoma of prostate .
Labelled with a n t ig a s tr ic s in ,  PAP method. x470.
FIG. 9 .3  Progastricsin  in poorly d i f fe r e n t ia te d  pros ta t ic  
carcinoma. Some malignant c e l ls  (arrows) are 
negative.
Labelled with a n t ig a s t r ic s in ,  PAP method. x210.
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DISCUSSION
The results confirm the hypothesis that progastricsin production by 
the normal prostatic epithelium is reproduced in prostatic carcinomas. 
Sim ila r  arguments apply to the foca lity  of labelling as in the case of 
gastr ic  carcinoma (Chapter 8 ) .  The fa ilu re  to detect progastricsin in 
60% of prostatic  tumours could be because the PAP technique was 
in s u f f ic ie n t ly  sensitive to enable low in trace llu la r  levels to be 
demonstrated. However, i t  is more l ik e ly  that these tumours do not 
produce the zymogen. This could be because they arise from cells which 
do not normally produce progastricsin. Recent work (Reese et a l , 1987) 
suggests that progastricsin may be produced mainly in the central zone 
of the normal prostate and carcinomas arising peripherally might, on 
th is  basis, be postulated to be progastricsin negative. Studies have 
not yet been carried out to determine whether this is the case.
Although in principle progastricsin might be a useful marker of 
prostatic  carcinoma, in practice this is for a number of reasons 
u n lik e ly .  F i r s t ly ,  immune labelling of carcinomas for prostatic acid 
phosphatase is well established as being both specific and sensitive in 
ind icating  th e ir  prostatic origin (Jobsis et a l , 1978). Progastricsin 
la b e ll in g  might complement but is unlikely to replace such a useful 
diagnostic te s t .  Secondly, metastatic gastric carcinoma would have to 
be excluded. While raised serum levels of progastricsin might indicate 
production by a prostatic malignancy, the usefulness of this would be 
mitigated by the presence of raised or lowered levels due to gastritis  
(Samloff et a l , 1982) as well as to gastric carcinoma. Further work has
not so fa r  been undertaken in this f ie ld .
At present the most l ike ly  practical application the results 
described in th is  chapter might have appears to be that i f  a deposit of 
metastatic adenocarcinoma contained progastricsin, a primary in prostate 
would have to be excluded before the presence of a gastric primary could 
be stated with confidence. This w ill  be more fu l ly  discussed in Chapter 
11.
CHAPTER 10
ASPARTIC PROTEINASES IN PRIMARY MALIGNANT TUMOURS
OTHER THAN STOMACH AND PROSTATE
INTRODUCTION
I t  has been shown in Chapters 8 and 9 that pepsinogen and 
progastricsin occur in malignant tumours arising from the tissues in 
which the zymogens are produced normally. Renin is known to be present 
in malignant neoplasms of the kidney (Lindop & Fleming, 1984). I t  has 
not, however, been demonstrated that production of these enzymes or 
zymogens is confined to tumours of these sites. Cathepsin D and SMP, 
on the other hand, are normally widely distributed in the body and 
th e i r  presence might be anticipated in a variety of tumours.
In the present study, pepsinogen, progastricsin, cathepsin D and 
SMP were localised by the immunoperoxidase method in a variety of 
neoplasms.
The d is tr ibu tio n  of cathepsin D was compared with that of 
lysozyme.
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MATERIALS AND METHODS 
Anti sera
Anti sera to pepsin, gastricsin, cathepsin D and SMP were used in 
PAP method as described in Chapter 3.
Ti ssues
Adenocarcinomas from the following sites were studied for the 
presence of aspartic proteinases as follows, the number of cases being 
given in brackets:
Pepsinogen - colon (21), breast (18), endometrium (16), ovary (20),  
gall bladder (1 ) ,  b ile  duct (2) and pancreas (14). 
Progastricsin -  colon (31), breast (18), endometrium (16), ovary (14), 
b i le  duct (2 ) ,  pancreas (22). Serial sections of selected 
cases of pancreatic carcinoma were examined for progastricsin 
and pepsinogen.
Cathepsin D - colon (6 ) ,  breast (6 ) ,  ovary (6 ) ,  pancreas (2 ) ,
kidney (5 ) .  Other tumours examined were: carcinoma of bladder
(8 ) ,  squamous carcinoma of bronchus (8) and skin (5 ),  various 
soft tissue sarcomas (5 ) ,  Hodgkin's (5) and non-Hodgkin's (9) 
lymphoma. Some benign tumours, namely
dermatofibroma (2) and breast fibroadenomas (5 ),  were also 
examined.
Six of the carcinomas of colon studied for cathepsin D were 
also labelled for lysozyme.
SMP -  colon (16), breast (9 ) ,  endometrium (10), ovary (9 ) ,  prostate
( 9 ) ,  kidney (6 ) .  Other tumours examined were carcinoma of 
lung, both squamous (7) and undifferentiated (6 ), Hodgkin's 
lymphoma (6) and a selection of non-Hodgkin's lymphomas (9 ).
Absorption controls were performed on selected strongly positive 
cases. Antigastricsin  was pre-incubated with gastricsin as previously 
described (Chapter 3 ) .  Anticathepsin D at 1 : 200 was pre-incubated 
fo r  1 hr at room temperature with a d ifferent preparation of cathepsin 
D (1 mg/ml), kindly supplied by Dr. A.J. Barratt, Strangeways 
Laboratory, Cambridge. The d ilu tion  of anti serum was higher than in 
the rest of the study to economise on antigen.
RESULTS
Pepsinogen
There was no evidence of pepsinogen in the carcinomas studied, 
except one case of pancreatic carcinoma, in which there was focal 
strong lab e ll in g  of the tumour ce lls .
Progastricsin
Two cases of pancreatic carcinoma were considered to show defin ite  
evidence of progastricsin in the malignant cells  (Fig. 10.1). One of 
these was the case referred to above, in which pepsinogen was detected 
in some of the progastricsin-containing ce lls .  Two additional cases 
appeared to show staining; i t  was considered that this might be a 
resu lt  of d iffusion from the overlying duodenal lumen, but similar 
sections labelled with antipepsin showed no sign of pepsinogen (Fig. 
10.1a and b). One papillary tumour, probably of the ampulla of Vater, 
was also positive . One breast carcinoma showed strong reactiv ity  in 
the cytoplasm of the malignant cells  (Fig. 10.2). An absorption 
control in the la t t e r  case showed complete abolition of staining 
following pre-incubation of antigastricsin with gastricsin.
Cathepsin D
Carcinomas from colon, breast, ovary, kidney, bladder and pancreas 
a ll  contained cathepsin D in neoplastic or stromal ce lls , or in both 
types, the predominance varying considerably from case to case (Fig.
10.3 and 1 0 .4 ) .  Antilysozyme labelled the stromal cells of colonic 
carcinoma, although the neoplastic ep ithelia l cells were negative.
Squamous carcinomas of bronchus showed labelling of only 
occasional tumour c e l ls ,  although in some cases staining was widespread 
(F ig . 10.5JL The connective tissue, however, showed strong labelling of 
macrophages as did the adjacent lung. Squamous carcinomas of skin
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showed la b e ll in g  of only occasional tumour cells  and some stromal 
c e l ls .  The malignant connective tissue tumours were generally negative 
with la b e ll in g  of only focal cells  in one case. One of the two 
dermatofibromas showed a strongly positive reaction, apparently with 
histiocytes; the other was negative. Two of the breast fibroadenomas 
were positive with labe lling  of very occasional glands in each.
Malignant lymphomas
All lymphomas, except one case of non-Hodgkin's lymphoma, showed 
strong cytoplasmic re a c t iv i ty ,  mainly in large cells  scattered 
throughout the tumour. In one case of lymphocyte dominant Hodgkin's 
disease some of the cells  in the granulomas seemed to contain cathepsin 
D, although the rest of the tumour tissue was negative (Figs.
10.6- 10.8) .
Controls
At a d i lu t io n  of 1/200, higher than that used for the rest of the 
study, the anticathepsin D s t i l l  gave strong labelling in all the 
selected cases studied. The labelling of most cells  was abolished, or 
in the most strongly positive c e l ls ,  considerably reduced by 
pre-incubation of antiserum with cathepsin D.
SMP
There was equivocal staining in one case of colonic carcinoma and 
weak superfic ia l staining in 5 others. Staining was cytoplasmic and 
not c le a r ly  granular. One carcinoma of ovary was positive and 3 others 
weakly so. Breast carcinomas were in 2 cases focally positive. Three 
renal carcinomas were strongly positive (Fig. 10.9), but i t  was noted 
that th is  was p a rt icu la rly  prominent adjacent to areas of haemorrhage. 
The lung carcinomas were not convincingly positive. The Hodgkin s
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lymphomas were negative, but in 2 cases there was intense labe lling  of 
plasma c e l ls .  The non-Hodgkin's lymphomas were likewise negative, but 
in 1 case there was strong lab e llin g  of some plasma c e l ls .
FIG. 10.1 P a p il la ry  carcinoma of pancreas projecting into  duodenal 
1 umen
a) Progastricsin  in tumour c e l ls .
A n tig a s tr ic s in ,  PAP method. x42.
b) Absence of pepsinogen from s im ila r  f i e l d  to  a ) .  
Anti human pepsin, PAP method. x42.
t . i  ' I  - <i 'j• ’ ( I ! - /
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FIG. 10.2 Progastricsin  in scirrhous carcinoma of breast.  
A n tig a s tr ic s in ,  PAP method. x420.
FIG. 10.3 Cathepsin D in adenocarcinoma of colon, in th is  case 
mainly in the stromal c e l l s ,  most of the tumour ac in i  
being negative.
PAP method. x350.
FIG. 10.4 Cathepsin D i n  breast carcinoma. The enzyme is present 
both in the invasive carcinoma (C) and in macrophages 
(M) in the lumen of a normal breast duct.
PAP method. x l55 .

FIG. 10.5 Cathepsin D in  squamous carcinoma of bronchus. There is 
granular la b e l l in g  of the cytoplasm of the tumour c e l ls  
( l e f t ) ,  while the polymorphs ( r ig h t )  are unlabelled .
PAP method. x508.
FIG. 10.6 Cathepsin D in malignant lymphoma (d if fu s e  
c e n tr o b la s t ic ) .
PAP method. x l l 5 .
FIG. 10.7 Cathepsin D in  h is t io c y t ic  c e l ls  o f L & H Hodgkin's 
disease.
PAP method. x !15.

FIG. 10.8 Cathepsin D in  nodular sclerosing Hodgkin's disease.
The enzyme appears to  be mainly in the cytoplasm of 
large c e l ls .
PAP method. x324.
FIG. 10.9 SMP in  carcinoma of kidney. Although there is  la b e l l in g  
of tumour c e l ls  (C ) ,  there are large numbers o f adjacent 
red blood c e l ls  (B) containing SMP. (Compare F ig .
6 .1 3 ) .
PAP method. x508.

150
DISCUSSION
Pepsinogen appears to be se lec t ive ly  present in carcinomas only of 
the stomach. Progastricsin, on the other hand, is produced by 
carcinomas of prostate (Chapter 9) and, less frequently , pancreas and 
sporadically , breast. Cathepsin D, however, appears to be present in 
most i f  not a l l  tumours studied and may be a re f le c t io n  of metabolic 
a c t iv i t y ,  of which lysosomal degradation of proteins is part. I t  has, 
th ere fo re , no s p e c if ic ity  as a tumour marker. Cathepsin D has been 
postulated to have a ro le  in producing cachexia, possibly by enhancing 
proteolysis in muscle and other tissues (Greenbaum & Sutherland, 1983). 
This e f fe c t  has been inh ib ited  in animals by the aspartic proteinase 
in h ib ito r  pepstatin , probably at the lysosomal le v e l ,  although i t  is 
possible that increased production by the neoplasm i t s e l f  could have a 
ro le .
Caution is required in in terp re ta tion  of the SMP resu lts . One 
problem is the presence of SMP in red blood cell membranes (Chapter 3 ) .  
There was c lear  evidence of surface p o s it iv ity  in ce lls  which were in 
contact with red blood ce l ls  (F ig . 6 .1 3 ) ,  and i t  is possible that 
d iffus ion  could explain some of the positive resu lts . Absorption 
controls have not been performed fo r  SMP because a s u f f ic ie n t ly  large  
supply of pure enzyme was not available to us. This would not, 
however, overcome the p o s s ib il i ty  of d iffusion e ither from red blood 
c e l ls ,  or from in tes tina l contents into the surface of colonic 
carcinomas. Perfusion-fixation  of tissues might help exclude the 
p o s s ib i l i ty  of d iffus ion .
While there appears to be no published evidence of aspartic 
proteinases in other malignant tumours, there has been 
immunoelectrophoretic evidence of aspartic proteinases in benign 
tumours of the ovary (Hirsch-Marie et a l , 1978). Pepsinogen (P G I- II  in
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the authors' terminology: see Chapter 1) was found in four cases, 
progastricsin (P G III)  in f iv e  and SMP in three , combinations being 
present in several cases. The terminology of the ovarian tumours is  
not c lear but i t  appears that none of the carcinomas were pos it ive .  
Immunohistological confirmation of th is  work would be worthwhile.
CHAPTER 11
DETECTION OF PROGASTRICSIN IN METASTATIC ADENOCARCINOMA
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INTRODUCTION
I t  has been demonstrated previously (Chapter 8) that progastricsin  
occurs in the neoplastic e p ith e l ia l  ce l ls  of carcinomas of stomach and 
prostate, less commonly pancreas and only rare ly  in primary tumours of 
other s i te s .  I t  thus appears to be a re la t iv e ly  specif ic  marker for  
tumours of these tissues. However, any diagnostic value progastricsin  
might have in routine histopathology would be increased i f  i t  could be 
demonstrated that i t  was also present in metastases from primary tumours 
of these but not other s ite s .  In th is  chapter two studies are 
described. The f i r s t  was undertaken in order to determine whether 
progastricsin was present in the regional lymph nodes of gastrectomy 
specimens in which the primary carcinoma contained progastricsin; th is  
study was undertaken i n i t i a l l y  on cases in Glasgow and la te r  on cases in 
Leeds. The second study was conducted in order to establish whether 
progastricsin was present in metastatic adenocarcinomatous deposits and, 
i f  so, to determine whether the primary neoplasm was in stomach or some 
other s i te .
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MATERIALS AND METHODS 
Anti serum
Rabbit an t ig as tr ic  gastricsin  was used in both parts of the study 
on metastatic carcinoma. In the f i r s t  part ,  which deals with local 
lymph node metastases of primary gastric  carcinoma, the antiserum was 
used at 1:100 in the PAP method as previously (Chapter 3 ) ,  while in the 
second part ,  which concerns widespread metastases, i t  was used at 1:1000 
in the immunogold-silver (I6SS) method. Normal gastric  mucosa served as 
a positive control in a l l  staining runs.
Immunogold-silver method (IGSS)
The method used was that published previously (Holgate et a l ,
1986). T i t ra t io n  experiments showed that the primary antiserum gave 
strong la b e ll in g  of normal gastric body mucosa at a l l  d i lu t ions  down to 
1:1000.
Controls
Blocking controls were performed on selected cases as before 
(Chapter 3 ) .
Cases studied
1. Local lymph node metastases of gastric  carcinoma
In the study above (Chapter 8) the neoplastic e p ith e l ia l  ce lls  of 
33 cases of gastric  carcinoma were found to contain progastricsin. In 
12 of these cases the gastrectomy specimen included metastatic tumour in  
local lymph nodes, the to ta l number of involved nodes being 36.
Sections of these were labelled with an tigastr ics in  by the PAP method. 
T h ir ty - f iv e  lymph node metastases from 14 cases of colonic carcinoma and 
15 such deposits from 7 cases of breast carcinoma were also examined for  
progastricsin .
155
In a s im ila r  but separate study at Leeds General In firm ary,  
sections of local lymph node metastases of 26 progastricsin-containing  
gastric  carcinomas (Chapter 8) were labelled for progastricsin, also by 
the PAP method.
2. Widespread lymph node and l iv e r  metastases from various primary 
carcinomas
Cases of metastatic adenocarcinoma in lymph nodes and l iv e r  
were selected from the biopsy f i l e s  of the Pathology Department, Leeds 
General In firm ary . The records of each case were examined and the 
following information was extracted:
a) the s i te  of the primary carcinoma,
b) the s i te  of the metastasis and
c) whether the metastasis was diagnosed before, a f te r  or at the same
time as the primary tumour.
In addition , in a l l  cases where the metastasis contained 
progastricsin and the primary tumour was non-gastric, at least one o f  
any blocks ava ilab le  from the primary was labelled fo r progastricsin by 
the IGSS and PAP methods.
S ta t is t ic a l  analysis
The Chi-square tes t with Yates* correction was used in analysis of 
the re s u lts .
RESULTS
1« Local lymph node metastases of gastric  carcinomas
Twenty-eight of the 36 lymph nodes containing secondary gastric  
carcinoma labe lled  fo ca lly  fo r  progastricsin in the tumour ce l ls  (10 out 
of 12 cases) (Figs 1 1 .1 -1 1 .3 ) .  The single metastasis from 1 breast 
carcinoma was strongly positive (1 out of 15 nodes) (Fig 11 .4 ) .  None of  
the 35 lymph node secondaries from colonic carcinoma (14 cases) were 
pos it ive .
The results in the Leeds cases were s im ila r .  In each of the 25 
cases of progastricsin positive gastric  carcinoma, at least 1 lymph node 
secondary was pos it ive . Altogether 50 (76%) of 66 lymph nodes contained 
progastricsin positive carcinomas.
2. Widespread lymph node and l iv e r  metastases from primary carcinomas 
of various sites
The results are summarised in Table 11.1. The results of 
s ta t is t ic a l  analysis are presented in Table 11.2. The figures show 
examples of progastricsin in metastatic carcinomas in lymph nodes from a 
primary in breast (Fig 11.4) and in l iv e r  from primaries in stomach (Fig
11.5) and breast (Fig 1 1 .6 ) .
Blocks of the non-gastric primary tumours were available  in the 
f i l e s  in  4 cases in which there was a progastricsin-containing  
metastasis in lymph nodes and in 5 where there was one in l iv e r .  In the 
former group the primary was in breast (2 ) ,  uterus (1) and lung (1) and 
in the l a t t e r  group, breast (1 ) ,  colorectum (2 ) ,  and ampulla of Vater 
(1 ) .  In none of these primary carcinomas was progastricsin  
demonstrated, e i th e r  by the IGSS or PAP method.
FIG. 11.1 Progastricsin  in m etastatic deposit of carcinoma in 
local lymph node in extraserosal fa t  of gastrectomy 
specimen.
A n tig a s tr ic s in ,  PAP method. x250.
FIG. 11.2 Progastricsin  in local lymph node metastasis of g as tr ic  
carcinoma.
A n tig a s tr ic s in ,  IGSS method. x47.
FIG. 11.3 High power of 11.2 showing progastricsin  in tumour 
a c in i .
A n tig a s tr ic s in ,  IGSS method. x288.

FIG. 11.4 Progastricsin  in m etastatic deposit of adenocarcinoma in 
a x i l la r y  lymph node from primary in breast. 
A n tig as tr ic s in ,  IGSS method. x288.
FIG. 11.5 Progastricsin  in l iv e r  metastasis from primary g as tr ic  
carcinoma. Histology is not ava ilab le  from the primary, 
which was not resected, but there was a large f i l l i n g  
defect in the stomach on barium meal.
A n tig a s tr ic s in ,  IGSS method. x l90 .
FIG. 11.6 Progastricsin  in l i v e r  metastasis from primary carcinoma 
of breast. A small deposit in the adrenal was also 
pos it ive  in th is  case but the primary in breast was 
negative.
A n tig a s tr ic s in ,  IGSS method. x288.
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DISCUSSION
I t  can be seen that progastricsin-containing metastases in lymph 
nodes are s ig n if ic a n t ly  more l ik e ly  to come from a primary in stomach or 
prostate than in other s i te s .  The results fo r  metastases in abdominal 
lymph nodes only do not reach significance and metastases in l iv e r  do 
not s ig n if ic a n t ly  corre late  with a primary in stomach or in stomach and 
pancreas together.
In a general hosp ita l,  7-10% of patients with h is to lo g ic a lly  
confirmed metastatic tumour have no evidence of a primary malignancy 
(Stewart et a l , 1979; T a t te r s a l l ,  1987). This does not preclude therapy 
(Greco, Vaughn & Hainsworth, 1986), although i t  is important that  
tre a ta b le  cancer be excluded. Investigation of the patient should, 
however, be minimised (Stewart et a l , 1979; Altman & Cadman, 1986; Simon 
& Bartucc i, 1986). Immunohistochemical study now allows d iagnostically  
d i f f i c u l t  malignancies to be c lass if ied  into carcinoma, lymphoma or 
other type in 93% of cases (Gatter et a l , 1985). Currently the s i te  of a 
carcinoma cannot generally be fu r th e r  specified from histology or 
immunohistochemistry. I t  appears from the results of the present study 
that the demonstration of progastricsin in lymph nodes allows the 
presence of a primary in stomach and prostate to be suggested. Five out 
of 17 gastric  metastases in l iv e r  were id e n t i f ie d ,  but th is  was not 
s t a t is t ic a l ly  s ig n if ican t as metastases from each of a varie ty  of 
primary s ites were also sometimes pos it ive . I t  may be noted that both 
cases of metastatic prostatic  carcinoma in lymph nodes were 
progastricsin pos it ive . In practice a primary in prostate could be 
diagnosed by c l in ic a l  examination or by demonstration of acid 
phosphatase in the metastasis.
The presence of progastricsin in metastases from non-gastric 
primaries is also of in te re s t .  I t  has already been shown (Chapter 10) 
that progastricsin is not found in such primary s ite s ,  apart from
pancreas and one breast. In the present study, progastricsin could not 
be convincingly demonstrated in any of the primaries studied, even 
though i t  was present in occasional metastases of carcinomas from 
breast, lung, colorectum, thyro id , uterus and ampulla of Vater in 
addition to pancreas. The explanation could f i r s t l y  be a cross-reaction  
of the antibody with some tissue component. Secondly, there could 
genuinely be progastricsin production by the tumour c e l ls ,  presumably 
because i t s  gene is switched on.
F in a l ly ,  progastricsin was demonstrated in 10 out of 54 metastases 
from unknown primaries. No conclusions have been drawn from th is  
observation, as the probab il ity  of the primary being undetected is  
l i k e ly  to  be influenced by i ts  s i te ,  but i t  could well be that some or 
a l l  of these primaries were in the stomach or, perhaps, prostate.
CHAPTER 12 
FUTURE STUDIES
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As a resu lt  of the work described in th is  th es is ,  four aspartic  
proteinases have been localised in normal tissues and in a varie ty  of 
neoplasms. The re la t iv e  s p e c if ic i ty  of pepsinogen and progastricsin  
and, possibly, SMP fo r  carcinomas of stomach suggest a number of fu rther  
l ines  of enquiry and some possible applications. I f  a para ff in  section 
of a given metastatic adenocarcinoma is found to contain progastricsin,  
a gastr ic  o rig in  may be suggested with about 50% like lihood  of being 
correc t. This may be of value to the diagnostic histopathologist in the 
biopsy room. The p o s s ib il i ty  of a s im ila r  application fo r  SMP is  
currently  under investigation and i t  may be that a panel of antibodies 
would y ie ld  higher s p e c if ic ity  and s e le c t iv i ty .
Tumour-specific antigens may have diagnostic uses in c l in ic a l  
practice . The serum levels  of the aspartic proteinases have been 
studied, but do not appear to re f le c t  the presence or amount of a 
tumour, as the e f fe c t  of g a s tr i t is  overwhelms the e f fe c t  of zymogen 
production by tumour (see Chapter 3 ) .  Radiological loca lisa tion  of 
tumour, however, may be possible. For example, rad io labelled  monoclonal 
antibody to the oncogene protein p62c“myc has been used to localise  
lung tumours on scans (Chan et a l , 1986). The protein is not on the 
cell membrane but in the nucleus and is assumed to be released by 
necrotic tumour c e l ls .  Such an application for antibodies to aspartic  
proteinases could be explored, despite the in t ra c e l lu la r  location of the 
zymogens. S im ila r ly ,  a therapeutic ro le ,  by drug ta rgetting  with 
monoclonal antibodies to aspartic proteinases could be postulated 
(Embleton, 1987).
The biological ro le  of aspartic proteinases is also under 
investigation . The function of SMP, or cathepsin E as i t  now appears to  
be, is completely unknown and requires fu r th e r  study.
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Recently, aspartic  proteinases have been found in a rather  
unexpected s i te ,  namely in retroviruses such as Human Immunodeficiency 
Virus (H IV ),  Type I (Kay et a l , 1987). A re tro v ira l  proteinase, which 
processes the £ac[ polyprotein into  i ts  separate core proteins, contains 
the sequence Asp-Thr-Gly, which is conserved in aspartic  proteinases 
(F ig . 1 .1 ) .  Study of a model of the £ol  ^ proteinase of HIV I by 
pattern -recogn ition , structure prediction and molecular modelling 
techniques, suggests that the v ira l  proteinase corresponds to a single  
aspartic  proteinase domain, which may be active as a dimer (Pearl & 
Taylor, 1987). Furthermore, the proteinase a c t iv i ty  of three  
retroviruses has been inh ib ited  by pepstatin (Katch et a l , 1987). 
Cathepsin D has previously been located in h isto log ical sections with 
b io t in -1abe lled  pepstatin (Matthews et a l , 1981) and s im ilar  
lo c a lis a t io n  of retroviruses might be conceivable. However, any future  
treatment of re trov irus  in fection  such as AIDS with aspartic proteinase 
in h ib ito rs  would have to take into account the e f fe c t  on normal ce lls  in 
which aspartic  proteinases have been demonstrated, as described in th is  
th es is .
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